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"Pooh, promise me you won't forget about me, ever. 
Not even when I am a hundred." 
Pooh thought for a little. 
"How old shall I be then?" 
"Ninety-nine." 
Pooh nodded. "I promise," he said. 
 
A.A. Milne 
The House at Pooh Corner
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Abstract  
Cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is one of the most common forms of hereditary 
vascular dementia (VaD).  Characterised by early-onset strokes and cognitive 
impairment in the absence of vascular risk factors, CADASIL is an ideal model to 
understand the pathophysiology of VaD. Pathogenic mutations in the NOTCH3 gene, 
which encodes a single-pass transmembrane cell surface receptor expressed 
predominantly in vascular smooth muscle cells (VSMC), cause severe vascular 
alterations including VSMC degeneration, hyalinosis, deposition of CADASIL-specific 
granular osmiophilic material (GOM) and white matter (WM) changes. While these 
changes have been well-described, their causative mechanism or difference between 
sporadic VaD is poorly understood. The aim of the project was to quantitatively 
characterise various aspects of cerebral pathology of CADASIL in order to reveal the 
pathological basis of CADASIL phenotypes, especially of cognitive dysfunction.  
Firstly, we assessed vascular and perivascular changes in CADASIL brain areas and 
found significant vessel wall thickening and perivascular space enlargement, even 
compared to sporadic VaD. Secondly, by using immunogold electron microscopy, 
NOTCH3 extracellular domain (N3ECD) was located within GOM in the wall of 
cerebral arteries/arterioles/capillaries, establishing at least one component of GOM and 
its wide-spread existence in the vasculature. This study also suggested the possible 
existence of intracellular N3ECD accumulation and involvement of inflammatory 
response in the pathogenesis of CADASIL. Finally, we provide neuronal density data 
from the hippocampal formation in CADASIL brains to identify the neural substrates of 
VaD in CADASIL. Overall, the number of neurons in CA1, CA2 and entorhinal cortex 
was relatively spared in CADASIL while pyramidal neuronal subpopulation, as shown 
by SMI32 immunoreactivity, was slightly decreased. In addition, SMI32 staining 
revealed extensive chronic damage to WM tracts, especially those in the frontal-parietal 
area. These data suggest that vascular dysfunction and inflammation result in frontal 
disconnection, which could underlie cognitive impairment in CADASIL patients.  
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Chapter 1.  Introduction 
1.1 Introduction 
Cerebrovascular disease is not only one of the major causes of death in many developed 
countries, but is also a principle cause of dementia and disability. Vascular dementia 
(VaD), Alzheimer‘s disease (AD) and dementia with Lewy bodies (DLB) are the most 
common forms of dementia. In the past, they were considered three different diseases of 
old age unconnected in terms of pathogenesis, but it is now widely accepted that ‗pure‘ 
VaD, AD or DLB are rare and they usually coexist to a varying extent. Of all the factors 
affecting their pathology, vascular abnormalities and their effects on brain are attracting 
considerable attention from researchers as the involvement of neurovascular 
dysfunction in AD pathology is becoming more clear (Bell and Zlokovic, 2009). In 
1997, Snowdon et al. (1997) reported an interesting observation from the nun study; 
those who have experienced lacunar infarcts in the basal ganglia, thalamus, or deep 
white matter have higher risk and severity of AD, suggesting the interaction between 
VaD and AD. Subsequent studies have also supported this result (Heyman et al., 1998, 
Esiri et al., 1999), and at the same time, helped to characterize clinical and pathological 
differences and resemblances of VaD and AD. While the need to understand VaD has 
been increasing, most VaD cases are sporadic and thus difficult to study due to their 
heterogeneous pathogenesis: age, hypertension, diabetes, smoking, cardiovascular 
disease, hypercholesterolemia and other risk factors create varying pathologies, 
obscuring the pure effect of vascular abnormalities (Román, 2004).  Given these 
circumstances, studies on the pathology of recently widely recognised familial type of 
VaD, cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) could have significant implications in understanding 
the pathogenesis of cerebrovascular disease and dementia.   
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1.1.1 Vascular dementia and small vessel disease 
VaD is defined as cognitive dysfunction as a result of cerebral infarcts, haemorrhages, 
and white-matter changes due to cerebrovascular diseases (Román et al., 1993). Due to 
its nature, VaD develops suddenly or gradually, and often (though with exceptions) 
progresses in a slow and stepwise manner as patients experience repeated ischemic 
events while AD always develops and progresses gradually (Román, 2003, Fischer et al., 
1990). Diagnosis of VaD is affected by the criteria used, and of all the diagnosis criteria 
based on different definitions of VaD, National Institute of Neurological Disorders and 
Stroke-Association Internationale pour la Recherche et l’Enseignement en 
Neurosciences (NINDS-AIREN) (Román et al., 1993) is one of the most widely used 
criteria proposed mainly for research purposes. The criteria include 1) dementia: 
impaired memory and two or more impaired cognitive domains, 2) cerebrovascular 
disease demonstrated by neurological examination and neuroimaging, 3) a temporal link 
between stroke and dementia, 4) other clinical features consistent with probable VaD, 
and 5) features that make diagnosis of VaD uncertain. It should be noted that diagnosis 
of VaD is applicable only with the absence of other dementia-causing pathologies 
(Erkinjuntti, 1994). Their specificity for diagnosis of VaD is markedly high, but the 
sensitivity is low and thus many VaD patients can be misdiagnosed as other forms of 
dementia (Wetterling et al., 1996). 
VaD can be divided into two main subtypes by using blood vessel size: large-vessel 
(18%) and small-vessel dementia (74%) (Staekenborg et al., 2008). The large-vessel 
dementia, which is often acute-onset, occurs after multiple large-vessel or subcortical 
strokes, or after a single infarct in a strategic arterial location, such as right posterior 
cerebral artery, anterior cerebral artery, and left gyrus angularis (Román, 2003). Small-
vessel dementia, on the other hand, is caused by lacunar infarcts, microinfarcts, and 
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incomplete infarction in the white matter (WM). The underlying cause of these infarcts 
is cerebral small-vessel diseases (SVD), which can be subdivided into atherosclerosis 
type, cerebral amyloid angiopathy (CAA) type, hereditary non-CAA SVD (e.g. 
CADASIL), inflammatory and immunologically-mediated SVD (e.g. Wegener‘s 
granulomatosis) and venous collagenosis type (Pantoni, 2010). It has been suggested 
that SVD is deeply involved in the onset of VaD (Esiri et al., 1997).  
Cerebral (arterial) SVD is characterised by progressive pathological changes of 
intracerebral end-arteries and arterioles, such as hyalinosis, arteriosclerosis and fibroid 
necrosis, which cause occlusion, stenosis and loss of vascular reactivity, consequently 
promoting the incomplete infarcts and/or acute focal ischemia with complete tissue 
necrosis (lacunar infarcts) (Kalaria and Erkinjuntti, 2006, Pantoni, 2010). Blood-brain 
barrier (BBB) disruption, focal inflammation, and apoptosis of oligodendrocytes may 
also contribute to the development of cerebral pathology. Those brain pathologies 
usually manifest as gait disorder, articulation disorder, emotional disturbances and 
cognitive dysfunction (Schmidtke and Hüll, 2005). The cognitive dysfunction in SVD is 
often milder compared to that in AD, showing impaired frontal and subcortical 
functions (e.g. memory retrieval and attention/executive functions) with rather spared 
hippocampal functions (e.g. episodic and recognition memory) (Kertesz and Clydesdale, 
1994, Traykov et al., 2002). 
1.1.2 Familial small vessel diseases 
Hereditary cerebral SVD with an early onset of dementia was first described in a 
Swedish family in 1977 (Sourander and Walinder, 1977). The autosomal dominant 
disease, which is here referred to as ―Swedish VaD,‖ caused multiple small infarcts 
affecting central WM, grey matter (GM) and pons. In response to the report, Stevens et  
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Disorder 
Onset 
age 
Mutated 
gene 
Characteristic clinical features 
CADASIL 36.7 NOTCH3 
Migraine, stroke/TIA,  dementia,  mood disorder, 
WMH in temporal poles, frontal lobes, external 
capsules, periventricular WM 
Swedish VaD 34.6 ? 
Stroke, dementia, mood disorder , motor dysfunction, 
WMH  in basal ganglia and thalamus 
CARASIL 20-30 HTRA1 
Gait disturbance, scalp alopecia, lumbago, stroke, 
dementia and WMH in brain stem, middle cerebellar 
peduncle, external capsule 
PADMAL 36.7 ? 
Gait disturbance, dysarthria, mood disorder, dementia, 
WMH in brain stem and basal ganglia, pontine infarcts  
Portuguese-
French  SVD 
40-50 ? 
Motor hemiplesia, executive dysfunction, WMH in 
temporal lobes, internal capsules, periventricular WM 
HIHRATL 36.1 COL4A1 
Infantile hemiparesis, migraine, intracranial 
aneurysms, leukoaraiosis, subcortical microbleeds, 
lacunar infarcts,  
RVCL 30-40 TREX1 
Retinopathy, nephropathy, stroke, migraine, dysarthria, 
apraxia, stroke, dementia 
Table 1.1. Hereditary small vessel disease (SVD). CADASIL: cerebral autosomal 
dominant arteriopathy with subcortical infarcts and leukoencephalopathy, VaD: vascular 
dementia, CARASIL: cerebral autosomal recessive arteriopathy with subcortical infarcts 
and leukoencephalopathy, PADMAL: pontine autosomal dominant microangiopathy and 
leukoencephalopathy, HIHRATL: hereditary infantile hemiparesis, retinal arteriolar 
tortuosity and leukoencephalopathy, RVCL: retinal vasculopathy and cerebral 
leukodystrophy, WMH: white matter hyperintensities as seen on T2-weighted MRI. 
al. (1977) described a similar early-onset autosomal dominant SVD with recurrent 
cerebral ischemic episodes affecting basal ganglia, thalamus, corpus callosum and 
cerebral WM. The existence of hereditary VaD has been increasingly recognised since 
then. A French group also reported a family of early-onset stroke syndrome 
characterised by migraine attacks, leukoencephalopathy, subcortical infarcts and 
vascular smooth muscle cell (VSMC) degeneration (Baudrimont et al., 1993), which 
were later described as major clinical phenotypes of CADASIL (Chabriat et al., 1995). 
CADASIL was linked to mutations in the NOTCH3 gene (MIM# 600276) and 
distinguished from the Swedish VaD, which lacked the CADASIL-characteristic 
magnetic resonance imaging (MRI) WM hyperintensities and NOTCH3 mutations 
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(Joutel et al., 1996, Low et al., 2007). Several other CADASIL-like familial SVD have 
also been identified, including CARASIL (cerebral autosomal recessive arteriopathy 
with subcortical infarcts and leukoencephalopathy, or Maeda syndrome) (Fukutake, 
1999), PADMAL (pontine autosomal dominant microangiopathy and 
leukoencephalopathy) (Ding et al., 2010), Portuguese-French type familial SVD 
(Verreault et al., 2006), HIHRATL (Hereditary infantile hemiparesis, retinal arteriolar 
tortuosity, and leukoencephalopathy) (Vahedi et al., 2003), and RVCL (retinal 
vasculopathy and cerebral leukodystrophy) (Richards et al., 2007) (Table 1.1). Whilst 
they are not linked to NOTCH3 mutations, there may be similar underlying pathogenic 
mechanisms to those associated with CADASIL. 
1.2 NOTCH3 
1.2.1 Structures of NOTCH receptors and ligands 
The NOTCH gene family, which encodes relatively large single-pass transmembrane 
cell surface receptors, includes four homologues in mammals (NOTCH1-4). The four 
NOTCH homologues share the same basic structure comprising the extracellular 
domain (NECD, or amino (N)-terminal) consists of epidermal growth factor (EGF)-like 
repeats followed by 3 cysteine rich lin-12/Notch repeats and one trans-membrane 
domain, and an intracellular domain (ICD) which includes RAM (RBP-jκ-associated 
molecule) domain, cdc-10/ankyrin repeats and PEST (proline, glutamic acid, serine and 
threonine) sequence at the carboxyl (C)-terminal (Figure 1.1) (Bellavia et al., 2008). Of 
all the NOTCH homologues, NOTCH3 (UniProtKB/Swiss-Prot #Q9UM47), ~300kDa 
receptor comprised of 2321 amino acids, has a distinctively different structure compared 
to the others. NOTCH3 lacks the equivalent of EGF-repeat 21 and parts of EGF-2 and 3,  
resulting in only 34 EGF-repeats compared to 36 in NOTCH1 and 2 (Lardelli et al., 
1994). NOTCH3 ICD also shows significant differences, with higher amino acid  
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Figure 1.1. Structures of NOTCH homologues and Notch ligands. Red bars indicate 
regions significantly different from Notch1/2. LNR: lin/Notch repeats, TM: trans-membrane 
domain, RAM: RBP-jκ-associated molecule domain, ANK: cdc-10/ankyrin repeats, TAD: 
transactivation domain, PEST: proline, glutamic acid, serine and threonine sequence, NT: 
N-terminal domain, DSL: Delta-Serrate-Lag2 domain and CR: cysteine-rich region. 
identity and shorter TAD (transactivation domain), which could underlie the weak 
transactivation ability of NOTCH3 ICD (Bellavia et al., 2008). Moreover, a recent study 
claimed that EGF7-10 and 21-22 in NOTCH3 are involved in ligand binding as opposed 
to the commonly accepted EFG- repeat 10 and 11 (Peters et al., 2004, Lin et al., 2010), 
though its validity should be carefully evaluated Those structural differences may 
contribute to the functional differences between NOTCH homologues (Bellavia et al., 
2008). 
NOTCH receptor proteins regulate cell fates or control the ability of non-terminally 
differentiated cells, during development, to respond to proliferation and maturation 
signals via local cell interactions (Artavanis-Tsakonas et al., 1999). The four NOTCH 
receptors may interact with the DSL (Delta-Serrate-Lag2) family of ligands, Serrate-like 
(Jagged1 and 2) and Delta-like (Delta-like1, 3 and 4), or non-DSL ligands (e.g.  
F3/Contactin, DNER, MAGP-1/-2) to signal various downstream targets (Fortini, 2009). 
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The DSL domain, N-terminal domain and the first two of the multiple tandem EGF-
repeats in the extracellular domain are required for NOTCH receptor-ligand binding 
(Parks et al., 2006). Jagged1 and 2 contain twice as many EGF-repeats as Delta-like 
ligands and also specific cysteine-rich regions (CR) (D'Souza et al., 2008). The 
intracellular region of DSL ligands varies, but often contains C-terminal PDZ (PSD-
95/Dlg/ZO-1) ligand motif and multiple lysine residues (D'Souza et al., 2008). In 
VSMC, NOTCH3, Jagged1, NOTCH1 and Jagged2 are expressed (Hofmann and Iruela-
Arispe, 2007), the former two are down-regulated via the ERK pathway after vascular 
injury (Campos et al., 2002).  
1.2.2 Sequential regulations in Notch signalling pathway 
The activity of the NOTCH receptor is regulated by modification at EGF-repeats and 
also by a series of proteolytic processes (S1-4) mediated by three different proteases: 
furin-like convertase, a disintegrin and metalloprotease (ADAM 10) (Bozkulak and 
Weinmaster, 2009), and presenilin-dependent -secretase (Figure 1.2). NOTCH EGF-
repeats are first modified by O-fucosyltransferase-1 (O-FucT-1) in endoplasmic 
reticulum (ER). It glycosylates serine or threonine residues at consensus sequences of 
EGF repeats after binding, recognizing the sequences of the conserved cysteine residues 
that form disulphide bonds (Luo and Haltiwanger, 2005). Following the O-
glycosylation, some of the O-fucose residues are further glycosylated by an O-fucose-
β1,3-N-acetylglucosaminyltransferase called Fringe in the trans-Golgi network (Blair, 
2000, Rampal et al., 2005). The NOTCH heterodimer produced by the first S1 cleavage 
in the Golgi apparatus is presented on the plasma membrane to interact with 
Jagged/Delta at EGF-repeats 10-13 (Peters et al., 2004, Hambleton et al., 2004). The 
interaction triggers transendocytosis of ubiquitinated NECD-ligand complex by the 
ligand- presenting cell through clathrin/AP2/Epsin1 dependent or independent pathways 
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(Sorkin and Von Zastrow, 2009, Fortini, 2009). The physical force of trans-endocytosis 
exposes the transmembrane domain (S2 site), enabling cleavage by ADAM 10, which 
dissociates NECD (Chitnis, 2006, Le Borgne et al., 2005, Nichols et al., 2007). The 
subsequent S3 and S4 cleavages by intramembrane aspartyl protease -secretase on the 
plasma membrane or endosomal compartment releases ICD, which translocates to the 
nucleus and binds a transcription factor called CSL (CBF-1/RBP-Jκ, Su(H) and Lag-1) 
(Fortini, 2009, Fortini and Bilder, 2009). The two cleavages by -secretase also produce 
a short fragment called NOTCH β-peptide (Nβ), suggesting a close resemblance 
between amyloid precursor protein cleavages by α/β and -secretase in AD (Okochi et 
al., 2006). The following dissociation of corepressors and recruitment of Maml 
(mastermind-like) promotes the expression of its target genes, for example, 
Hairy/enhancer of split (HES) and HES-related transcription factor (HRT). HES and 
HRT families are transcriptional factors that regulate the expression of various down-
stream target genes, of which examples were discussed in 1.2.3 (Artavanis-Tsakonas et 
al., 1999, Beatus et al., 1999, Iso et al., 2001, Jarriault et al., 1995, Utatsu et al., 1997). 
Although both Jagged and Delta promote the release of the ICD, it has been reported 
that the consequent cellular response differs between Jagged- and Delta-induced Notch 
signalling (de La Coste and Freitas, 2006, Jaleco et al., 2001, Neves et al., 2006). For 
example, Jagged1-induced Notch3 signalling promotes the differentiation of VSMCs 
via RBP-Jκ, while Delta4-induced signalling does not (Doi et al., 2006). The 
mechanism of the ligand-selective effects is yet to be determined, but a key factor 
modulating the preference of NOTCH to either of the ligands was identified: 
glycosylation of EGF-repeats. Fringe, which has three homologues (Lunatic, Manic, and 
Radical), modifies various EGF repeats and the differences in the glycosylation pattern 
affects the Notch signalling activation by ligands, either positively or negatively, 
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Figure 1.2. Notch signalling pathway. (A) illustrates the series of proteolytic cleavage and 
modification events in the Notch signalling pathway. NOTCH receptor is glycosylated by 
O-fucosetransferase1 (O-FucT-1) and Fringe in the endoplasmic reticulum (ER) and the 
trans-Golgi network, respectively, after translation. (1) NOTCH is first cleaved at S1 site by 
a furin-like convertase to form a functional heterodimeric receptor. Binding of NOTCH 
receptor to ligands (Jagged and Delta-like) induces trans-endocytosis of the extracellular 
domain (NECD) by the ligand-presenting cell in Mib1/Neur1 dependent way (2). (3)The 
NECD dissociation enables a second cleavage at S2 site by ADAM-10, followed by S3/4 
cleavage by -secretase on the plasma membrane or in the endosome (4). The resulting 
intracellular domain (ICD) translocates to the nucleus and binds to a DNA binding protein, 
CSL (for CBF1/RBP-Jк, Suppressor of Hairless and Lag-1). The following recruitment of 
the coactivator, Maml (mastermind-like), promotes transcriptional activity of its target genes, 
such as the hairy/enhancer of split (Hes) and HES-related transcription factor (HRT). The 
surface expression of NOTCH is modulated by suppressor of deltex (Su(dx))/Nedd4-
mediated degradation and deltex (Dx)-mediated recycling. (B) depicts how NOTCH dimer 
is thought to interact with the ligand from the signalling cell. 
depending on the combination of NOTCH receptor and Fringe. Lunatic and Manic 
Fringe are suggested to enhance Delta1-induced Notch1 signalling whilst inhibiting 
Jagged1-induced Notch1 signalling. However, Radical Fringe activates both in the same 
way as Lunatic Fringe does in Notch2 signalling induced by Delta1 and Jagged1 (Hicks 
et al., 2000, Yang et al., 2005). Interestingly, Lunatic Fringe glycosylation does not 
suppress NOTCH1-Jagged binding, yet the interaction does not induce following S2 
cleavage (Yang et al., 2005). As adequate physical force of trans-endocytosis is 
essential for S2 cleavage (Chitnis, 2006, Parks et al., 2000), this could be explained by 
the fact that fringe modifies the potency of the receptor-ligand binding but does not 
affect the binding itself (Yang et al., 2005). Few studies so far have investigated the 
differential effects of Fringe on Notch3 signalling and its downstream targets, which 
would greatly help the understanding of CADASIL molecular pathogenesis.  
1.2.3 Physiological functions of Notch3 signalling in vasculature 
Notch signalling is involved in various physiological processes including neurogenesis, 
retinal development, somitogenesis, adipogenesis, limb development, myogenesis and 
hematopoiesis (Shawber and Kitajewski, 2004). NOTCH3 gene is expressed 
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ubiquitously both in vascular and nonvascular components of brain until the early 
postnatal developmental stage, but is restricted to arterial VSMCs in adults (Irvin et al., 
2001, Lacombe et al., 2005), suggesting the VSMC specific function of Notch3 
signalling. 
1.2.3.1 Arterial development and formation 
Although the specific expression of NOTCH3 implies its critical role in VSMC, 
NOTCH3 knockout mice are viable and fertile without serious abnormalities in 
embryonic vascular development while knockout of NOTCH1, which is expressed in 
vascular endothelial cells, results in embryonic lethality due to the defects in angiogenic 
vascular remodelling (Krebs et al., 2000, Krebs et al., 2003). Arteries in NOTCH3-/- 
mice were normal at birth but developed abnormal clustering of α-actin- and smooth 
muscle-myosin heavy chain (SM-MHC)-positive cells and failed to form a normal 
VSMC layer in the tunica media of arteries during the postnatal stage. The significant 
decrease in the expression of smoothelin, a specific arterial VSMC marker, was also 
observed in the mutant arteries, suggesting impaired terminal differentiation of VSMCs 
(Domenga et al., 2004). An in vitro study using aortic smooth muscle cells supported 
the NOTCH3 function in VSMC differentiation by showing that NOTCH3 ICD 
promotes the expression of SM22α, SM-MHC, h-caldesmon and smoothelin (Doi et al., 
2006) (Figure 1.3).  
Several other in vitro studies demonstrated that both Notch1 and Notch3 signalling 
similarly affects VSMC proliferation and migration via CBF-1/RBP-Jk-dependent 
pathway (Wang et al., 2007, Campos et al., 2002, Sweeney et al., 2004). The VSMC 
growth was promoted upon Notch3 signalling activation by the suppression of cell- 
cycle inhibitors p27KIP1 and p21WAF1/CIP1 (Campos et al., 2002, Wang et al., 2003), 
or by the increased expression of platelet-derived growth factor receptor (PDGFR) –β 
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Figure 1.3. Putative molecular mechanisms of VSMC functions and Notch3 signalling. 
Notch3 signalling plays a critical role in VSMC functions. Notch3 signalling regulates 
expression of HES-related transcription factor (HRT)-1, platelet derived growth factor 
receptor (PDGFR)–β, matrix-metalloproteinase (MMP) -2/-9 and VSMC markers (α-actin, 
SM22α , SM-MHC etc.), which are involved in proliferation, migration and differentiation 
of VSMCs. HRT-1 activate phosphatidylinositol 3-kinase (PI3K)/Akt pathway which acts as 
an anti-apoptotic mechanism. Notch3 signalling can activate RhoA/Rho kinase pathway, 
which organises actin and cell adhesion molecules necessary for myogenic tone. The 
crosstalk with ERK/MAPK pathway up-regulates the expression of caspase (Csp) 8 
inhibitor, c-FLIP. Noth3 ICD may inhibit the degradation of X-linked inhibitor of apoptosis 
(XIAP), which inhibit Csp3, 7 and 9. Dot arrows indicate unknown molecular mechanisms. 
(Jin et al., 2008). The activation of Notch3 signalling was also suggested to increase the 
expression of N-cadherin on the cell surface, which contributes to alter cell growth/ 
migration behaviour with preference to the colony formation over spreading  (Wang et 
al., 2007, Lyon et al., 2010). Moreover, the expression of matrix-metalloproteinase 
(MMP) -2 and -9, which are crucial for VSMC migration, was shown to be down-
regulated by Notch3 signalling though its molecular basis is still unclear (Delbosc et al., 
2008). Contrary to the above reports, however, only NOTCH1+/- and not NOTCH3-/- 
mice exhibited reduced VSMC proliferation and migration (Domenga et al., 2004, Li et 
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al., 2009). As shown by Kitamoto et al. (2005), the lack of Notch3 signalling did not 
affect the expression of NOTCH1, which also interact with Jagged1 to promote 
proliferation and repress migration, thus Notch1 signalling may act as a redundancy 
mechanism in NOTCH3 deficient mice.  
Viewed collectively, the data indicates that the main role of Notch3 signalling in the 
vasculature is the regulation of postnatal arterial differentiation and maturation of 
VSMCs rather than of migration and proliferation during the embryonic stage, which 
can be partially compensated for by NOTCH1 (Domenga et al., 2004, Kitamoto et al., 
2005, Li et al., 2009, Sweeney et al., 2004).  
1.2.3.2 Apoptosis 
Though not vital, Notch3 signalling has an important role in deciding VSMC fate; the 
activation of NOTCH3 inhibits apoptosis while loss of NOTCH3 does not result in the 
opposite (Wang et al., 2007, Sweeney et al., 2004, Domenga et al., 2004). Several 
NOTCH-apoptotic mechanisms have been proposed so far. The main pathway is the 
inhibition of Fas-mediated apoptosis, which is a major apoptotic pathway in VSMCs. 
Notch3 signalling was suggested to increase the expression of c-FLIP (Fas-associated 
death  domain like interleukin-1β-converting enzyme-like inhibitory protein), which 
competitively inhibits caspase-8, via cross-activation of ERK/MAPK pathway rather 
than RBP-Jκ-HRT1 (Wang et al., 2002). NOTCH1 ICD was shown to increase the 
expression of X-linked inhibitor of apoptosis (XIAP), which inhibits the activation of 
caspase-3, -7 and -9, by direct binding to prevent its ubiquitination (Liu et al., 2007). It 
is highly plausible that NOTCH3 ICD has a similar function and promotes cell survival 
via XIAP together with c-FLIP activation. Another proposed mechanism involves 
HRT1, a Notch signalling downstream target. HRT1 activates phosphatidylinositol 3-
kinase (PI-3K)/Akt pathway, which is known to promote cell survival via NF-κB, Bcl-
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2-associated death promoter (BAD), glycogen synthase kinase 3 (GSK3) and others 
(Downward, 2004, Wang et al., 2007, Wang et al., 2003).  
1.2.3.3 Vascular tone 
Studies on NOTCH3 deficient mice revealed decreased pressure-induced myogenic tone 
and increased flow-induced dilation in cerebral resistance arteries (Domenga et al., 2004, 
Belin De Chantemèle et al., 2008). The underlying mechanism may involve the 
activation of RhoA/Rho kinase pathway by Notch3 signalling (Büssemaker et al., 2007, 
Belin De Chantemèle et al., 2008). RhoA/Rho kinase is suggested to modulate the 
organization of actin filaments, integrins and cadherins, of which integrity is pivotal for 
unperturbed myogenic tone, as well as the phosphorylation of myosin light chain (Belin 
De Chantemèle et al., 2008, Dubroca et al., 2005b). CADASIL patients are known to 
exhibit impaired vascular autoregulation (Gobron et al., 2007, Peters et al., 2005a, 
Hussain et al., 2004), further emphasising the importance of Notch3 signalling in 
vascular mechanotransduction.  
1.3 CADASIL 
Since the report of Swedish hereditary multi-infarct dementia (Sourander and Walinder, 
1977), the presence of hereditary stroke disorders have been increasingly recognised. 
CADASIL is probably the most common and well-studied disease of all, which was 
linked to the pathogenic mutations in the NOTCH3 gene (Joutel et al., 1996). It is 
characterized by arteriosclerosis of small vessels with degeneration of VSMC, and 
multiple small infarcts in WM and deep (subcortical) GM of the brain. More than 600 
CADASIL families have been estimated to exist worldwide, with over 100 reported 
families in UK, France and Germany (Adib-Samii et al., 2010, Opherk et al., 2004, 
Peters et al., 2005b). The reports of CADASIL families are rather concentrated in the 
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developed countries, but it is more likely to be the simple reflection of accessibility to 
accurate diagnostic tools than actual disease predilection. The world wide prevalence of 
CADASIL is unknown, but it was calculated to be 1.98 patients with a definite 
diagnosis per 100,000 and 4.14 per 100,000 if the predicted mutation carriers were 
included in the west Scotland population (Razvi et al., 2005). There is no gender 
difference in the prevalence though the long-term prognosis for disability and death is 
worse for men than women by 6 years (Opherk et al., 2004). Hypertension and smoking 
are risk factors for strokes, which is a main cause of dementia and disability in 
CADASIL (Adib-Samii et al., 2010). 
1.3.1 Clinical and pathological features of CADASIL  
1.3.1.1 Diagnosis 
CADASIL often manifests as migraine attacks around individuals second to third 
decade, followed by TIAs/strokes and depression 10 years after onset (Chabriat et al., 
1995) (Figure 1.4). Over 80% of patients suffer recurrent strokes and dementia by the 
time of death, which is 54.8 ±10.6 years (Felician et al., 2003, Desmond et al., 1999). 
Thus, CADASIL is suspected when WM hyperintensity on MRI, especially in temporal 
poles or external capsules, coincides with a history of migraine (often with aura) or 
transient ischemic attack (TIA) despite the relative young age (<60 years) (Chabriat et 
al., 1995, Pantoni et al., 2010). Family history of stroke and dementia is also considered 
as a strong indication of CADASIL. As those clinical or neuroimaging features are 
frequent in CADASIL but not specific, the genetic screening for NOTCH3 mutation is 
essential to confirm CADASIL and distinguish from CADASIL-like disorders. General 
mutational hot spots (exon 3, 4 and 5) or frequent mutational spots in a specific genetic 
background (e.g. exon11 in Italian population) are often targeted for the screening 
(Peters et al., 2005b). It should be noted that full genetic screening is necessary to  
   Introduction Chapter 1 
 
16 
Figure 1.4. Time course of CADASIL symptoms and pathologies. The initial symptoms 
manifest as migraine or transient ischemic attack (TIA) around 20-30 years of age, when 
white matter hyperintensity (WMH) is detected by MRI.  
completely eliminate the diagnosis of CADASIL as >100 potential NOTCH3 mutational 
spots spread over 23 exons. Alternative to the genetic diagnosis, skin biopsy is 
performed to confirm CADASIL-specific granular osmiophilic material (GOM), which 
show 100% congruence with NOTCH3 mutations (Tikka et al., 2009). Immunostaining 
of skin biopsy samples for N3ECD also provide a good indication of CADASIL with 
96% sensitivity and 100% specificity though caution should be taken to avoid false-
negative results (Lesnik Oberstein et al., 2003, Joutel et al., 2001) 
1.3.1.2 Neuroimaging 
Neuroimaging features in CADASIL are rather unique as it demonstrates a relatively 
specific spatial distribution of lesions. Characteristic lesions in CADASIL brain are 
small subcortical infarcts and diffuse white matter abnormality with enlarged 
perivascular spaces (PVSs) (Singhal et al., 2005, Coulthard et al., 2000) (Figure 1.5). 
MRI abnormalities have been demonstrated to correlate with strokes, disability and 
cognitive dysfunction from extensive neuroimaging studies (Dichgans et al., 1999, 
Singhal et al., 2005). In particular, lacunar infarcts were associated with cognitive 
Age (years) 
10 20 30 40 50 60 
Migraine 
Stroke/TIA 
Depression 
Dementia 
Death 
GOM 
WMH 
A NECD 
   Introduction Chapter 1 
 
17 
decline, but not WM hyperintensities on T2-weighted MRI (Viswanathan et al., 2007, 
Liem et al., 2007).  
Abnormal WM changes often start from the frontal lobes even before the manifestation 
of symptoms (Chabriat et al., 1995, Dichgans et al., 1998, Stromillo et al., 2009), 
helping the early diagnosis in the presence of family history. The WM pathologies 
gradually spread to the periventricular WM, frontal, temporal and parietal lobes, 
external capsules, corpus callosum, basal ganglia and brain stem, frequent and severe in 
this order in symptomatic CADASIL patients as the disease progresses with ageing. The 
involvement of the anterior temporal poles is common and a strong indication of 
CADASIL though no study so far has sufficiently explained the unique susceptibility of 
anterior temporal poles (Singhal et al., 2005). Those lesions are mostly subcortical, and 
cortical, as cerebellar lesions are rarely observed in CADASIL (Chabriat et al., 1998). 
However, SPECT (single photon emission computed tomography) studies reported 
hypoperfusion in temporal and frontal cortices, basal ganglia, cingulate cortex in 
addition to the subcortical areas, and it was not always consistent with the area of 
hyperintensities (Mellies et al., 1998, Scheid et al., 2006). This is actually due to a 
Figure 1.5. Neuroimaging in CADASIL. Axial MR images of genetically confirmed 
CADSIL patients. A-B, T2 weighted MR image showing variable degrees of periventricular 
and deep WM hyperintensities in patients of the same age at 50 years. One patient (A) had 
severe psychiatric symptoms and the other (B) exhibited aggressive behaviour. C, FLAIR 
MR sequence demonstrating high signals (diagnostic for CADASIL) in WM of the temporal 
poles in a 61-year-old CADASIL patient.  D, shows localization of microbleeds (arrows) in 
a CADASIL patient (kind courtesy of M Dichgans, Munich). 
B C D A 
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limitation of conventional MRI, which is good at detecting the presence of macro- but 
not microscopic lesions. Indeed, MTI (magnetization transfer imaging) and DTI 
(diffusion tensor imaging) scans revealed ultrastructural damage, such as axonal and 
myelin loss, in normal appearing WM in CADASIL (Iannucci et al., 2001, Chabriat et 
al., 1999), suggesting that the WM disturbance and destruction are more extensive than 
it appears on T2-weighted MRI. The damage is also evident in the form of reduced 
glucose metabolism in cortical and subcortical regions (Tatsch et al., 2003). 
1.3.1.3 Cognitive profiles  
The cognitive profiles of CADASIL are very similar to sporadic SVD. Several large 
cohort studies have characterised the neuropsychological deficits in CADASIL. At the 
early stage of the disease before incidents of TIA or strokes, the neuropsychological 
symptoms are relatively restricted to the impairment of frontal executive functions, 
which monitor, select and control cognitive processes; diminished working memory, 
attention and error monitoring are observed in CADASIL (Amberla et al., 2004, Peters 
et al., 2005c). The executive dysfunction is usually assessed by the verbal fluency 
(semantic) test as recalling categorical words requires constant planning of retrieval 
strategies, attention and monitoring of the processes, and shifting of the effective 
strategies (Abrahams et al., 2000). Verbal fluency impairment is a characteristic of SVD, 
however, it is more severe in CADASIL, implying the additional contribution of 
CADASIL‘s unique pathology, namely WM lesions in the temporal poles (Charlton et 
al., 2006). Left prefrontal, temporoparietal, and bilateral anterior temporal regions are 
suggested to be the main components of semantic cognition (Pobric et al., 2007), and 
thus WM abnormalities in those regions as described previously would underlie the 
diminished verbal fluency in CADASIL. 
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As the disease progresses, the broader spectrum of neuropsychiatric functions are 
affected. At the post-stroke stage, cognitive processing speed, visuospatial ability, 
reasoning, set shifting and ideational praxis are often impaired while orientation, 
recognition and receptive language skills remain intact (Peters et al., 2005c, Buffon et 
al., 2006, Amberla et al., 2004). After 60 years of age, most CADASIL patients start to 
manifest cognitive deficit with impaired verbal function and motor speed (Buffon et al., 
2006, Amberla et al., 2004), but the pattern of memory impairment differs from that in 
AD, with relatively spared episodic memory (Amberla et al., 2004). Verbal memory 
tests, which examine encoding, storage and retrieval processes of episodic memory, 
reveal worse immediate and delayed free recall in CADASIL. However, the recall 
usually improves when cues are given even in demented patients, indicating that 
memory impairment in the majority of CADASIL patients is not due to the defect in 
encoding and storage but in the retrieval process, though the minority show poor 
delayed recall even with cueing, which is indicative of hippocampal-type amnesia as in 
AD (Epelbaum et al., 2010, Buffon et al., 2006, Peters et al., 2005c).  
Collectively, CADASIL is characterised by executive dysfunction, slow memory 
processing speed and memory retrieval deficit with relatively intact episodic memory, 
which are feature of subcortical ischemic vascular dementia. 
1.3.1.4 Migraine with aura 
Migraine is one of the most frequently observed initial symptoms in CADASIL, often 
manifesting from 10-30 years of age. Approximately 70% of migrainous patients 
experience typical aura prior to the attack, which is the combination of visual (e.g. 
Scintillating scotomas, photopsia and blurred vision), sensory (mainly face and arm), 
aphasic or motor aura (predominantly arm) (Vahedi et al., 2004). One of the proposed 
mechanism of migraine involves vascular factors: the migraine attack is triggered by 
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vasodilation and hyperperfusion following aura caused by vasoconstriction (Pollock et 
al., 2008, Dalkara et al., 2010). Indeed, Yetkin et al. (2007) reported decreased flow-
mediated and increased NO-mediated vasodilation in CADASIL patients with migraine. 
The impact of migraine on cognitive functions is controversial. Some argue that 
migraine affects executive functions (Schmitz et al., 2008, Mulder et al., 1999) while 
others claim no effect (Baars et al., 2010). In either case, there may be a common 
mechanism between migraine disorders and migraine in CADASIL as migraine itself is 
a risk factor for strokes (MacClellan et al., 2007). 
1.3.1.5 Other common symptoms 
The other common symptoms include mood disturbances, seizure, ataxia, dysarthria and 
visual defects. Ataxia is the most frequent, with 90% of patients showing gait 
disturbance, limb akinesia with rigidity and psychomotor slowing, but without resting 
tremor or abnormal movements as in Parkinson‘s disease (Dichgans et al., 1998). As a 
result, 63% of individuals aged over 65 are classified as Rankin Disability Scale 4 or 
above, requiring assistance with walking and other activities. Male gender is a risk 
factor for early immobilisation: mean ages for requiring walking assistance and 
bedriddenness are 59 and 62 in men and 62 and 67 in women, respectively (Opherk et 
al., 2004). Mood disorders including dysthymia, apathy, depression, anxiety and 
jealousy delusion occur in 20-30% of patients often with underlying dementia 
(Dichgans et al., 1998, Chabriat et al., 1995, Reyes et al., 2009). They manifest in the 
course of disease progression and rarely present at the onset (Valenti et al., 2008).  
While most of the symptoms are exclusively related to the central nervous system, a few 
cases with visual abnormality have been reported. CADASIL arteriopathy affects the 
vasculature of the eyes and causes arterial narrowing and sheathing, leading to optic 
nerve rarefaction and retinal dysfunction, though the visual function is not always 
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damaged (Rufa et al., 2005, Roine et al., 2006, Parisi et al., 2007, Parisi et al., 2003). 
Several studies also reported sensorineural hearing loss, but its significance is unknown 
(Phillips et al., 2005, Scheid et al., 2006). 
1.3.1.6 Vascular changes 
Similar to the NOTCH3 deficient mice, cerebral and peripheral arteries in CADASIL 
develop normally during the embryonic period with no sign of vascular pathologies, 
which gradually accumulate postnatally and are prominent by the age of 20 (Brulin et 
al., 2002, Oberstein et al., 2008, Ruchoux et al., 2003). The most striking change is 
observed in VSMCs, which are destroyed and lost completely or partially from vessel 
walls, especially in small arteries (<500 µm in diameter) in contrast to the NOTCH3 
deficient mice, which showed no alteration in VSMC death (Domenga et al., 2004, 
Okeda et al., 2002). Remaining VSMCs are irregular-shaped or swollen, with partially 
disturbed plasma membrane and dense granular osmiophilic material (GOM) at a close 
proximity to the cell surface (Schro  der et al., 2005, Kalimo et al., 2002). GOM is 
uniquely found in the vessel wall of CADASIL and is suggested to contain some lipids 
or lipoproteins and N3ECD (Kalaria et al., 2004, Ishiko et al., 2006). N3ECD 
accumulation is also found on the plasma membrane of VSMCs, but the toxicity of 
those CADASIL characteristic deposits are unknown (Joutel et al., 2000).  
Ultrastructural changes are also found in vascular endothelial cells. The skin biopsy 
findings include dense and irregular-shaped cytoplasm of vascular endothelial cells with 
large vacuoles and notably increased microfilament bundles at their abluminal side 
(Ruchoux and Maurage, 1998). Adjacent basal lamina is also disrupted, either focally 
duplicated or detached from endothelial cells (Ruchoux and Maurage, 1998, Schro  der et 
al., 2005). As the disease progresses, cells are disorganized and the disjunction between 
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VSMCs and endothelial cells becomes pronounced, further exacerbating the vascular 
destruction (Brulin et al., 2002). Apparently, the ultrastructural changes of endothelial 
cells damage the arterial autoregulatory function: CADASIL shows impaired 
endothelial vasodilation in the resistance arteries (Stenborg et al., 2007). Marked 
thickening of vessel wall due to the intimal and adventitial hyalinosis and fibrosis may 
also prevent normal flow-mediated vasodilation (Okeda et al., 2002, Miao et al., 2004).  
The above pathological changes seem to alter the integrity of the vessel wall, making 
them susceptible to infarcts. Indeed, intracerebral microbleeds are often found around 
degenerated small vessels (Dichgans et al., 2002). Whereas intracerebral haemorrhages 
are rare, multiple small infarcts are commonly found in WM, deep GM and brain stem 
(Kalimo et al., 2002). Damage to brain tissue can be more extensive than normal due to 
the impaired vasoconstriction after stroke as demonstrated by the Notch3 mutant mice 
study (Arboleda-Velasquez et al., 2008). 
1.3.2 Mechanisms of CADASIL pathogenesis 
1.3.2.1 NOTCH3 mutations and polymorphisms  
Over 150 pathogenic mutations have been identified in NOTCH3 so far (Table 1.2). A 
mutational hot spot lies between the second and sixth of the 33 exons where almost 90% 
of the mutations cluster (Figure 1.6A). From the protein structural point of view, the 
mutation clusters are roughly divided into three regions: N-terminal region (or 
mutational hot spot, EGF1-6), ligand binding region (EGF8-14) and Abruptex region 
(EGF24-27) (B). The majority of mutations are missense (or point) involving either loss 
or gain of a cysteine residue. Other types of mutations include seven coding region 
deletions, one insertion, two splice site, one frameshift mutation and one duplication 
(Federico et al., 2005, Mazzei et al., 2004, Mazzei et al., 2008, Opherk et al., 2004, 
Peters et al., 2005b, Tikka et al., 2009), all of which result in an uneven number of 
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cysteines in the mutated EGF repeats instead of the normal even number of six. It has 
been suggested the 3D structural change due to abnormal disulphide bridging plays a 
role in the molecular pathology of CADASIL. Six studies, however, have reported point 
mutations and deletions, which involve no cysteine residue (marked with * in Table 
1.2) (Adachi et al., 2006, Kim et al., 2006, Mazzei et al., 2004, Mizuno et al., 2008, 
Santa et al., 2003, Ferreira et al., 2007). Ungaro et al. (2009) also identified eight 
possible pathological mutations without cysteine involvement (R107W, Q151E, A198T, 
R207H, E309K, R592S, V644D and H1235L). The cysteine-sparing mutations may 
imply the significance of the positions on structural formation, enzymatic modification 
or protein interactions. It should be noted that six of those mutations result in loss of 
arginine, which is known to be involved in the maintenance of protein conformation and 
the enhancement of protein stability in other proteins (Borders Jr. et al., 1994, Mrabet et 
al., 1992, Woods, 2004).  
A number of NOTCH3 polymorphisms have also been identified in CADASIL. The 
most frequently found polymorphisms include c.684G>A (rs1043994) in exon 4 and 
c.381C>T (rs3815188) in exon 3 followed by c.2616T>C (rs1043996) in exon 16 
(Ungaro et al., 2009).   
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Table 1.2. NOTCH3 mutations in CADASIL reported since 1996. Most mutations are 
clustered in exon 3 and 4. Five mutations which do not involve cysteine residue are 
indicated with *. del: deletion, ins: insertion, fs: frameshift, dup: duplication. 
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Figure 1.6. Distribution and frequency of NOTCH3 mutations. Bars show number of 
loss/gain of cysteine and non-cysteine involving mutations per exons (A) and EGF-repeats 
(B). Details of mutations are listed in Table 1.2.  
1.3.2.2 Animal models 
Animal models, either knock-in or Tg, are useful tools to investigate the molecular and 
clinical pathology using conditions which are closer to those found in humans. Several 
mouse models have been developed to explore the effects of CADASIL mutations, and 
have succeeded in reproducing CADASIL pathologies to some extent.  
Knock-in mice with R142C mutation in mouse NOTCH3 (R141C in human) showed no 
vascular, WM or cognitive abnormalities, suggesting only human NOTCH3 mutation 
(R141C) is pathogenic (Lundkvist et al., 2005). On the other hand, Tg mice with 
restricted expression of full-length human NOTCH3 (R90C) mutant to VSMCs 
successfully exhibited CADASIL specific features such as GOM, N3ECD accumulation 
A 
B 
Ligand binding region Abruptex region 
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and disruption of VSMC anchorage; consistent with these morphological changes, the 
mice exhibited significant deficits in cerebrovascular response and reactivity (Ruchoux 
et al., 2003, Lacombe et al., 2005). Tg mice with C428S mutation also developed 
N3ECD accumulation and GOM (Monet-Leprêtre et al., 2009). The problem with those 
Tg mice is that while they exhibit characteristic vascular pathologies, they failed to 
develop brain parenchyma lesions. The limitation probably stems from insufficient 
disease duration for the development of pathology, which is dependent on age, due to 
the significantly shorter life span of mice. Recently, Joutel et al. (2010) solved the 
problem by overexpressing mutant NOTCH3 (R169C) in a pattern similar to 
endogenous NOTCH3. The Tg mice succeeded to exhibit most of the CADASIL 
pathologies such as GOM, N3ECD accumulation, and progressive WM damage. They 
also showed reduced capillary density, impaired cerebrovascular autoregulation and 
subsequent decreased cerebral blood flow even without apparent structural abnormality 
of arteries, suggesting the vascular functional deficiency underlies the disease initiation.  
1.3.2.3 Molecular pathogenesis  
The key question is how the NOTCH3 mutations lead to vascular degeneration and 
dysfunction, eventually resulting in arteriopathy and leukoencephalopathy in CADASIL 
patients. Many studies have tried to define the molecular pathogenesis of CADASIL 
without definitive success; loss and gain of functions have been considered and tested, 
resulting in varying and sometimes contradicting results. Although those studies shed 
light on a part of the molecular pathogenesis, the initial trigger of CADASIL vascular 
pathology is still shrouded in mystery. 
There are various stages in the Notch3 signalling pathway which could be affected by 
the mutations. The most likely sites are at the proteolytic cleavages of NOTCH3 and the 
NOTCH3 receptor-ligand binding (Figure 1.2). Three reports demonstrated that 
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NOTCH3 receptors with mutations within and near the ligand binding domain (e.g. 
C428S, C455R and C542Y) exhibited diminished signalling activity due to varying 
mechanisms. C428S mutation either impaired ligand binding or obtained dominant-
negative property, while C542Y mutation retarded presentation to the cell surface 
(Joutel et al., 2004, Monet-Leprêtre et al., 2009). C455R mutation was also shown to 
disrupt NOTCH3-ligand binding (Peters et al., 2004). On the other hand, mutations 
located in the mutational hot spot (e.g. R133C, R141C, C183R and C185R) seem to 
affect S1 cleavage possibly due to the impaired glycosylation by Fringe (Haritunians et 
al., 2005, Karlström et al., 2002, Peters et al., 2004, Arboleda-Velasquez et al., 2005). 
However, while impaired S1 cleavage may result in the reduced surface expression of 
mutant NOTCH3 (R141C), Jagged1-induced signalling activity remained intact (or even 
increased with C185R) in all of the cases (Haritunians et al., 2005, Peters et al., 2004, 
Karlström et al., 2002). Moreover, contradictory to the above reports, at least three other 
in vitro studies on CADASIL (R90C, R133C, C185R) or CADASIL-like mutations 
have shown that NOTCH3 mutations in exons 3 and 4 do not impair full-length receptor 
maturation, intracellular trafficking or the signalling mechanism and retain the ability to 
activate RBP-Jκ (Joutel et al., 2004, Haritunians et al., 2002, Low et al., 2006). A 
transgenic mouse study further confirmed that mutant NOTCH3 (R90C) was fully 
functional and RBP-Jк activity remained normal despite the presence of arterial defects 
and NECD/GOM accumulation (Monet et al., 2007). In contrast to the mutations in the 
ligand binding domain and the mutational hot spot, little is known about the impacts of 
mutations near the Abruptex region. At least one in vitro study reported that R1006C 
mutation did not impair receptor processing or RBP-Jк-dependent Notch3 signalling 
activity (Joutel et al., 2004). Albeit from a NOTCH1 study, however, the Abruptex 
region, which is highly glycosylated by Manic Fringe, was demonstrated to compete 
with Delta for the Notch ligand binding domain (Shao et al., 2003, Pei and Baker, 2008). 
   Introduction Chapter 1 
 
28 
The mutations in this region seem to alter the Fringe modification, resulting in enhanced 
Notch1 signalling (de Celis and Bray, 2000, de Celis et al., 1991). Thus, NOTCH3 
mutations in EGF24-27 may result in increased Notch3 signalling but we await the 
confirmation from in vitro and in vivo studies.  
The above data indicate that there are no consistent outcomes of NOTCH3 mutations in 
regards to Notch3 signalling activity. It suggests that NOTCH3 mutations subtly and 
differentially affect receptor trafficking, processing and/or signalling activity depending 
on the position of the mutation. Or, the mutation affects the function specific to VSMC, 
possibly under a specific condition, as NOTCH3 function can be cell-type and context 
specific while many of those in vitro studies used non-VSMC cell lines (Beatus et al., 
1999, Iso et al., 2003). Another thing to be noted is that the phenotypes of CADASIL or 
NOTCH3 transgenic (Tg) mice only partially overlap with those of NOTCH3 deficient 
mice: both showed impaired arterial myogenic response (though again, the type of 
alteration differs between studies), but VSMC degeneration, N3ECD accumulation and 
GOM were only reported in NOTCH3 Tg mice (Domenga et al., 2004, Dubroca et al., 
2005a, Hussain et al., 2004, Peters et al., 2005a, Joutel et al., 2010, Belin De 
Chantemèle et al., 2008). Hence, loss of NOTCH3 function cannot sufficiently explain 
the whole range of CADASIL pathologies.  
An alternative hypothesis is (toxic) gain of function, a common mechanism in many 
neurodegenerative diseases. This hypothesis is supported by the fact that most mutations 
are located in the regions of poorly conserved sequence (Donahue and Kosik, 2004, 
Federico et al., 2005), and that in most cases, Notch signalling activity remains intact. 
Deposits or aggregations of misfolded proteins due to a novel folding pathway are often 
the cause of toxicity (Bucciantini et al., 2002, Kirkitadze et al., 2002), and as described 
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earlier, characteristic accumulations of N3ECD and GOM are found in the CADASIL 
vasculature, indicating that the clearance of the NECD may be damaged by the 
mutations (Joutel et al., 2000, Dziewulska and Rafalowska, 2008). The increased 
cytoplasmic expression of ubiquitin, which modulates NOTCH3 endocytosis and 
lysosome degradation (Jia et al., 2009, Sorkin and Von Zastrow, 2009) in VSMC and 
vascular lamina media also support the idea. In fact, several studies demonstrated the 
accumulation of Notch3 mutants (R133C and C185R) in ER, upregulation of unfolded 
protein response related proteins and increased susceptibility to stress, proposing ER 
stress responses as a cause of VSMC degeneration (Ihalainen et al., 2007, Takahashi et 
al., 2010). The ER stress hypothesis is also supported by the studies demonstrating the 
increased multimerization and intracellular aggregation of Notch3 mutants (R133C, 
R141C and C183R) (Opherk et al., 2009, Karlström et al., 2002). However, those 
results derived from in vitro studies over-expressing mutant NOTCH3 and no report has 
been made of intracellular NOTCH3 accumulation in human biopsy samples. Moreover, 
arteries in Tg mice (R90C) start to exhibit pathological changes even before the 
accumulation of N3ECD and GOM (Ruchoux et al., 2003). The authors stated that the 
first apparent pathological changes were the disjunction of VSMCs and increased 
number of dense intracellular plaques. Another study on Tg mice also reported that 
overexpression of both Notch3 mutant (R169C) and wild type did result in cytoplasmic 
inclusions in mice as seen in in vitro studies but only mutant Tg mice developed 
vascular defects and WM lesions (Joutel et al., 2010). Therefore, cerebrovascular 
dysfunction and rarefaction were proposed as the causes of WM damages. Although 
there still is a possibility that abnormal accumulations exacerbate the existing vascular 
pathology – especially considering that overexpression of NOTCH3 accelerated the 
onset of WM lesion formation – other alterations which result in the disturbance of 
VSMC adhesion followed by impaired myogenic response, seem to be the initial trigger.  
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Structural integrity maintained by cell-cell adhesion molecules, such as cadherin and 
connexin, is important for the regulation of myogenic tone, which was suggested to be 
modulated through the RhoA/Rho kinase pathway (Lagaud et al., 2002, Earley et al., 
2004, Belin De Chantemèle et al., 2008). In addition, Lyon et al. (2010) recently 
demonstrated that inhibition of N-cadherin in VSMC resulted in decreased migration 
(contributing to reduced intimal thickening, which is not observed in CADASIL) and 
increased apoptosis further supporting the possible involvement of cadherin in 
CADASIL pathology. As mentioned in 1.2.3.1, N-cadherin expression is regulated by 
Notch3 signalling though its exact mechanism is still unclear  (Wang et al., 2007). As 
all the in vitro and in vivo studies mentioned previously examined only CBF-1/RBP-Jκ-
dependent Notch3 signalling activity and found no change in some cases, the cadherin 
expression and myogenic tone may be regulated by RBP-Jκ-independent pathway.  
Considering all the data presented above, the alteration of cell-cell adhesion molecules 
due to unknown mechanisms may play an important role in the initiation of the vascular 
pathology leading to impaired vascular tone, while the other pathologies, such as 
N3ECD accumulation and GOM deposits, could stem from other mechanisms (e.g. 
impaired endocytosis or degradation) and may be contributing to the development of 
vascular and neuronal pathologies in CADASIL. Interestingly, Joutel and colleagues 
(2008) reported an SVD case with NOTCH3 mutation characterized by CADASIL-like 
features including TIA/stokes, diffuse WM hyperintensity and enlarged PVS, but lacked 
hallmarks of CADASIL, e.g. involvement of temporal pole on MRI, GOM and NECD 
accumulation. The mutation L1515P was in the juxtamembranous region critical for 
NOTCH3 heterodimerization, and resulted in activated Notch3 signalling despite the 
defect in S1 cleavage due to the unstable NECD-ICD heterodimer. The pathologies and 
phenotypes of this mutation imply that CADASIL pathologies cannot be simply 
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explained by loss or gain of NOTCH3 functions, and unidentified NOTCH3-mediated 
pathway or crosstalk may be involved in the pathogenesis. Future studies should include 
investigation into the molecular basis of cell-cell adhesion molecule induction by 
NOTCH3, crosstalk between NOTCH3 and other pathways, and also RBP-Jк-
independent pathway. 
1.3.2.4 Phenotypic variability and modifiers 
Another confounding feature of CADASIL is its diverse phenotypic variability between 
individuals: patients with the same mutation, even from the same family, often manifest 
different clinical symptoms and different ages of onset, while patients with different 
mutations or zygosity can exhibit similar symptoms (Uyguner et al., 2006, Singhal et al., 
2004, Dichgans et al., 1998, Tuominen et al., 2001). Several studies have reported 
associations between certain genotypes and phenotypes. Mutations in the ligand binding 
domain (e.g. C428S, C440G and C455R), which result in the reduced Notch3 signalling 
activity, were linked to milder cognitive impairment and disability despite the higher 
volume of WM hyperintensity on MRI (Arboleda-Velasquez et al., 2002, Monet-
Leprêtre et al., 2009, Singhal et al., 2004). C455R was also associated with the early 
onset of stroke (Arboleda-Velasquez et al., 2002). Two mutations from the mutational 
hot spot (exon 4) resulted in similar phenotypic features: C117F was associated with a 
lower age at death and the C174Y mutation with a lower age at onset for stroke and 
death (Opherk et al., 2004). On the other hand, patients with R153C, also in the 
mutational hot spot, exhibited increased number of microbleeds and those with S180C 
showed anticipation of onset age (Lesnik Oberstein et al., 2001, Nakamura et al., 2005). 
However, even with those mutations, the phenotypic differences are subtle, and with 
most of the mutations, there is no clear genotype-phenotype association (Adib-Samii et 
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al., 2010, Singhal et al., 2004, Opherk et al., 2004), suggesting the involvement of 
modifying factors, either genetic or environmental, in CADASIL.  
A population-based study has suggested the strong genetic influence on severity of WM 
hyperintensity though the modifying gene(s) has yet to be identified (Opherk et al., 
2006). The connection between NOTCH3 polymorphisms and onset or strokes has been 
suspected but no association have been found (Mizuno et al., 2002). The only 
association between CADASIL phenotype and genetic variance found so far was 
between the NOTCH3 polymorphism rs1043994 (G684A), which is frequently found in 
CADASIL patients, and migraine (especially without aura) (Ungaro et al., 2009, 
Schwaag et al., 2005). The authors speculated that the polymorphism may be in linkage 
disequilibrium with another NOTCH3 variant as it does not lead to the amino acid 
substitution. Also, the influence of apolipoprotein-E genotype, which was implicated in 
various brain injuries, and cardiovascular risk factors were tested without any positive 
results, except for the elevated homocysteine level and migraine (Singhal et al., 2004, 
Van Den Boom et al., 2006). Another candidate for genetic modifier was mitochondrial 
mutation for two reasons. Firstly, mitochondrial dysfunction has been reported in 
CADASIL (Dotti et al., 2004, De La Peña et al., 2001). Secondly, a mitochondrial 
mutation (5650G > A), which was also reported in a CADASIL patient, was previously 
related to myopathy (McFarland et al., 2008, Annunen-Rasila et al., 2007). However, no 
association was identified in a small-scale study (Abu-Amero et al., 2008). 
Environmental factors require special attention especially when the study subjects are 
from the same family. As Mykkänen et al. (2009) pointed out in the report of an 
identical twin, environmental and life style factors seem to significantly affect the 
severity and the progression of disease. The twin with the smoking habit from a very 
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young age experienced the first stroke 14-years earlier than the other, and suffered more 
lacunar infarcts and exhibited more severe functional disability compared to the other, 
who had no smoking history and participated in intense physical activity. Another study 
also confirmed the association between early onset of stroke and smoking (Singhal et al., 
2004). Although no other environmental factors have been associated to the CADASIL 
phenotypes so far, other factors already related to neurodegenerative diseases, such as 
air pollution, diet, and exercise, should also be considered (Migliore and Coppedè, 
2009). 
1.3.3 Therapeutic approaches 
Treatment of CADASIL is currently restricted due to the poor understanding of the 
disease pathogenesis. Cholinesterase inhibitors have been proven to be effective in 
improving cognitive decline and disability in AD, especially in those with 
cerebrovascular factors (Erkinjuntti et al., 2002, Kumar et al., 2000). Cholinesterase 
inhibitors including donepezil were also tested on VaD and have been shown to 
improve cognitive function (but not global, functional or behavioural outcome), and 
work better for patients with cortical and multiple territorial lesions (compared to those 
predominantly with subcortical lesions) or without hippocampal atrophy (Kavirajan and 
Schneider, 2007, Román et al., 2010). A randomised clinical trial of donepezil on 
CADASIL patients showed a similar result, demonstrating no positive effect on global 
cognitive function or physical functions but enhanced executive functions and 
processing speed (Dichgans et al., 2008).  The lack of significant clinical improvement 
with cholinesterase inhibitors has lead to the search for new treatment strategy, i.e. 
improvement of cerebral perfusion, which correlates with disability and cognitive 
impairment (Bruening et al., 2001). Ca2+ channel blocker lomerizine successfully 
increased cerebral blood flow (CBF) and improved the cognitive decline in CADASIL 
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during 2-year treatment period, demonstrating the efficacy of this approach (Mizuno et 
al., 2009). Acetazolamide, a carbonic anhydrase inhibitor which works as cerebral 
vasodilator, has also been tested on CADASIL patients and was shown to increase CBF 
though whether it can improve cognitive impairment is yet to be tested (Huang et al., 
2010, Chabriat et al., 2000). Another approach, albeit from in vitro study, was recently 
proposed by an American group, which showed that long-term treatment with valproate, 
an anticonvulsant/mood stabiliser, can inhibit VSMC apoptosis by activating Notch3/c-
FLIP cascade (Yuan et al., 2009). Though its potential is unknown, it may help to delay 
the disease progression.  
These treatments, however, are only symptomatic and thus it is important to establish 
the basic knowledge of CADASIL pathology to find a complete therapy. 
1.4 Vascular functions and cerebrovascular disorders 
The brain is heavily dependent on constant blood supply and its interruption, even 
momentary, can cause serious damage that manifests as neurological symptoms. 
Regardless of the molecular pathogenesis in CADASIL, it is the disruption of the 
physiological cerebrovascular functions that is the most likely direct cause of brain 
damage. The following sections describe the structure and function of the 
cerebrovasculature from the physiological viewpoint, and also document pathological 
changes in SVD.  
1.4.1 Blood-brain barrier  
At the luminal surface, blood vessels in the brain are lined with single-layer cerebral 
endothelial cells tightly adhered to the basement membrane and joined end to end by 
tight junctions. The cerebral endothelium is further surrounded by an elastic lamina, 
VSMCs and loose connective tissues in arterioles and arteries (Figure 1.7). The tight 
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endothelial layer called the BBB functions as a physical barrier, which restricts the 
molecular traffic to and from the brain. There are only three routes through the BBB, 
carrier-mediated transport, receptor-mediated transcytosis, and active efflux transport, 
which transports nutrition to the brain (e.g. oxygen and glucose), remove neurotoxins or 
metabolic byproducts from the brain, and modulate ion balance of which disruption is 
critical for neurons (Eisert and Schlachetzki, 2008). Additionally, the intracellular and 
extracellular enzymes help to inactivate potentially neurotoxic lipophilic substrates, 
preventing them from penetrating BBB via a diffusive route (Abbott et al., 2006). The 
proper functioning and integrity of BBB requires the interactions between cerebral 
endothelial cells and astrocytes, pericytes, and the extracellular matrix as well as 
neuronal activities (Persidsky et al., 2006). The significance of the so-called 
neurovascular unit in brain homeostasis has been extensively studied. Astrocytes, of  
Figure 1.7. Neurovascular unit. Endothelial cells (EC) are connected with tight junctions 
(arrowheads) to form the Blood-Brain Barrier (BBB). In the larger vessels, the EC layer is 
further surrounded by vascular smooth muscle cells (VSMC), fibroblasts (FB) and 
connective tissues. The structure and functions of BBB and arterial myogenic tone are 
controlled by the interactions between vessels and pericytes (P), astrocytes (AC) and 
neurons (N). BL: basal lamina, PVS: perivascular space 
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which end feet almost completely surround the capillary surface, play an important part 
in the formation and maintenance of the BBB. They not only promote the expression of 
tight junctions and strengthen the physical barrier, but also modulate the expression of 
membrane transporters and enzymes to maintain transport and metabolic barrier 
function (Abbott et al., 2006). The functions of other neurovascular components are 
rather ill-defined compared to astrocytes. The lack of pericytes results in capillary 
deformation, suggesting their role in BBB formation (Sandoval and Witt, 2008). Several 
different subtypes of neurons have been reported to interact with endothelial cells and/or 
astrocytes, and their decreased activities were found in pathological states with BBB 
dysfunction, but no direct evidence of their function over the BBB has been found so far 
(Hawkins and Davis, 2005).  
BBB dysfunction is often observed in SVD patients with leukoaraiosis (Topakian et al., 
2010). Although BBB dysfunction can be a part of the disease progression as in 
multiple sclerosis, it is suggested to be secondary pathology to ischemia and hypoxia in 
SVD (Hawkins and Davis, 2005). Initial changes observed after ischemia are swelling 
of endothelial cells, astrocytes and neurons, and degradation of the vascular 
extracellularmatrix (Sandoval and Witt, 2008). Secretion of cytokines (e.g. interleukin-
1β and TNF-α) and chemokines (e.g. monocyte chemoattractant protein-1) by the 
endothelium, and the following infiltration of leukocytes also occur at the early stage of 
post-ischemic changes and are suggested to contribute to inflammation, oedema and 
neuronal injury (del Zoppo, 2009). In addition, ischemia causes the disruption of tight 
junctions, basal lamina and glia limitants, and the increased activity of pinocytosis and 
vesicular transport in endothelial cells, all of which contribute to the increased 
permeability of the BBB (Eisert and Schlachetzki, 2008). Of all the components of the 
neurovascular unit, neurons and astrocytes are particularly vulnerable to ischemia-
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induced inflammation and oxidative stress compared to microglia/pericytes and 
endothelial cells (Eisert and Schlachetzki, 2008).  
1.4.2 Cerebrovascular tone 
Cerebral arteries are generally divided into the leptomeningeal and perforating arteries 
and extend into various brain regions to supply oxygen and nutrition (Tatu et al., 2008). 
Here again, the neurovascular unit plays a pivotal role in ensuring stable cerebral 
perfusion. CBF is modulated by the neuronal activity directly or indirectly via 
astrocytes and endothelial cells. Vasoactive substances from neurons (e.g. acetylcholine, 
norepinephrine and 5-HT), astrocytes (e.g. 20-HETE and prostaglandin E2) or 
endothelial cells (e.g. NO, prostacyclin and endothelin) induces changes in intracellular 
ion concentration (K+, H+ and Ca2+) and light chain myosin phosphorylation in VSMC 
to promote vasodilatation or vasoconstriction (Iadecola, 2004, Hamel, 2006). The local 
vasodilation is transmitted to upstream vessels, through the conduction of the vessel 
response or change in flow (shear stress) that induces endothelium-dependent 
vasodilation, for the efficient control of blood flow and pressure within the 
cerebrovasculature (Iadecola, 2004).  
Impaired cerebrovascular tone has been suggested to contribute to the development of 
chronic ischemia and the following leukoaraiosis in SVDs (Markus, 2007). Some of the 
recently characterised examples of the hereditary SVDs are CADASIL, CARASIL and 
HIHRATL (Table 1.1). Not only the NOTCH3 gene mutations in CADASIL but also 
those in HtrA serine protease 1 (HTRA1) gene and procollagen type IV α1 (COL4A1) 
gene are demonstrated to cause cerebrovascular dysfunction (Dubroca et al., 2005a, 
Stenborg et al., 2007, Oide et al., 2008, van Agtmael et al., 2010). CARASIL is an 
autosomal recessive SVD with leukoencephalopathy and severe arteriopathy 
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characterised by VSMC degeneration, vessel wall thickening, medial hyaline 
degeneration and splitting of the internal elastic lamina (Oide et al., 2008, Arima et al., 
2003). The mutations in HTRA1, a repressor of TGF-β signalling, result in increased 
TGF-β activity in the small cerebral arteries (Hara et al., 2009) while constitutive 
activation of TGF-β was reported to result in the inhibition of endothelin1–induced p38 
MAPK/27kDa heat shock protein pathway, leading to the vasoconstriction defect (Tong 
and Hamel, 2007). On the other hand, COL4A1 mutations in HIHRATL, which cause 
detachment of endothelium, affect NO-mediated vasodilation. Although the mechanism 
is yet to be determined, deposition of mutant collagen type IV was suggested to induce 
ER stress response, leading to reduced NO synthesis (van Agtmael et al., 2010). The 
presence of hereditary SVDs with mutations in genes related to vascular autoregulation 
emphasises the importance of unperturbed cerebral perfusion. 
1.4.3 Perivascular lymphatic drainage system 
Two cerebral drainage pathways, namely cranial/spinal arachnoid villi and the 
lymphatic drainage, are responsible for the drainage of cerebral interstitial fluid (ISF) 
and cerebrospinal fluid (CSF) into the blood circulation and the lymphatic system, 
respectively (Weller et al., 2009). While the former pathway is the main route of CSF 
drainage in human, the latter is important for the perivascular drainage of ISF. ISF flows 
along the basement membrane of capillaries and also between VSMCs in arterial walls, 
eventually draining to deep cervical lymph nodes at the base of the skull (Clapham et al., 
2010, Weller et al., 2009) (Figure 1.8). The perivascular drainage helps the removal of 
solutes from the brain; the best example would be Aβ, which accumulates in 
cerebrovascular walls of the elderly and AD to cause CAA due to the disrupted 
clearance of amyloid-β through the perivascular pathway (Weller et al., 2008). Weller‘s 
group (2006) proposed cerebrovascular tone as the driving force that generates reverse 
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flow against blood flow along the perivascular pathway. Thus, the disruption of 
cerebrovascular tone, either by ageing or disease pathology, results in the prolonged 
time for ISF/solutes to be in close contact with vessel walls, promoting the deposition of 
proteins prone to accumulate, such as Aβ within the basement membranes. The 
deposition causes ―protein-elimination failure arteriopathy (PEFA)‖ that may increase 
susceptibility to haemorrhage and ischemia, and further disrupts the drainage of ISF and 
solutes (Weller et al., 2010).  Given the overall evidence for cerebrovascular 
dysfunction in SVD, it is plausible that PEFA is involved in their pathogenesis. 
Figure 1.8. Perivascular lymphatic drainage pathway. Interstitial fluid (ISF) and solutes 
from brain parenchyma move along the basement membrane of capillaries and arteries, and 
then adventitia around leptomeningeal arteries to drain out into cervical lymph nodes at the 
base of the skull. Arterial pulsation is the driving force of the perivascular drainage pathway, 
which flows opposite to the blood flow. Solutes can be ingested by vascular smooth muscle 
cells (VSMCs) and perivascular macrophages (Mac). Pia: pia mater, Arach: arachnoid, SAS: 
subarachnoid space, BM: basement membrane 
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1.5 Aims and thesis outline 
In view of the foregoing background, the aims of the study were to characterise the 
cerebral pathology of CADASIL in order to reveal the pathogenic basis of the disorder 
phenotypes, especially related to cognitive dysfunction. The main issues addressed in 
this thesis are:  
1)  The extent of vascular and perivascular changes and the difference between 
sporadic SVD, with reference to the characteristic anterior temporal pole MRI 
hyperintensity in CADASIL.  
2) Relationship of GOM and N3ECD and possible involvement of a perivascular 
drainage system in CADASIL pathogenesis. 
3) Involvement of hippocampal pathology and/or WM disconnection to CADASIL 
cognitive impairment. 
The following chapter describes general materials and methods used in this study, 
chapters three to six contain results, and the final chapter contains an overall discussion. 
Chapter three and four were devoted to the characterisation of the vascular and 
perivascular pathology in CADASIL. Vessel wall thickening and PVS enlargement 
were quantitatively assessed and compared with controls and sporadic SVD cases. 
Localisation of GOM and the N3ECD accumulation in CADASIL in relation to 
arterioles and capillaries were also evaluated using bright-field immunohistochemical 
and electron microscopic immunohistochemical methods. The subsequent chapters 
address neuronal pathology in CADASIL. The density of neurons in hippocampal 
formation, which has been reported to be decreased in several forms of dementia, was 
quantified using a 3-dimentional stereology method. The result provided an insight into 
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the neuronal basis for the cognitive features in CADASIL, for the first time. The density 
of damaged axons, as indicated by SMI32 immunostaining, was also measured to 
evaluate the distribution and extent of WM damage in CADASIL. In conclusion, a 
comparison of pathological changes associated with cognitive deficit in CADASIL and 
other dementias were discussed. 
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Chapter 2.  Materials and Methods 
2.1 Introduction 
This chapter describes the diagnostic criteria for CADASIL, SVD and Cognitive 
function after stroke (COGFAST) cases, and definition of controls. It also outlines the 
brain sampling methods and histological protocols used to stain brain sections followed 
by the details of image and statistical analysis.  
2.2 Study subjects 
2.2.1 Cognitive tests 
Cognitive functions of COGFAST and CADASIL patients were evaluated by clinical 
psychologists using following cognitive tests. 
2.2.1.1  Mini-mental state examination  
Mini-Mental State examination (MMSE) is a short questionnaire test for screening 
cognitive impairment (Folstein et al., 1975). It is the most commonly used cognitive test 
for its sensitivity and specificity though they can be affected by age, sex, cultural 
background and educational level (Gagnon et al., 1990, Crum et al., 1993). The MMSE 
is comprised of five sections: orientation, registration, attention and calculation, recall, 
and language and praxis. Most frequently used cut off score is 23 and a score of 23 or 
less suggest the presence of cognitive impairment. For classification purpose, scores of 
27-30 is considered normal, 21-26 as mild cognitive impairment, 10-20 as moderate and 
<10 as severe cognitive impairment (van Gorp et al., 1999, Mungas, 1991). 
2.2.1.2 CAMCOG 
CAMCOG (Cambridge Cognitive Examination), which is a cognitive test section of 
CAMDEX (Cambridge Mental Disorders of the Elderly Examination), was designed to 
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assess various cognitive functions for the diagnosis and grading of dementia (Roth et al., 
1986). It comprises of 67 items covering broader range of cognitive functions 
(orientation, language, memory, praxis, attention, abstract thinking, perception and 
calculation) and is modified by age and educational level, thus more effective in 
differentiating non-demented and demented (including mild dementia) individuals than 
MMSE (de Koning et al., 1998, Lindeboom et al., 1993). The commonly-used cut point 
of CAMCOG is 79/80 where 92% sensitivity and 96% specificity can be achieved (Roth 
et al., 1986). 
2.2.2 Diagnosis and definition of groups 
2.2.2.1 Cerebral small vessel disease and CADASIL 
Cerebral SVD is a general term for diseases with pathological alternations of small 
arteries, arterioles venules and capillaries of the brain, which result in small, and often 
silent, subcortical infarcts, WM lesions, haemorrhages and microbleeds. The cause of 
the pathological changes varies between cases, well-known examples including 
Binswanger‘s disease and CADASIL (Kalaria and Erkinjuntti, 2006). SVD cases in this 
study include those of mixed sex with pathological changes in small vessels and 
multiple small/micro infarcts or lacunar infarcts. Age range was 67 - 96 years. 
CADASIL is a familial form of cerebral SVD caused by defects in VSMC. The 
CADASIL cases in this study were either a member of the known CADASIL families or 
individuals initially suspected of CADASIL based on MRI, clinical features and family 
history, and confirmed of the diagnosis by the genetic screening for the NOTCH3 
mutation. Alternatively, skin biopsy was performed to confirm CADASIL-specific 
GOM.  For details, see Table 2.1. 
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Subjects Age(yr) Sex Mutation 
Disease 
Duration (yr) 
Notable clinical features 
and risk factors 
CAD1 44 F Arg153Cys 8 Cardiac arrhythmias 
CAD2 52 M Arg141Cys 10 No vascular risk 
CAD3 53 F Arg133Cys 6 No vascular risk 
CAD4 55 M Arg558Cys 11 Brief history of gout 
CAD5 58 M - n/a n/a 
CAD6 59 M Arg169Cys 12 No vascular risk 
CAD7 61 M Arg169Cys 10 Obesity (55yr -) 
CAD8 63 M Arg141Cys 10 Enlarged thyroid 
CAD9 65 M Arg141Cys 13 Parenchymatous goitre 
CAD10 66 F - n/a n/a 
CAD11 68 F Arg133Cys 18 Smoking history 
CAD12 68 M Arg153Cys 28 Smoking, prostate tumour 
Table 2.1. Details of CADASIL cases.  
2.2.2.2 COGFAST cases 
COGFAST study is a prospective cohort study following up cognitive functions of post-
stroke patients. The aims of the study are to elucidate the mechanism of delayed 
cognitive impairment after stroke and to determine factors influencing the fate of post-
stroke survivors. To eliminate acute post-stroke cognitive impairment and noise, 
patients who were older than 75 years old and without cognitive impairment at three 
months after stroke were recruited for the study. MRI and cognitive tests were 
conducted at the entry to the study and subsequently, changes in cognitive functions 
were evaluated once a year after stroke using MMSE and CAMCOG. Follow-up MRI 
scans were also taken for patients enrolled into structural of functional study. Autopsy 
was performed 24-92 hours after death and the brain was fixed in 10 % buffered 
formalin for 1- 8 months. Braak stage and CERAD (consortium to establish a registry 
for Alzheimer's disease) score were determined by a neuropathologist. From 54 
COGFAST cases autopsied so far, demented cases were selected for analysis based on 
the criteria that they have no or little AD pathology (Braak stage ≤ 3) and with MMSE 
score of less than 21. The age range of the resulting cases was 82 – 98 years. 
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2.2.2.3 Control criteria 
Controls were selected on the basis of the absence of any significant vascular or 
neurological pathology.  As the mean age of CADASIL and SVD or COGFAST cases 
were significantly different, two control groups (young and old controls) each age-
matched to each disease group were prepared. Cause of death varied between cases but 
cancer (gastric, bowel and lung) was inevitably frequent in young controls.  
2.2.3 Brain tissues 
Formalin fixed, paraffin embedded blocks of human brain tissue were obtained from the 
Newcastle Brain Tissue Resource Centre, Institute for Ageing and Health, Newcastle 
University. Some of the control cases were acquired from the Medical Research Council 
Sudden Death Brain & Tissue Bank, the University of Edinburgh. 2 CADASIL cases 
were acquired by courtesy of Dr. Kretzschmar, Ludwig Maximilians University, 
Munchen, Germany. The use of the tissue for our research project was additionally 
approved by the Brain Bank Committee. The primary Neuropathological diagnosis and 
observations were transcribed from postmortem reports. Brains with fixation length of 
less than 10 months were selected for the studies where possible to reduce the 
variability in immunohistochemical (IHC) staining intensity due to the fixation length. 
CADASIL brains were obtained from Newcastle (n = 4), Oxford (1), London (1), 
Bristol (3), America (1) and Germany (2) (Table 2.1). As the Bristol cases (CAD2, 8 
and 9) were fixed for notably long time, they were excluded when fixation length 
significantly affects the intensity of IHC. Brain areas investigated in this study are 
frontal lobe, temporal lobe (hippocampus and entorhinal cortex) and temporal pole. 
2.2.3.1 Frontal lobe 
Frontal lobe, which consists of motor, premotor and prefrontal regions, is associated 
with executive functions, attention, long-term memory, speech, emotions and reasoning 
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(Chayer and Freedman, 2001). Impairment in frontal lobe functions is implicated in 
various disorders such as SVD, schizophrenia and attention deficit disorder (Nakamura 
et al., 2008, Krain and Castellanos, 2006, Chen et al., 2009). As hyperintense MRI 
signal is observed in the frontal lobes of asymptomatic and symptomatic CADASIL 
patients (Coulthard et al., 2000), frontal lobe tissues at the coronal level of 4-5 in 
Newcastle Brain Map were selected for the analysis (Figure 2.1). The area contains 
Brodmann areas (BA) of 8 and 9, dorsolateral prefrontal cortex, which are involved in 
management of uncertainty, attention and working memory.  
2.2.3.2 Hippocampal areas and entorhinal cortex 
Hippocampus and adjacent entorhinal cortex are important areas for autobiographical, 
declarative and episodic memory. Information from other areas of the brain is sent to 
dentate gyrus and CA1 through layer II and III of entorhinal cortex, respectively. The 
information travels through CA3, CA1, subiculum and finally back to layer V of 
entorhinal cortex, which relay the signal to neocortex via parahippocampal and 
perirhinal cortex (Amaral and Lavenex, 2006). Temporal lobe block was chosen from 
coronal level of 16-18, where entorhinal cortex (BA28 and 34) is present. Hippocampal 
areas and entorhinal cortex were defined as described by the others (Amaral and 
Insausti, 1990, Insausti et al., 1998). CA2 forms a tight band of large pyramidal cells, 
which broaden at the border between CA1 containing a substantially heterogeneous 
group of neurons. Layer V of entorhinal cortex, consisting of large pyramidal neurons, 
is located above medium-sized pyramidal layer III (caudal or rostral) or cell-sparse layer 
IV (intermediate).  
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Figure 2.1. Newcastle Brain Map. Brain tissues were obtained from the described 
coronal levels. Numbers indicate Brodmann areas. Block code was marked with 
alphabets (navy letters). 
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2.2.3.3 Temporal pole 
Temporal pole is an area where MRI hyperintense signal is frequently found in memory 
and personal semantic memory (Olson et al., 2007). Temporal pole blocks from the 
coronal level of 10-12, including BA20, 21, 22, 28, 36 and 38, were used for the study.  
2.2.3.4 Routine pathological evaluations 
As a routine diagnostic procedure, brain samples were examined by neuropathologists 
for the pathological changes consistent with AD, DLB and vascular dementia. Routine 
staining methods include silver staining, modified Bielschowsky, Gallyas and 
Palmgren‘s stain, luxol fast blue (LFB), and haematoxylin and eosin (H&E). Vascular 
lesions were noted as cortical/subcortical multiple infarcts, lacuna infarcts, 
microinfarcts and small vessel disease. AD pathology was evaluated using Braak 
staging and CERAD rating. Cortical Braak staging is commonly used pathoanatomical 
classification of AD stages. The pathological states are categorized into six distinct 
stages based on the topographical distribution pattern of neurofibrillary tangles and 
neuropil threads in the brain (Braak and Braak, 1991). Those tangles are primarily 
restricted to the transentorhinal region at stage I-II and spread to entorhinal region, 
moderately affecting CA1 at stage III and then severely at stage IV. At stage V, all 
regions in hippocampus and neocortex are affected and the pathology is aggravated at 
stage VI. Stages I and II are asymptomatic with more than 50% of individuals over 50 
years old reaching these stages (Duyckaerts and Hauw, 1997). From stage III, 
neurofibrillary tangles and neuropil threads begin to cause neuronal death, causing 
cognitive impairment, and patients are diagnosed of dementia by stage V.   
CERAD is also a neuropathological criterion for the diagnosis of AD. The plaque score 
is graded based on the number of neuritic plaques per x100 light microscopic field 
(none, sparse, moderate and frequent) and age at death: score A indicates uncertain 
Materials and Methods Chapter 2 
 
49 
evidence of AD, B is suggestive of AD and C is an indication (Mirra et al., 1991). The 
plaque score is further integrated with clinical history of dementia to determine the 
certainty of AD diagnosis. 
2.3 Histology 
Paraffin embedded blocks were cut into 10 - 30 µm sections using a microtome 
(Shandon Finesse E+, Thermo Electron Corporation) and sections were mounted onto 
4 % APES coated slides. Slides were dried in 37 ˚C incubator for 2 days and the wax 
was melted at 60 ˚C for 30 minutes prior to the dewaxing in xylene. The concentration 
of the primary antibody was determined for each by titering using positive control 
sections. 
2.3.1 H&E  
H&E staining was used to visualize brain tissue for PVS and sclerotic index (SI) 
analysis. After dewaxing and re-hydration, 10-µm sections were immersed in 
haematoxylin solution for 30 seconds and rinsed in water. The sections were 
differentiated in 1% acid alcohol, washed in water and then in ammonia water to blue. 
Rinsed sections were counterstained in eosin for 3-4 minutes, dehydrated in increasing 
alcohol, and cleared in xylene before mounted in DPX.  
2.3.2 LFB 
LFB is a suitable staining for the visualisation of myelinated axons in WM. 10-µm 
sections were incubated in LFB solution for two hours at 60 °C and left at room 
temperature for 10 minutes before rinsed in 70% alcohol and then in water. The 
differentiation was conducted by immersing sections in 1% lithium carbonate for 
approximately 10 seconds followed by 70% alcohol until GM and WM are clearly 
distinguishable. The sections were counterstained with 0.1% cresyl fast violet (CFV) in 
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1% acetic acid for up to 5 minutes at room temperature and differentiated in 95% 
alcohol before mounted in DPX.  
2.3.3 CFV 
Nissl substance is granular basophilic bodies consisting of RNA and polyribosomes in 
the cell body and dendrites (Nievel and Cumings, 1967, Scott and Willett, 1966). CFV 
was used to visualize neurons and glial cells (cell nuclei) for the evaluation of neuronal 
and glial density changes in CADASIL and COGFAST. 30 µm sections were incubated 
in 0.1 % CFV in 1% acetic acid at 60 ˚C for 15 minutes. After rinsed in water, they were 
differentiated in 95% alcohol until only neuronal body and nuclei were stained purple 
and mounted in DPX. 
2.3.4 Standard procedure of single label immunohistochemistry 
Paraffin-embedded brain tissue blocks were cut into 10 - 30 µm sections. After 
incubated at 60 ˚C for 30 minutes, sections were transferred into xylene to dewax, 
followed by rehydration in decreasing concentrations of alcohol. The antigen retrieval 
was performed by microwaving sections in 0.01M citrate buffer (pH 6.0) for 10 minutes. 
The sections were quenched by 3% H2O2 for 15 minutes and blocked with normal 
horse serum (for anti-mouse antibody) or normal goat serum (for anti-rabbit antibody) 
for 30 minutes. Primary antibody diluted to a specific concentration with buffer was 
applied to the sections, which were then incubated at the room temperature for the 
specified length of time (1.5 – 2.5 hours). Biotinilated secondary anti-mouse/anti-rabbit 
antibody was applied to the sections with the blocking serum for 30 minutes, followed 
by incubation in tertiary antisera SABC for 30 minutes. Sections were treated with 3,3‘-
Diaminobenzadine for 5 minutes to visualize the positive antibody reaction as a brown 
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stain. After each step except blocking, sections were rinsed in buffer (PBS/TBS) for 5 
minutes x 3 times. 
2.2 Image analysis 
2.3.1 Image capture 
Zeiss Axioplan2 microscope coupled to a JVC 3 chip charge-coupled device (CCD) 
camera or an Infinity2 CCD camera was used to capture digital images of brain sections 
unless otherwise specified. While capturing images of cortex or stained axons in WM, 
the goniometer stage was adjusted to attain desired angle to the pial surface or the 
axonal tract, respectively. Magnification was chosen to reveal details of changes but 
give enough statistical power upon image analysis.  
2.3.2 Digital image analysis 
Images were analysed using Image Pro-Plus 4.0 (Media Cybernetics®). Area of the 
total immunoreactivity in the image or its percentage (PerArea) was measured by 
quantifying pixels attributed to the immunoreactivity (i.e. dark brown staining). The 
values in pixel were converted to µm2 by calibration. The image analysis, which is 
difficult to perform by Image Pro-Plus 4.0, was done using novel computer software 
created using Microsoft Visual Basic 2008/2010 Express Edition. The details of the 
software are described in each chapter. 
2.3 Statistical analysis 
Statistical analysis was performed using SPSS version 17. Kruskal-Wallis test was 
performed to assess the differences between groups, followed by Mann–Whitney U test 
to obtain p-values for each pair. When normal distribution was expected, One-Way 
ANOVA with Tukey‘s post hoc test was used instead. Spearman (rho) correlation was 
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used to test the relationships between ages, length of fixation, postmortem delay and 
quantified variables.
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Chapter 3.  Vascular and Related Perivascular Pathology 
in CADASIL 
3.1 Introduction 
CADASIL is characterized by multiple small infarcts in periventricular WM, 
subcortical GM and the pons. Hyperintensity upon T2-weighted and FLAIR sequences 
on MRI is frequently observed in WM, especially the temporal poles, thus is highly 
useful for the diagnosis of CADASIL (Kalaria et al., 2004, Dichgans et al., 1998). The 
characteristic arteriopathy, among which the most prominent are degeneration of 
VSMCs and thickening of blood vessel wall (Ruchoux et al., 1995, Miao et al., 2005), 
underlies the reduction of CBF (Tuominen et al., 2004, Lacombe et al., 2005). 
Thickening of tunica media of arteries/arterioles is caused by the increased matrix 
protein deposits, e.g. collagen and laminin (Lammie et al., 1997). Such a change occurs 
during the process of ageing (Uspenskaia et al., 2004), though slowly, and is accelerated 
in disease states such as chronic hypertension and SVD. Components and structure of 
endothelial cell also changes in CADASIL (Ruchoux and Maurage, 1998). Endothelial 
dysfunction, also reported in SVD, has been implicated in brain tissue deterioration via 
decreased CBF, impaired vascular autoregulation and increased BBB permeability 
(Topakian et al., 2010).   
The mechanism of how these vascular abnormalities lead to cognitive decline in 
CADASIL remains controversial. Much of the work in the area of dementia has 
reported the relationship between reduced CBF/Cerebral blood volume (CBV) and 
cognitive function in various types of dementia including CADASIL (Bruening et al., 
2001, Chabriat et al., 2000, Spilt et al., 2005, Osawa et al., 2004). In those studies, 
significant decrease in CBF/CBV was observed in patients with dementia compared to 
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those with no or mild cognitive impairment, suggesting severity of angiopathy is related 
to cognitive decline. Also, several studies have suggested the link between the enlarged 
PVSs, also referred to as Virchow-Robin spaces, and cerebral SVD with dementia 
including CADASIL (Cumurciuc et al., 2006, Doubal et al., 2010, Uggetti et al., 2001, 
Patankar et al., 2005). PVSs are cerebrospinal fluid-filled spaces around small 
perforating arteries and found more abundantly in WM. They are normally small and 
asymptomatic and are known to dilate further with age (Heier et al., 1989). The 
significantly enlarged PVSs are detectable as hyperintense areas in T2-weighted MR 
images similar to the infarcts. As an MRI study on the healthy elderly linked enlarged 
PVSs and worse cognitive function (non-verbal reasoning and visuospatial cognitive 
ability) (MacLullich et al., 2004), the enlarged PVSs in CADASIL may have significant 
impact on the pathology. The limitations of those MRI studies are that PVSs are only 
visible on MRI when the diameter exceeds 0.66mm while many of the vessels affected 
in SVD and their enlarged PVS are much smaller (Wang, 2009), and that those MR 
images are too low in resolution to quantify the size and thus only number of enlarged 
PVSs was scored. Hence, the aims of the study were (1) to quantify the arterial wall 
thickening and PVS enlargement using histologically stained human tissues from frontal 
lobe and temporal pole, where MRI hyperintensity is frequent, (2) to define CADASIL 
specific pathological features, and (3) to evaluate the relationship between vascular 
pathology and PVS enlargement. The results were presented in the publication I. 
3.2 Materials and Methods 
3.2.1 Subjects 
Demographic details of the subjects from which the brain samples were obtained at 
autopsy are given in Table 3.1.  
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 Frontal lobe 
Disease Group n 
Age (years) 
Mean SD 
Young  controls 6 60 7.3 
Old controls 7 79 6.3 
CADASIL 6 57 8.1 
Small vessel disease 9 78 8.2 
  
Temporal pole 
Disease Group n 
Age (years) 
Mean SD 
Young  controls 5 60 7.5 
Old controls 5 83 6.0 
CADASIL 9 58 7.5 
Small vessel disease 8 83 10.0 
Table 3.1. Sample number, mean age and standard deviation (SD) of the subjects.  Two 
control groups were age-matched to each disease group. 
Brain samples from frontal lobe and temporal pole were used in this study. Each case 
was selected based on the criteria detailed in chapter 2.1. Half of the SVD cases were 
demented at the time of death. Coronal sections at the level of BA9 were used for the 
analysis of the frontal lobe and BA20 to 22 for the temporal pole. Where available to 
match for similar age and gender, CADASIL cases were compared to young controls 
(Ycont) and SVD cases to old controls (Ocont).  
3.2.2 Histopathology 
Formalin fixed, paraffin embedded brain tissues from frontal lobe and temporal pole 
were serially cut into 10-µm-thick sections. Sections were stained in batches with H&E 
to minimize intra-assay variation. The slides were assigned random numbers and all 
analysis was performed blind to the diagnosis.  
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3.2.3 Image capture and analysis 
Sections were viewed with a Leitz Wetzlar Dialux 20 bright field microscope at 6.3x 
magnification and images were captured using a JVC 3CCD camera attached to an 
image capture board. As the area of frontal lobe sections is usually limited, all the 
arterial/arteriolar vessels (>50 µm) in WM were selected for the measurement of PVS 
and SI in frontal lobe. For temporal pole, at least 30 randomly-selected arterial/arteriolar 
vessels per case were sampled.  
Sclerotic index (SI), area of vessel wall (Vwall), lumen (Larea) and PVS were 
calculated from the mean internal diameters (mDint), mean external diameters (mDext) 
and mean diameter of PVS (mDpvs) using the formulae shown in Figure 3.1. SI was 
first mentioned by Lammie et al. (1997) and now widely used to evaluate the thickening  
Figure 3.1. Definition of the SI and PVS measurement variables. Formulae indicate how 
the variables were derived.  
SI = 1 – (Dint/Dext) 
Larea = [(Dint1 + Dint2)/4]2 π 
Vwall = [(Dext1 + Dext2)/4]2 π – Larea 
PVSc = [(Dpvs1 + Dpvs2)/4]2 π - [(Dext1 + Dext2)/4]2 π 
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of the blood vessel wall. SI of normal vessels is around 0.2-0.3, which increases to 0.3-
0.5 or even over 0.5 in severe SVD. The formulae for area estimation were derived from 
that for circular area, regarding the structure of blood vessels as a deformed circle. 
However, as the blood vessels and PVS have various shapes in reality, area of vessel 
(Vwall + Larea) and PVS in frontal lobe were quantified both by calculating from their 
mean diameters (PVSc) and by measuring in pixel using Image Pro-Plus Version 4.0 
(Media Cybernetics®, PVSi) at the beginning of the experiment. After the accuracy of 
the area estimation by calculation was confirmed, Vwall, Larea and Dpvs in temporal 
pole were quantified using the formulae only. Ratios of Larea and Vwall against PVS 
were calculated to assess the effect of vessel thickening on PVS. For temporal pole 
where MRI hyperintensity is most prominent, total PVS was estimated by measuring all 
the PVS larger than 100 µm in diameter in WM, and was divided by whole temporal 
pole WM area measured with Image Pro-Plus 4.0 to obtain the percentage of total PVS 
area in WM (%PVS). 
3.2.4 Image analysis software development 
To reduce the error caused while measuring lengths, computer software (VasCalc) was 
developed for the analysis, which greatly simplified SI and PVS evaluation. The user 
was prompted to draw user-specified number of lines, which was 2 in this study, to 
measure mDint, mDext and mDpvs. The centre of the first line was marked by a cross 
and the second line was drawn to cross the first line perpendicularly through the point. 
VasCalc calculated SI, Larea, Vwall and PVS using the formulae in Figure 3.1. See 
appendix I for full Visual Basic code. 
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3.2.5 Statistical analysis 
Kruskal-Wallis test was performed to determine the difference between groups. For the 
variables that showed significant difference, Mann-Whitney U test was used to obtain p 
values for each group pair. Correlation was tested using Pearson‘s correlation test. 
3.3 Results 
Gross examination of the sections revealed enlarged PVSs in frontal lobe and temporal 
pole of CADASIL cases (Figure 3.2). The PVSs were often located at the boundary 
between WM and GM. There was no obvious sign of infarcts in the temporal pole 
sections though many of CADASIL sections had significantly paler H&E staining - as 
pale as GM - in the WM, possibly due to the WM lesions. Some of CADASIL cases 
exhibited micro-infarct like lesions in frontal lobe, but the extent of decolorization of 
WM was less compared to that in temporal pole. 
 
 
 
 
 
Figure 3.2. Gross views of 
temporal pole sections from 
Ycont (A) and CADASIL (B). 
Note the distinctive PVSs in 
CADASIL. 
A 
B 
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3.3.1 Increased vessel wall thickness   
In general, the arteries/arterioles were slightly larger in frontal lobe than in temporal 
pole. There was no significant difference in frontal lobe mDint between groups, and 
mDext was significantly higher only in CADASIL (p = 0.001) (Figure 3.3). On the 
contrary, there was no significant difference in mDext but mDint in temporal pole. 
CADASIL mDint was significantly smaller compared to Ycont and SVD (both p < 
0.0001). The mDext was slightly larger in CADASIL but failed to reach statistical 
significance.  
SI, which indicates the ratio of vessel wall thickness against Dext, was calculated so that 
changes between different sized vessels can be compared (Figure 3.4). SI for controls 
was within the normal range defined by Lammie et al. (1997). SI of Ocont was 
increased compared to that of Ycont only in frontal lobe (p = 0.04). However, SI 
positively correlated with age both in frontal lobe (r = 0.215, p = 0.008) and temporal 
Figure 3.3. mDint and mDext in WM of frontal lobe (A) and temporal pole (B). There 
was no difference in mDint between groups in frontal lobe while m. Vessels in temporal 
pole were slightly smaller than those in frontal lobe. Significant differences compared to 
age-matched controls are marked with *. Error bars ± 2SE. 
A B 
* 
* 
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pole (r = 0.232, p = 0.001) when analyzed combined control groups, implying that there 
is a subtle effect of ageing on vessel wall thickening both in frontal and temporal lobes. 
CADASIL had markedly higher SI compared to all other groups (p < 0.0001) both in 
regions. The SI value of CADASIL was marginally higher in temporal pole than frontal 
lobe while those of the other groups were kept constant. Unexpectedly, SVD, of which 
mDint and mDext were not statistically different from Ocont, also showed significance 
against Ocont (p = 0.014 and < 0.0001 in frontal lobe and temporal pole, respectively) 
though the increase was moderate in comparison to that of CADASIL (p < 0.0001). 
Figure 3.4. SI in frontal lobe (A) and temporal pole (B). CADASIL showed significant 
increase in SI compared to other groups. Small vessel disease (SVD) also showed increased 
SI compared to old controls (Ocont). * P < 0.05 and ** P < 0.0001 vs. age-matched controls. 
Error bars ± 2SE. 
3.3.2 Enlarged perivascular spaces in CADASIL 
Values of vessel area (Vwall + Larea) and PVS, which were obtained using both 
VasCalc and Image Pro-Plus, were compared to evaluate the precision of the formula. 
Vessel area was accurately estimated using VasCalc. Although PVSc was accurate and 
B A 
** 
* 
** 
** 
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there was no significant difference when compared to PVSi, the PVSc were frequently 
slightly higher than PVSi (Figure 3.5 A). The error became larger especially when the 
shape of PVS was notably elongated in one direction, resulting in the larger difference 
between two diameters measured to calculate mean. The error was reduced in 
proportion to the number of lines drawn to calculate the mean diameter. As the accuracy 
of the formulae was confirmed, PVS in temporal pole was analyzed only with VasCalc 
(B). CADASIL showed significantly larger PVS than the others both in frontal lobe and 
temporal pole (p = 0.015 and < 0.0001 compared to Ycont, respectively). Unexpectedly, 
PVS in SVD remained at the control level. PVSc was larger in temporal pole compared 
to frontal lobe, which is consistent with MRI findings of characteristic WM 
hyperintensity in the temporal poles. 
Figure 3.5. PVS area in frontal lobe (A) and temporal pole (B). PVS in frontal lobe was 
measured both by calculation (PVSc) and Image Pro-Plus (PVSi) (±SE). There was no 
significant difference in PVS area value between two methods. P values are of PVSc. 
CADASIL showed significantly increased PVS area, more so in temporal pole. * P < 0.05 
and ** P < 0.0001 vs. age-matched controls. Error bars ± 2SE. 
A B 
** 
* 
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As the area of PVS is strongly dependent on the size of the blood vessel and does not 
always represent the extent of pathological changes, the ratio of Larea to PVSc was 
calculated. The magnitude of PVS enlargement in CADASIL became even more 
prominent with the Larea:PVS ratio especially in temporal pole (Figure 3.6). Again, the 
extent of PVS enlargement was greater in temporal pole irrespective of disease group. 
Importantly, the ratio of Larea to PVSc significantly correlated with SI not only in 
CADASIL but also in other disease groups (correlation in combined groups r = 0.312, p 
= 0.0001), indicating the close relationship between vessel wall thickening and PVS 
enlargement. There was a trend of positive correlation between PVSi and age (r = 0.213, 
p = 0. 062) in frontal lobe, but otherwise no effect of ageing on PVS was found. 
Figure 3.6. Ratio of luminal area (Larea) to PVSc in frontal lobe (A) and temporal pole 
(B). CADASIL showed significantly larger PVS even considering the size of the vessels. * 
P < 0.05 and ** P < 0.0001 vs. age-matched controls. Error bars ± 2SE. 
3.3.3 Higher percentage of PVS in temporal pole white matter 
Area percentage and number of PVS with mDpvs > 100 μm were quantified to relate 
PVS enlargement to whole temporal pole WM. %PVS was highest in CADASIL (p = 
B A 
* 
** 
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0.009 vs. Ycont) as expected (Figure 3.7). Interestingly, Ocont showed highest number 
of PVS per WM followed by CADASIL (p = 0.10 and 0.064 compared to Ycont, 
respectively) while age-matched SVD was as low as Ycont. However, the result does 
not necessarily indicate the increased vascularity in the temporal pole of Ocont as it is 
possible that the difference between Ycont and Ocont is merely due to Ocont having 
more blood vessels with PVS larger than 100 μm in diameter. The number of PVS was 
clearly significantly increased in Ocont than Ycont, but Mann-Whitney test revealed no 
difference, probably type II error due to the small sample number.  
Figure 3.7. PVS in relation to WM area in temporal pole. Percentage and number of PVS 
(No.PVS/WM) were shown in A and B, respectively. * P < 0.05 vs. age-matched controls. 
Error bars ± 2SE. 
3.4 Discussion 
The present study quantitatively examined the hyalinization of arteries/arterioles and 
PVS enlargement for the first time in CADASIL and SVD using histologically stained 
human brain tissues. We confirmed the thickening of vessel wall in SVD and even more 
extensive changes in CADASIL, suggesting that in CADASIL the overall tissue 
A B * 
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changes are more severe than that in sporadic cases. PVS size was also significantly 
increased in CADASIL compared to all the other groups while that in Ocont and SVD 
group was unchanged. The result contradicted with the previous studies, which linked 
enlarged PVSs with ageing and cerebrovascular disease (Heier et al., 1989, Doubal et al., 
2010, Patankar et al., 2005). Those studies, however, quantified number of enlarged 
PVS visible on MR images, which were likely to be around much larger blood vessels 
(e.g. perforating arteries with diameter of 50 – 400 μm) than those in this study (50 – 
100 μm). As the vessels affected in SVD are mainly small arteries and arterioles, our 
method provided advantage in detecting subtle changes overlooked in MRI studies. In 
this regard, the lack of PVS enlargement in SVD in contrast to CADASIL is an 
interesting implication that their pathophysiology may be different.  
The causes of PVS dilation have been argued but remain inconclusive. One of the 
possible causes is the BBB breakdown. Enlarged PVSs are often observed in patients 
with hypertension, Binswanger‘s disease, cerebral SVD etc. (Doubal et al., 2010, 
Benhaïem-Sigaux et al., 1987). As a MRI study on multiple sclerosis demonstrated, 
PVSs volume was increased in the proximity of BBB breakdown (Wuerfel et al., 2008). 
Considering that chronic cerebral hypoperfusion can cause BBB disruption and 
subsequent changes in vascular morphologies similar to CADASIL (Ueno et al., 2002), 
it is plausible that dysfunction of BBB, possibly leakage of toxic substances,  
contributes to PVS enlargement in CADASIL, in which frontal and temporal 
hypoperfusion have been reported (Mellies et al., 1998). Another possibility is the 
disrupted perivascular drainage of ISF. Several studies have shown that tracers injected 
into brain are cleared through the lymphatic drainage route within the capillary/arterial 
wall to lymph nodes (Weller et al., 2009). The theoretical model of the drainage system 
suggested that the driving force of the lymphatic drainage flow is vascular pulsation 
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(Weller et al., 2009), which is disrupted in CADASIL due to the impaired vascular 
reactivity (Lacombe et al., 2005, Hussain et al., 2004, Dubroca et al., 2005a). The 
reduced vascular tone, possibly caused by Notch3 signalling dysfunction, would be 
promoted by the accumulation of extracellular matrix proteins observed in CADASIL 
vasculature, which thicken and stiffen the arterial wall. The diminished arterial 
pulsation could lead to the reduced efficiency of lymphatic drainage, consequently 
accumulating protein deposits and further blocking the drainage pathway as in AD 
(Weller et al., 2008). Indeed, we noted correlation between vessel wall thickening and 
PVS enlargement. The hypothesis is also supported by a case report of macroadenoma 
with dilated PVS in the temporal stem (Cerase et al., 2009). Interestingly, the enlarged 
PVS on MR image disappeared after surgical resection of macroadenoma. The authors 
speculated that the PVS dilation was due to the mechanical obstruction of lymphatic 
drainage system by macroadenoma. In addition to the blockage of drainage system, the 
abnormal protein accumulation may cause damage to WM, resulting in PVS 
enlargement though the mechanism of such pathological changes is still unclear. Some 
suggested the involvement of inflammatory reactions (Wuerfel et al., 2008), which was 
also supported by our previous study showing increased CD45 immunoreactivity in 
CADASIL brain (unpublished data).  
We noted the increased number of PVS per WM in Ocont and CADASIL but not in 
SVD (Figure 3.7B). The increase may simply be reflecting a larger fraction of 
arteries/arterioles with mDpvs > 100 µm within total population, especially in case of 
CADASIL. However, considering the number of PVS in SVD, which was age-matched 
to Ocont and is more likely to cause PVS dilation, was as low as Ycont, it can also be 
interpreted as an indication of angiogenesis at least in Ocont. Another interesting 
finding is that changes in SI and PVS size were always more severe in temporal pole 
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than in frontal pole (e.g. Figure 3.4 and Figure 3.6). MRI hyperintensities are 
frequently found both in frontal lobe and temporal poles in CADASIL (Coulthard et al., 
2000). Our results attest the profound MRI hyperintensity in temporal poles rather than 
in frontal lobe. However, according to Ihara et al. (2010), WM changes by 
hemodynamic disturbance in frontal lobe precedes those in temporal pole in vascular 
dementia. The contradicting higher susceptibility of temporal pole to CADASIL 
pathology despite the ubiquitous expression of mutant NOTCH3 may be due to a 
‗CADASIL specific mechanism,‘ which needs to be carefully considered in the future. 
Further research, especially regarding the mechanisms of PVS dilatation, should benefit 
solving the puzzle of the CADASIL pathology.
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Chapter 4.  NOTCH3 Accumulation in the Brain 
Vasculature of CADASIL Subjects 
4.1 Introduction 
Arteriopathy is a key component of CADASIL pathogenesis, underlying subcortical 
infarcts and leukoencephalopathy. Whereas the previously examined vascular wall 
thickening is a characteristic but not a specific change in CADASIL, the N3ECD 
accumulation and GOM deposits are uniquely found in the vasculature of CADASIL 
patients (Tikka et al., 2009, Joutel et al., 2001). Joutel et al. (2000) first described the 
accumulation of N3ECD but not the ICD in the cerebrovasculature including arteries, 
veins and capillaries, and showed that it was located on the VSMC plasma membranes 
in apposition to the GOM. Under transmission electron microscopy (TEM), GOM is 
seen as a particulate, 1-2 μm-sized periodic acid-Schiff positive granular deposit. These 
are detected as electron-dense masses sited at intervals around VSMCs. Recently, it has 
also been reported to be found in the capillary basement membrane, frequently 
associated with pericytes but to a lesser extent when compared to deposits in arterioles 
of skin and muscle biopsy specimens (Lewandowska et al., 2010). The significance of 
the localization of GOM in the vasculature in terms of the pathogenesis of CADASIL is 
still debated. Similarly, the composition of GOM and the mechanisms how it is formed 
remain largely unknown. Only one report by a Japanese group (Ishiko et al., 2006) 
demonstrated the existence of N3ECD, but not the ICD, within the GOM found in 
microvessels in skin biopsy samples and hence questioned the previous widely accepted 
idea that N3ECD accumulates on the plasma membrane (Joutel et al., 2000). 
Considering the above data, it is plausible to consider that N3ECD-containing GOM is 
secreted by VSMC, possibly to remove potentially cytotoxic, aggregation-prone mutant 
N3ECD. The question to be asked is at what stage this occurs in the processing of 
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NOTCH3 along the signalling pathway. As described in the introduction, the interaction 
between NOTCH3 receptor and ligand induces its endocytosis and subsequent 
proteolytic cleavage, which dissociates NECD from ICD (Figure 1.2). Both of the 
above studies demonstrated the absence of the ICD in GOM (Ishiko et al., 2006, Joutel 
et al., 2000), suggesting that the N3ECD-GOM secretion or accumulation occurs after 
the stage of ligand-induced transendocytosis, in which case NOTCH3 ligands, such as 
Jagged1 and Jagged2, should also be found in GOM.  
The aim of the study was to verify the previous reports by assessing the localisation and 
distribution of the N3ECD accumulation in the cerebrovasculature of genotyped and 
clinically characterised CADASIL patients. Further, we seek to test the existence of 
other Notch-associated proteins in GOM in order to provide an insight into its formation 
mechanism.  
4.2 Materials and Methods 
4.2.1 IHC for light microscopic examinations 
For the screening of NOTCH3 accumulation specificity, the following cases were used: 
9 CADASIL (refer to Table 2.1, mean age = 58), 8 Ycont (mean age = 58), 7 middle-
range age controls (mean age = 75), 6 Ocont (mean age = 97) 7 young VaD (mean age = 
66) and 7 old VaD (mean age = 92). 10-μm sections from temporal lobe blocks were 
stained with anti-N3ECD antibody (A1-1, 1:25000 for 2.5 hours; courtesy of Dr. 
Watanabe), anti-ubiquitin antibody (1:50 for 2 hours; Dako, Denmark), anti-Jagged1 
antibody (1:1000 for 2 hours; abcam, US), anti-CD45 (1:200 overnight at 4 °C, Dako, 
Denmark) and anti-CD68 (1:200 for 1 hour, Dako, Denmark) which were later labelled 
with random numbers for blinded analysis. Images of representative areas in GM and 
WM were taken at x10 magnification. The A1-1 immunoreactivity in blood vessels was 
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evaluated using semi-quantitative scores: none (–), mild/slight (+), moderate (++) and 
frequent/abundant (+++). The analysis of A1-1, ubiquitin and Jagged1 was performed 
by Yamamoto Y, and the CD45 and CD68 immunoreactivity in WM was quantified 
using Image-Pro Plus 4 by Tham C.   
4.2.2 Transmission electron microscopy 
4.2.2.1  Subjects 
Figure 4.1. Pedigree of the examined CADASIL patient (II-3). Filled symbols indicate 
affected individuals and stroked line indicates deceased family member. 
A male patient (CAD12 in Table 2.1 and II-3 in Figure 4.1) with a strong family 
history of CADASIL (R153C) first experienced stroke at the age of 39. He had a 
smoking history and was taking aspirin daily. He suffered from frequent TIAs and 
multiple cerebrovascular accidents, which often manifest as sudden onset of weakness, 
vertigo and double vision. MRI revealed lesions in subcortical regions, brainstem and 
basal ganglia and signs of cerebral and corpus callosum atrophy. In later life, his 
physical functions were severely impaired with abulic, pseudobulbar, pyramidal, 
cerebellar and extrapyramidal signs, requiring him to use a wheelchair and be fed by 
percutaneous endoscopic gastrostomy. He showed symptoms of mild anxiety and 
depression. His cognitive functions were also seriously diminished and exhibited typical 
stepwise progression of subcortical type dementia. The patient experienced a massive 
stroke 9 days prior to death and died at the age of 68. The cause of death was suspected 
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to be pneumonia, but the autopsy also revealed an extensive prostate tumour causing 
pyelonephritis. The brain was removed and dissected within 12 hours postmortem. The 
brain had a more gelatinous consistency than was normal.  
As a control, brain tissue from an 89 year-old female was also sampled. The patient had 
a history of hypertension and an episode of possible TIA, but was cognitively intact. 
She died of ischemic bowel disease and multiple organ failure following surgery. 
4.2.2.2 Tissue sampling and embedding 
Brain tissue was sampled from GM and WM in frontal and temporal lobes, and also 
from meninges. After 16-hours fixation in 2% paraformaldehyde and 0.05% 
glutaraldehyde in 0.1M phosphate buffer (PB, pH7.4), the samples were rinsed in two 
changes of PB for 15 minutes each. Half of each batch of samples was treated with 1% 
osmium tetroxide (OsO4) in 0.1M PB for 1 hour followed by rinses in PB for 4x15 
minutes. All the samples were then dehydrated in increasing concentrations of alcohol 
from 50% to absolute at 15 minutes intervals. The samples were cleared in two 10 
minutes changes of propylene oxide and then incubated in a 50/50% propylene oxide / 
epoxy resin mixture for 1 hour, followed by a 25/75% mixture for 1 hour and 2 changes 
of 100% epoxy resin for 1 and 2 hours, respectively, before being embedded in 
preformed beem capsules. The embedded samples were incubated at 37 °C for 2 hours 
before being placed into a 60 °C incubator for 48 hours. 
4.2.2.3 Immuno-gold labelling  
An Ultracut microtome (Reichert-Jung, Depew, NY) was used to cut 1 μm sections 
from embedded samples with the aid of a Histo Diatome knife and a DDK Delaware 
Diamond knife was used for cutting ultra thin sections (~700Å). 1 μm sections were 
placed on glass slides and stained with an aqueous solution of 1% toluidine blue and 1% 
NOTCH3 Accumulation in the Brain Vasculature of CADASIL Subjects Chapter 4 
 
71 
borax for 30 seconds on a hot plate in order to confirm the position of blood vessels in 
the section. The block was then trimmed to encompass the required structures and ultra 
thin sections then cut onto the water trough of the diamond knife. The sections were 
then placed onto 3.05 mm nickel 300 square mesh grids, which had been pre-treated 
with 10 % nitric acid. OsO4 treated sections were used for morphological examination 
and non- OsO4 treated sections were further processed for immuno-gold labelling with 
A1-1.  
Throughout the procedures, TBS (pH 7.4) containing 1% BSA and 0.1% tween20 was 
used as a buffer. The non-OsO4 epoxy-resin sections were etched with two changes of 
3% sodium meta-periodate for 20 minutes and heated in 0.01M citrate buffer (pH 6) at 
90 °C for 10 minutes to increase the antigenicity. After blocking with 5% bovine serum 
albumin (BSA), 5% normal goat serum and 0.1% gelatine in TBS for 30 minutes, the 
grids were incubated in antibodies against A1-1 (1:4000), Jagged1 (1:1000; abcam, 
USA), ubiquitin (1:50; Dako, Denmark), heat shock protein 27 (HSP27, 1:100; abcam, 
USA), α-actin (1:100; Dako, Denmark) and collagen IV (1:30, abcam, USA) diluted in 
buffer for 2 hours at room temperature. They were rinsed in four changes of buffer and 
subsequently incubated in EM Goat anti-Rabbit IgG 5 nm Gold probes (1:30; 
BBInternational, UK) for one and a half hours. Sections, which were not treated with 
the primary antibodies, were stained with anti-human IgG-5nm gold conjugate (1:30, 
BBInternational, UK) to assess the involvement of immune response. To increase the 
visibility of the gold particles, the sections were further treated with a Silver Enhancing 
Kit for Light and Electron Microscopy (BBInternational, UK). Subsequently, the 
sections were post-fixed in 2% buffered glutaraldehyde for 5 minutes. They were 
contrasted with uranyl acetate saturated in 70% ethanol for 15 minutes at 60 C and then 
with aqueous lead citrate for 5 minute at room temperature. EM images were taken 
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using a Philips 201 transmission electron microscope coupled to a Gatan multiscan 
camera, model 791 (Gatan, Pleasanton, CA). 
4.3 Results 
4.3.1 NOTCH3 ECD accumulation in CADASIL microvasculature 
Figure 4.2 and Table 4.1 summarize the light microscopic observation of A1-1 stained 
brain tissues. Distinct staining patterns, which were consistent with those by another 
N3ECD antibody (N2) described previously (Low et al., 2007), were observed in 
CADASIL tissue compared to all other groups. Except for CAD9, all CADASIL cases 
exhibited strong immunoreactivity in the vessel walls, although there was a slight 
difference in the size of the immunoreactive vessels and in stain intensity (Figure 4.2 A 
and B). Almost all small to large arterioles in both WM and GM were stained in 
CADASIL cases except for CAD4 and CAD8, in which small vessels in GM were 
negative for N3ECD or only faintly stained. The weak or no staining in CAD8 and 
CAD9, respectively, was probably due to the long fixation of the brain and consequent 
loss of antigenicity. The most distinctive difference was found in GM, where small 
vessels were still immunoreactive to N3ECD. The discontinuous, granular staining was 
found along the vessel walls of capillaries containing pericyte-like cells, which were 
also stained with A1-1 (B inset). Although most of the vessels were negative for 
N3ECD in controls, partial immunoreactivity was occasionally found in the wall of 
small vessels, possibly from pericytes or perivascular macrophages (C and D). Some, 
but very few, small vessels or larger arterioles in controls were stained in a similar 
pattern and always to a lesser extent than those in CADASIL (E and F). The number 
and the intensity of the microvascular staining in controls seemed to increase with age 
though such staining was rarely observed in a single isolated small vessel even in the 
controls aged over 100 years. Similarly, some VaD cases showed a few stained small  
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Figure 4.2. N3ECD accumulation in CADASIL vasculature. Large arterioles in WM (A) 
and small capillaries/arterioles in GM (B) of CADSIL were strongly stained with A1-1 (images 
from CAD7). The immunostaining in capillaries was granular with immunoreactive pericytes (B 
inset, arrowhead). Vessels in controls were mostly negative for N3ECD with stained 
macrophage-like cells, which may also be the source of partial immunoreactivity in small vessels 
(C and D from Ycont). A few arterioles of varying size in some of Ocont cases showed similar 
immunoreactivity as in CADASIL (E and F). Vasculature in VaD WM was also negative for 
N3ECD (G and H). Bars represent 50 μm, and 10 μm for insets. 
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Case (n) 
Age 
(yrs) 
Distribution in vascular profiles Other comments 
Arteries Arterioles Capillaries Perivascular cells 
CADASIL (9) 58    yes(4)/no(5) 
CAD1 44 +++ +++ +++ yes 
CAD2 52 ++ ++ + yes 
CAD3 53 ++ ++ ++ yes 
CAD4 55 ++ ++ – no 
CAD6 59 +++ +++ ++ no 
CAD7 61 +++ +++ +++ yes 
CAD8 63 + + +/– no 
CAD9 65 – – – no 
CAD11 68 +++ +++ ++ no 
Ycont (8) 58 – – – yes(4)/no(4) 
Mcont (7) 75 – – – yes(5)/no(2) 
Ocont (6) 97 – – (/+) – (/+) yes(6)/no(0) 
Young VaD (7) 66 – – – yes(4)/no(3) 
Old VaD (7) 92 – – – (/+) yes(7)/no(0) 
Table 4.1. Immunoreactivity of N3ECD antibody in CADASIL, controls and VaD. 
Score symbols show no (–), mild/slight (+), moderate (++) and frequent/abundant (+++) 
immunoreactivity. Only CADASIL cases exhibited extensive vascular immunoreactivity. 
A1-1 stained capillaries appeared more frequent in older cases in non-CADASIL cases. 
Immunoreactive perivascular cells were also more common among older cases. Ycont: 
young control, Mcont: middle-range age control and Ocont: old control.  
vessels in GM, more in old than young, though most vessels were unstained (G and H). 
Neuronal staining was observed in many of the cases and the intensity and number 
increased with age. Strongly stained macrophage-like cells were observed around large 
arteries/arterioles in many cases, more common in older cases (Table 4.1). The above 
observations indicate that NOTCH3 accumulation in vasculature, especially in small 
vessels, is a CADASIL specific feature. 
4.3.2 Distribution of ubiquitin and Jagged1 in CADASIL vasculature 
We hypothesized that ubiquitin and Jagged1, which are both known to bind to a Notch 
receptor at some point in the Notch signalling pathway, are the other components of 
GOM. Light microscopic observation revealed ubiquitin immunoreactivity in the tunica 
media of arterioles in CADASIL but not in the capillaries (Figure 4.3). Similar VSMC 
layer staining was present in controls but in notably fewer arterioles. The capillary 
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immunoreactivity was same for controls and CADASIL; some of the pericytes and 
perivascular cells, possibly macrophages, were strongly stained for ubiquitin. Jagged1 
immunoreactivity, on the other hand, was absent from the VSMC layer. The Jagged1 
staining was present in neurons and perivascular cells, which were significantly increased 
Figure 4.3. Ubiquitin and Jagged 1 immunoreactivity in CADASIL and control brain 
tissues. Vascular smooth muscle layer of arterioles was stained for ubiquitin in CADASIL 
whereas it was negative in controls. Jagged1 immunoreactivity was found mostly in neurons 
(inset) and perivascular cells. Bar represents 50 μm and 40μm for inset. 
4.3.3 Colocalisation of NOTCH3 ECD and GOM in small vessels 
As described in the previous section, IHC revealed N3ECD accumulation in brain 
arteries/arterioles as well as capillaries, which do not have VSMC. To determine the 
exact location of N3ECD accumulation in the cerebral vasculature, GM, WM and 
meninges samples from a CADASIL patient (CAD12) were processed for EM. The 
examination of 1 μm epoxy embedded tissue sections using light microscopy showed  
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Figure 4.4. Specificity of A1-1 antibody. A1-1 immuno reactivity was found almost 
exclusively inside GOM depositions around vascular smooth muscle cells (VSMC) (A and 
B). No labelling was observed in GOM in control and negative control tissues stained for 
N3ECD (C and D), α-actin (E) or collagen IV (F) stained sections whereas antibody-specific 
staining was present for the latter two. L: lumen, M: plasma membrane, N: nucleus. Bars 
represent 1 μm. 
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Figure 4.5. GOM depositions observed around VSMC in a meningeal artery. N3ECD-
containing GOM was abundantly found in the close proximity of VSMC (A). In addition, a 
linear labelling pattern was occasionally observed in the cytoplasm (arrows). B shows the 
heterogeneousity of GOM; the farther from the plasma membrane, the more loosely the 
granules were associated, which was also evident from the distribution of gold particles. L: 
lumen, M: plasma membrane. Bars represent 1 μm (A) and 2μm (B). 
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severe tissue disruption, possibly due to the extensive trauma of the stroke the patient 
suffered prior to death. A large amount of corpora amylacea was also observed in the 
WM.  
At EM level, some of the intracellular components, e.g. mitochondria, Golgi apparatus 
and ER, were damaged or completely lost in the blood vessels in GM and WM as 
expected, but the structural components of meningeal arteries were relatively well-
preserved. EM examination also revealed abundant deposition of 0.2-2 μm GOM within 
the vasculature. The electron-dense material was immunoreactive to the immuno-gold 
staining with A1-1 antibody (Figure 4.4 A, B and Figure 4.5). Such labelling of GOM 
was not observed in control (C) and negative control tissues (D) or when the sections 
were stained for α-actin (E) and collagen IV (F), confirming the specificity of A1-1 
immunoreactivity and thus the presence of N3ECD in GOM. N3ECD containing GOM 
were found not only around VSMCs in arteries and arterioles but also within basement 
membrane or around pericytes in the capillaries from GM (Figure 4.5, Figure 4.6 and 
Figure 4.7). Most of the GOM deposits were heterogeneously stained with uranyl 
acetate and lead citrate; the granular component of GOM were more loosely associated 
as distanced from the plasma membrane of VSMCs as if they are dispersed into ISF 
(Figure 4.5 B). Where the staining was darker, the more gold particles were attached, 
which suggests a concentration gradient of N3ECD within GOM. No clusters of gold 
particles unassociated with GOM were found on the plasma membrane.  
Interestingly, linearly arranged intracellular gold labelling was observed in the several 
arterial VSMCs in meninges, which relatively retained the structure of cell organelle 
(Figure 4.5 A arrows). They appear to be associated with disrupted membranous 
structure. Some pericytes contained several kinds of 0.1-0.3-μm inclusion bodies  
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Figure 4.6. N3ECD-labeled GOM depositions found in the tunica media of a small 
arteriole in GM. L: lumen, EC: endothelial cell, BL: basal lamina, VSMC: vascular smooth 
muscle cell. Bars represent 5 μm (A) and 1 μm (B), respectively.  
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Figure 4.7. Capillaries in GM. N3ECD-labeled GOM were found in the basement 
membrane of capillaries (A and B) and also around pericytes (C). A few gold particles were 
also associated with some of the vesicles in pericytes (arrowheads). Bars represent 2 μm (A, 
B and C) and 1 μm (C inset), respectively.  
distributed throughout the cytoplasm, some of which were opaque while others were 
more electron dense (granular pericyte, Figure 4.7 C). A few gold particles were 
attached to the darkly stained vesicles in the pericytes while almost none were found in 
the cytoplasm (C inset).  
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To identify other components of GOM, we stained ultra thin sections with antibodies for 
Jagged1, ubiquitin and HSP27. The background staining was slightly high with Jagged1 
antibody, but no significant amount of gold particles was specifically attached to GOM 
with any of the antibodies. Immunostaining for human IgG also showed no attachment 
of gold particles to GOM, suggesting lack of antibody production against mutant 
Notch3 within GOM. 
4.3.4 Immune response in CADASIL 
Percentage of CD45 and CD68 immunoreactivity (%Area), which are the markers of 
neucleated hematopoietic cells (e.g. B- and T cell) and monocytes/macrophages, 
respectively (Donovan and Koretzky, 1993, Holness and Simmons, 1993), was 
quantified to assess the involvement of immune response in the CADASIL pathology. 
Most of the CD45-positive cells were found around vessels whereas CD68-positive 
cells were abundantly found in the WM of CADASIL brains as shown in Figure 4.8. 
The significant difference was observed between CADASIL and age-matched controls 
for the CD45 %Area (p = 0.004) but not for CD68.  
Figure 4.8. CD45 
and CD68 
immunoreactivitie
s in the white 
matter of 
CADASIL brain. 
There was a 
significant increase 
in the percentage of 
CD45 
immunoreactivity 
between CADASIL 
and young controls 
(marked with *). 
Bar represents 50 
μm. 
CD45 
CD68 
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4.4 Discussion 
Since the report of the N3ECD accumulation in the vasculature of CADASIL patients, it 
has been thought that N3ECD accumulates on the plasma membrane adjacent to, but not 
within GOM until challenged by a study showing the existence of N3ECD within skin 
GOM (Joutel et al., 2000, Ishiko et al., 2006). Since no study has followed to confirm 
either of the results, we examined the presence of N3ECD in GOM using postmortem 
brain tissue from a CADASIL patient. Here, we confirmed that N3ECD in fact 
accumulates inside GOM deposits located at the basement membrane of arteries, 
arterioles and capillaries in the brain for the first time. GOM deposits, sized 0.5-2 μm, 
were found in close proximity to either VSMCs or pericytes, consistent with a recent 
observation by Lewandowska et al. (2010) in skin biopsies.  
The differences between our observations and that in Joutel‘s study may be attributed to 
the methodology used to demonstrate the localisation of GOM. The major problem in 
Joutel et al.‘s study (2000) was the use of pre-embedding method on paraffin embedded 
postmortem brain tissues fixed in buffered formalin. The method greatly limits the 
accessibility of antibody to the antigen and reduces antigenicity, which could explain 
the partial immunoreactivity adjacent to GOM (Ishiko et al., 2006). On the other hand, 
Ishiko‘s group (2006) used skin biopsy samples prepared using cryofixation and freeze 
substitution, which require several tissue-embedding processes at -60 to -80 °C but 
preserve the antigenicity. We sought an easier method that we could use on brain tissues 
fixed in paraformaldehyde at room temperature, but without false negative result, and 
optimised the post-embedding immunogold staining method. Our method successfully 
maximised the immunoreactivity by the combination of double etching and antigen 
retrieval in citrate buffer while reducing non-specific background staining as 
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demonstrated by the lack of staining in GOM in negative controls and collagen IV 
stained sections. 
The heterogeneous distribution of N3ECD suggested the presence of other components, 
and thus this study also attempted to demonstrate the involvement of other Notch-
related proteins in GOM deposition, namely Jagged1 and ubiquitin. Jagged1 is a major 
NOTCH3 ligand expressed in VSMCs and its interaction with NOCTH has been 
demonstrated to induce VSMC differentiation  (Hofmann and Iruela-Arispe, 2007, Doi 
et al., 2006). We hypothesized that Jagged1, ubiquitin and/or HSP27 were inherent in 
GOM with N3ECD, as ligand-N3ECD complex is reported to be endocytosed by 
ligand-presenting cells destined for lysosomal degradation, which involves the process 
of ubiquitination (Sorkin and Von Zastrow, 2009). Contrary to the expectations, 
however, GOM was completely devoid of Jagged1, ubiquitin and HSP27, though there 
still is a possibility that other Notch3 ligands expressed in VSMC, i.e. Jagged2 and 
Delta1, are expressed in GOM. In addition to those ligands, other DSL ligands, as well 
as non-DSL ligands such as Y-box protein-1, should also be tested as it has been 
suggested that NOTCH3 mutations alter Fringe glycosylation, which determines ligand 
preference of the receptor (Rauen et al., 2009, Arboleda-Velasquez et al., 2005).  
The other interesting observation of the present study was weak intracellular 
immunoreactivity in VSMCs and granular pericytes: slightly curved lines of gold probes 
in VSMCs and a few isolated gold probes on vesicles in pericytes, which have never 
been described previously. Although they have potentially valuable implications 
supporting gain-of-toxic-function (or ER stress) hypothesis (Takahashi et al., 2010), 
their reliability should be carefully considered for two reasons. One of the reasons is the 
major tissue disruption due to the patient‘s advanced disease state. The cyto-architecture 
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is normally disrupted in postmortem human material due to several factors inclusive of 
agonal state, extensive postmortem delay and immersion fixation but the consistency of 
the brain appeared flaccid and did not exhibit the normal rigidity associated with post 
mortem brain tissue. The tissue had clearly lost much of its morphological integrity and 
extensive vacuolation as well as corpora amylacea were evident. However, the 
vascularity appeared to be reasonably preserved. Close examination of the EM images 
revealed membrane-like structures underlying the linearly arranged gold particles in 
VSMCs. However, the loss of integrity of the structure does not allow further 
interpretation of possible labelled sites such as exposed ER, or VSMC plasma 
membrane invagination with GOM, which may be transected and appearing as 
unconnected islands within the cytoplasm. These structures can appear in TEM, as the 
sections are extremely thin and have little depth to follow continuity of membranes. In 
regard to the vesicular labelling in granular pericytes, the relative lack of clustered gold 
probes limits clear conclusion. More than 15 vesicles in the pericyte cytoplasm were 
labelled with a few probes in contrast to the rarely observed cytoplasmic staining. 
Although weak, the frequent staining implies the presence of N3ECD within the 
electron-dense vesicles. The vesicles are presumed to be endosomes or secondary 
lysosomes from their morphology, but their origin is difficult to ascertain from the EM 
image alone. There are two possible sources of N3ECD in those endosomes, either 
endogenous or exogenous. Surface expression of NOTCH3 receptor is regulated by its 
endocytosis from plasma membrane and the recycling or lysosomal degradation that 
follows (see Figure 1.2). The weak immunoreactivity of the vesicles may be due to the 
fact that N3ECD are not aggregated at that stage. However, it raises a question why 
such vesicles were not observed in VSMCs. Pericyte is known to have not only 
vasoconstrictive ability similar to VSMC but also macrophage-like properties, i.e. 
phagocytosis and pinocytosis (Thomas, 1999). It is plausible that N3ECD in the vesicles 
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were derived from GOM. In support of the notion, the phagocytic activity was reported 
in a previous EM study in our laboratory, which found a macrophage engulfing a GOM-
like electron-dense material (Low RC, unpublished data). Both pericytes and 
macrophage are important initiators of inflammatory response (Thomas, 1999), thus the 
above observations may not only imply clearance activity in the perivascular drainage 
system but also the involvement of inflammatory/immune responses in CADASIL 
pathology. Indeed, the observed marked increase of inflammatory cells, as indicated by 
CD45 immunoreactivity (Voskuhl et al., 2009), may corroborate the notion. However, if 
there is phagocytic activity, it does not seem to induce antibody production. Thus, 
questions remain with regard to the toxicity of GOM. To further pursue this issue, it 
would be interesting to examine cervical lymph nodes, where ISF drains into via 
perivascular drainage pathway to be filtered and GOM may activate immune system.  
A number of important limitations in the current study need to be considered. Firstly, 
limited availability of properly-fixed human brain tissue, suitable for immuno EM, only 
allowed us to examine one case each for CADASIL and control. Even though the 
specificity of N3ECD antibody and the identical staining pattern among CADASIL 
cases were confirmed at light microscopic level, it would have strengthened the 
arguments if more CADASIL cases and at least one control cases could be included. 
Secondly, the widespread ischemic changes impacted on the tissue integrity of the 
CADASIL brain as reflected by its postmortem gelatinous state. The vascular 
morphology was disturbed and many of the cell organelles were destroyed, which 
sometimes made it difficult to identify the further intracellular structures associated with 
the immunogold staining. Lastly, our optimised immuno-gold EM method significantly 
improved immunoreactivity, but often failed to detect lower concentration of antigens. 
Further studies using better morphologically preserved tissue, either from humans or Tg 
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mice, should be conducted to confirm the above findings of intracellular ultrastructural 
N3ECD gold labelling.  
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Chapter 5.  Neuronal and Vascular Pathology in CADASIL 
Compared to Sporadic Vascular Dementia 
5.1 Introduction 
The profile of cognitive impairment in CADASIL is similar to sporadic subcortical VaD 
and appears to start with impairment in processing speed and executive function, 
eventually leading to more widespread cognitive decline as the disease progresses 
(Dichgans, 2009). Cognitive function domains, e.g. reasoning, attention, memory, 
planning, recognition, speaking and perception, are managed by several different areas 
of the brain and the cross-interactions between them. Among those areas, the 
hippocampal formation including the subiculum and the entorhinal cortex, is essential 
for memory consolidation, attention and orienting reactions (Sweatt, 2004, Joseph, 
1996). Entorhinal cortex is a main interface connecting hippocampus and various 
cortical areas, including prefrontal cortex, cingulate cortex, temporal cortex, parietal 
areas and pyriform cortex (O'Keefe and Nadel, 1978). The inputs from cortical areas are 
sent to the dentate gyrus, CA3, CA1 and subiculum via the superficial layers (layer II 
and III) of entorhinal cortex, and are further conveyed to CA2, CA1, subiculum and 
back to the deep layers (layer V and VI) of the entorhinal cortex (Figure 5.1).  
Figure 5.1. Proposed neuronal inputs between hippocampal areas and adjacent areas. 
DG: dentate gyrus, S: subiculum and EC: entorhinal cortex 
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Pathological changes in the hippocampal formation have been reported in mild 
cognitive impairment and several forms of dementia. Atrophy of the entorhinal cortex 
and hippocampus - the former precedes the latter - is one of the most common changes 
in mild cognitive impairment and mild AD (Stoub et al., 2006, Pennanen et al., 2004). 
Loss of neurons is suggested as the cause of atrophy (Zarow et al., 2005), but the most 
affected areas (or subtypes of neurons) seem to differ depending on the disease 
pathology. Decreased neuronal density in the entorhinal cortex and hippocampal regions 
is implicated in cognitive decline in mild cognitive impairment and mild AD (Kordower 
et al., 2001, G mez-Isla et al., 1996, Kril et al., 2002a) while DLB showed loss of lower 
presubiculum pyramidal neurons only and not in the CA1 or entorhinal cortex (Harding 
et al., 2002, Gómez-Tortosa et al., 2000). The neuronal changes in VaD remain unclear. 
Two studies have measured hippocampal neuronal density in VaD using a stereological 
method. Zarow et al.(2005) reported that brains from ischemic vascular dementia 
patients retained neuronal number in CA1 and CA2. On the other hand, Kril et al. 
(2002b) found that the number of CA1 pyramidal neurons was substantially decreased 
in SVD with dementia. The contradicting results may stem from the difference in the 
criteria used for the selection of the dementia groups; the former study selected samples 
based on the number and location of infarcts, and the latter used demented group with 
significant vascular pathology (e.g. vessel wall thickening and PVS dilation) but no AD 
or other degenerative pathology (Zarow et al., 2005, Kril et al., 2002b). In addition to 
the problem with VaD criteria, the lack of sufficient data on neuronal density in VaD 
has limited us in drawing any conclusions. To our knowledge, no study has investigated 
the neuronal density changes in CADASIL. As the pathology underlying the cognitive 
dysfunction in CADASIL is rather uniform than in sporadic VaD or SVD, a study in 
neuronal density of the hippocampus and entorhinal cortex in CADASIL may provide 
clear insight into the cognitive impairment in SVD. 
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The cause of neuronal loss in the hippocampal formation may vary between diseases 
reflecting upon different degradative processes: abnormal protein deposition is the most 
likely candidate for both AD and DLB, and vascular factors for VaD and CADASIL. 
Cortical or subcortical microinfarcts or BBB breakdown in subcortical structures 
causing disruption to the limbic circuits, as suggested in chapter 3, may be the primary 
cause in CADASIL. Another possibility is the decreased CBF to the temporal lobe 
(Chabriat et al., 2000). Joutel and her group (2010) reported the rarefaction of 
capillaries in the corpus callosum but not in the cortex of the transgenic NOTCH3 
(Arg169Cys) mice. Our previous findings (Yamamoto Y and Kalaria RN, unpublished 
observations) indicated that the density of Glut-1 positive vasculature was decreased, 
albeit in frontal lobe, in CADASIL also support the notion that microvascular 
abnormality may contribute to the neuronal loss in the hippocampal formation.  
Therefore, in this chapter, we assessed density changes of neuronal population and 
vasculature in the hippocampus and entorhinal cortex to evaluate the neurovascular 
pathology in CADASIL. In addition, the density of a neuronal subpopulation 
immunoreactive to SMI32 antibody, a sensitive marker of ischemic insult (Leifer and 
Kowall, 1993), was assessed in order to examine the damage to the pyramidal neurons. 
The analysis was conducted using a three dimensional stereological system, which is the 
most reliable and accurate density estimation method currently available. 
5.2 Materials and Methods 
5.2.1 Subjects and IHC 
Formalin fixed, paraffin-embedded hippocampus blocks containing the anterior 
hippocampal formation from 8 CADASIL cases (mean age = 58, SD = 7.6), 10 
CADASIL age-matched controls (Ycont, mean age = 61, SD = 8.3), 7 older controls 
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(Ocont, mean age = 79, SD = 4.2), and 8 post-stroke demented COGFAST cases (mean 
age = 85, SD = 4.2, as described in chapter 2) were cut into 10- and 30-µm sections. 
Postmortem delay ranged from 14 to 72 hours and length of tissue fixation was an 
average of 6 months. There was no significant difference in fixation length and 
postmortem delay between groups. The 30-µm sections were stained with anti-non-
phosphorylated neurofilament H (mouse anti-SMI32/TBS 1:500, Covance, USA) to 
identify large pyramidal projecting neurons, and then counterstained with CFV to 
visualize all the neurons and glial cells present. During IHC, the sections were 
microwaved twice for 10 minutes for antigen retrieval. The 10-µm sections were stained 
with anti-glucose transporter-1 (rabbit anti-GLUT-1/PBS 1:200, Thermo Fisher 
Scientific Inc., USA) and CFV to identify vasculature for the quantification of the 
microvascular density in the hippocampal formation. 
5.2.2 Three dimensional stereology 
5.2.2.1 Principles  
In the past few decades, stereology has been increasingly recognised as an essential tool 
for the more precise quantification of geometrical properties in a three-dimensional 
structure. The keys to the accurate stereological estimation are uniform and random 
sampling and unbiased systematic interrogation. In principle, the sum of the probe 
dimensions and the parameter dimensions have to be larger than 3, e.g. area probe 
(dimensions, dim = 2) is used for length estimation (dim = 1) and volume probe (dim = 
3) for numbers (dim = 0) (Calhoun and Mouton, 2001). The density of linear objects, 
such as blood vessels and axons can be measured as length density since the number of 
the objects per volume strongly depends on the directionality of the object to the section 
surface. The length density of linear biological objects, which is the total length of the 
objects within a unit volume,  is estimated based on the probability of intersections 
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between probes and the objects as first proposed by George L. Buffon (1777) and later 
by Smith and Guttman (1953) for 3D application. Length per unit volume (length 
density, Lv) is related to two times the number of random intersections and area of 
sampling probe (plane).  
 
For the estimation of object density, on the other hand, volume (3D) probes (dissector 
box) are randomly placed on the image of thin sections for the number of object within 
to be counted. The density is calculated using the following formula.   
 
 
The volume of objects (VN), in number-weighted distribution, is estimated using the 
‗nucleator‘ method developed by Gundersen (1988). The unique point (e.g. nucleolus) 
of the object within the dissector box is defined by the researcher and distances to the 
boundary of cell membrane are used to calculate the volume. 
 
n is the total number of point-sampled linear intercepts and l3n,i is the cube of the ith 
point-sampled intercept length. Larger number of random distance measurements 
improves the efficiency and accuracy of the volume estimation.  
5.2.2.2 Estimation of neuronal and glial densities and neuronal size 
The immunostained 30-μm brain sections were analyzed using the computer assisted 
stereology toolbox (Visiopharm Integrator System; Visiopharm, Denmark). Each region  
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Figure 5.2. 3D stereology: counting rules and the volume estimation method. The 
middle 15-μm depth was scanned through to identify neurons and glial cells within the 
dissector box. Glial cells and neurons with a nucleolus inside or touching the green lines 
were counted and measured for volume estimation. Neurons were marked with N, SMI32 
positive neurons (coloured brown) with S and glial cells with G. The intersections of lines 
with cell membrane were marked by the researcher for volume estimation. 
of interest (ROI), i.e. entorhinal cortex layer V (ECV) and hippocampus regions (CA1 
and CA2) defined as described in chapter 2, was outlined using a Zeiss Axioplan 
Photomicroscope coupled to a Pixelink PL-B623CF colour digital video camera 
(Pixelink U.K.) at x2.5 objective magnification. Cell counts and volume estimation 
were conducted under x100 magnification while the XY and Z motorised stage (Prior 
ProScan II, Prior Scientific Instruments Ltd, Cambridge, U.K.) provided systematic 
random sampling of the field to be analysed. The unbiased dissector and nucleator 
methods were used to estimate density and size of neurons and glial cells. The thickness 
of the tissue was measured using a Heidenhain gauge (Heidenhain GB Ltd, London, 
U.K.) for one in every ten fields during analysis to correct for artificial damage and 
shrinkage during tissue processing. There was no significant difference in mean section 
thickness between groups. Approximately 40 to 80 fields per ROI were analysed to 
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achieve the same sampling fraction for each ROI between sections. Each dissector box 
measured 56.43 μm long x 45.14 μm wide. CFV staining revealed purple neurons with a 
pale nucleus and a single darker-shade nucleolus, as well as glial cells, of which nucleus 
only was heterogeneously stained. Neurons were counted and measured only when the 
nucleolus came into focus either fully inside the dissector box or touching one of the 
three non-forbidden planes (green lines; right, top and upper side) within the dissector 
height, which was set at 15 μm (see Figure 5.2). SMI32 positive (+) neurons were 
separately counted from the total number of neurons (SMI32(+) and negative (-)) which 
was also counted. Volumes of neurons were estimated based on six randomly projected 
lines extended from a point defined by the researcher, which in this case was the 
nucleolus. For glial cells, of which cytoplasm was unstained with CFV, only density 
was measured following the same counting rules. Coefficient of error was calculated 
using the Gundersen-Jensen method (Gundersen and Jensen, 1987).  
5.2.2.3 Estimation of vascular density 
Glut1 immunostained brain sections were analyzed using the Visiopharm Integrator 
System. The ROIs in CA1, CA2 and whole entorhinal cortex (layer II to VI) were 
outlined using a Zeiss Axioplan Photomicroscope coupled to a Pixelink PL-B623CF 
colour digital video camera (Pixelink U.K.) at x2.5 objective magnification. 60, 100 and 
40% of CA1, CA2 and entorhinal cortex, respectively, were analysed under x25 
magnification. A dissector box of 571.12 μm long x 456.93 μm wide was placed on an 
image at each sampling point, and the number of intersections between the dissector box 
(area probe) and the spine of vessels were counted following the same counting rules as 
neurons: vessels fully inside the dissector box or their spine touching green lines were 
counted. The length density was calculated as described in 5.2.2.1. 
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5.2.3 Statistical analysis 
Cell counts were divided by ROI volume, derived from ROI area multiplied by ROI 
depth 15 μm, to obtained density. Neuronal/glial densities and neuronal volume were 
compared between groups using both Kruskal-Wallis and Mann-Whitney U tests. 
Correlation was tested using Pearson‘s correlation test. 
5.3 Results 
There were no significant changes in the density of glial cells between groups, except in 
CA1 and CA2 between Ocont and Ycont, which had fewer cells (p = 0.040 and 0.072). 
There was no correlation between neuronal densities and fixation length or postmortem 
delay. The SMI32 and CFV staining pattern of representative areas for each disease 
group is presented in Figure 5.3. In general, control tissues had stronger 
immunoreactivity and more SMI32(+) neurons compared to CADASIL and COGFAST. 
5.3.1 Neuronal density changes 
Figure 5.4 shows the total neuronal density in each disease group as well as the 
SMI(+/-) density. Unexpectedly, there was no significant difference between Ycont and 
CADASIL in total neuronal density, defined as all CFV(Nissl) stained neurons, but only 
trends of decreases in CA1 and CA2 (p = 0.101 and 0.073) (A). The COGFAST also 
showed marginal decrease in total neuronal density in the ECV (p = 0.053) and not in 
the other regions. The statistical difference is partly derived from higher density in 
Ocont than Ycont, which may be accounted for by the biological variability among 
controls. Moreover, the total neuronal density did not correlate with either CAMCOG or 
MMSE scores.  
On the other hand, the density of SMI32(+) and (-) neurons showed dramatic changes 
(Figure 5.4 B). Although statistically not significant due to the large variation in the  
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Figure 5.3. Representative images for each ROI in brain tissues stained with CFV and 
SMI32 antibody. Controls had more SMI32 staining in neurons than CADASIL or 
COGFAST groups. ECV: entorhinal cortex layer V. Bar represents 50 μm. 
Ycont group, CADASIL brains had 40.4, 28.8 and 40.1 % lower density of SMI32(+) 
neurons compared to Ycont in the ECV (p = 0.055), CA1 and CA2, respectively. 
Significant difference between Ocont and COGFAST cases in SMI32(+) (p = 0.004) but 
ECV CA1 CA2 
Y
c
o
n
t 
O
c
o
n
t 
C
A
D
A
S
IL
 
C
O
G
F
A
S
T
 
Neuronal and Vascular Pathology in CADASIL Compared to Sporadic Vascular Dementia Chapter 5 
 
96 
not SMI32(-) density was also noted in the ECV, suggesting a greater insult in the area 
in COGFAST and loss of large pyramidal neurons, which are immunoreactive to SMI32. 
The effect of ageing was limited to loss of SMI32 expression as indicated by the notable 
increase of SMI32(-) neuronal density in ECV in Ocont (p = 0.042) and slight increase 
in CA1 (p = 0.109) compared to Ycont. 
Figure 5.4. Neuronal density changes in entorhinal cortex layer V (ECV) and 
hippocampus regions CA1 and CA2. The total neuronal density (mm
-3
) was relatively 
preserved in CADASIL and COGFAST (A). SMI32 positive neuronal density was 
decreased in CADASIL while SMI32 negative neuronal density was slightly increased (B). 
*: Significance (P < 0.05) and †: trend (P < 0.1) vs. age-matched controls or between 
controls. Error bars ± 2SE 
A 
* * 
B 
* 
† 
† 
† 
† 
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Correlation analysis between SMI32(+) and SMI32(-) neuronal densities was performed 
to note if the decrease in the density of SMI32 positive neurons in Ocont, CADASIL 
and COGFAST is a true reflection of large pyramidal neuronal loss or merely the loss of 
SMI32 immunoreactivity. As expected, controls showed negative correlation between 
SMI32(+) and (-) neurons (Ycont and Ocont combined; ECV: R = -0.495, p = 0.051; 
CA1: R = -0.777, p = 0.0001; CA2: R = -0.884, p = 0.0001). However, there was no 
significant correlation in any of the regions in CADASIL (ECV: R = -0.338, CA1: R =  
-0.578, CA2: R = -0.046) and COGFAST (ECV: R = -0.613, CA1: R = -0.151, CA2: R 
= -0.257), suggesting imbalances between the decrease of SMI32(+) and the increase of 
SMI32(-) densities. These results indicate that while the expression of SMI32 was 
reduced in Ocont, only small numbers of large pyramidal neurons (SMI32(+) neurons) 
were lost in CA1 and CA2 of CADASIL (coinciding with decreased SMI32 expression), 
and in ECV of COGFAST (Table 5.1). 
 
CADASIL  COGFAST 
ECV CA1 CA2  ECV CA1 CA2 
Total N → ↓ ↓  ↓ → → 
SMI32 (+) ↓ → (↓) → (↓)  ↓↓ → → 
SMI32 (-) → (↑) → → (↑)  → → → 
Table 5.1. Summary of neuronal density changes in CADASIL and COGFAST 
compared to age-matched controls. →: no change, ↑↑/↓↓: statistically significant 
increase/decrease, ↑/↓: trend of increase/decrease, (↓) decreased mean. Decreased total 
neuronal density (Total N) coincided with decreased SMI32(+) density indicates loss of 
SMI32(+) neurons, while spared Total N and decreased SMI32(+) but increased SMI32(-) 
mean loss of SMI32 expression. Imbalance between SMI32(+) decline and SMI32(-) 
increase may suggest slight neuronal loss. 
5.3.2 Neuronal volume 
In general throughout all the groups, the volume of SMI32(+) neurons was larger by 
6.88-37.90%  than that of SMI32(-) neurons in ECV and CA2. There were no 
significant changes apparent in neuronal volumes between CADASIL and Ycont. 
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However, neurons in COGFAST showed significantly increased volumes in the ECV 
compared to age-matched controls (p = 0.038) (Figure 5.5). The volume change was 
greater in SMI32(+) neurons than in SMI32(-) neurons (data not shown).  
Figure 5.5. Neuronal volumes in entorhinal cortex layer V (ECV) and hippocampus 
regions CA1 and CA2. There was no significant difference in volume except between 
Ocont and COGFAST in ECV. Error bars ± 2SE. 
5.3.3 Vascular density 
Length density of Glut-1 immunoreactive small vessels was estimated to evaluate the 
microvascular changes in relation to neuronal changes. Although CADASIL samples 
compare to Ycont showed 12.1% decrease in length density in CA1 region, the Kruskal-
Wallis test indicated no significant differences between the groups in any of the ROI 
(Figure 5.6). The lack of significance may be partly accounted for by small sample size. 
Neuronal density correlated (controls: R = 0.365, p = 0.034; CADASIL: R = 0.637, p = 
0.014; COGFAST: R = 0.685, p = 0.001) with vascular length density when ROIs were 
combined, confirming the close relationship between neurons and vasculature. In 
general, length density was CA2= ECV >CA1. 
* 
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Figure 5.6. Mean length density of Glut-1 immunoreactive vasculature. There were no 
significant differences between the groups. Error bars ± 2SE 
5.4 Discussion 
This study provided the first quantitative data in relation to cognitive dysfunction in 
CADASIL. Hippocampal atrophy and neuronal density changes in mild cognitive 
impairment and mild AD have been described previously (Kordower et al., 2001, 
G mez-Isla et al., 1996, Kril et al., 2002a), while results for sporadic VaD varied 
possibly due to the differential underlying pathology in VaD (Zarow et al., 2005, Kril et 
al., 2002b). CADASIL brain pathology is relatively uniform in this regard, being largely 
described to be SVD type, and thus suitable to explore the degree of hippocampal 
changes with respect to cognitive dysfunction in VaD. 
Our results showed that total neuronal density is relatively preserved in CADASIL and 
COGFAST though the number of neurons was slightly decreased in hippocampus (CA1 
and CA2) in CADASIL and in ECV in COGFAST. These results partially agree with 
the findings from the two previous studies on sporadic VaD. Kril et al.‘s study (2002b), 
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which included only SVD cases without other neuropathological abnormalities, 
demonstrated loss of pyramidal neurons in CA1. The lack of significant neuronal loss in 
the CADASIL group may be due to the significant age difference between CADASIL 
(mean age = 58 years in this study) and sporadic SVD (mean age = 86 years in Kril‘s 
study) though such age effect was not observed among our CADASIL cases. 
COGFAST, on the other hand, included largely but not exclusively SVD cases with 
post-stroke dementia as in Zarow et al.‘s study (2005) (mean age = 81), which showed 
no change in CA1 and CA2 neuronal densities. The different patterns of neuronal loss 
may stem from the difference in their pathogenesis; chronic or acute hypoperfusion, 
micro- or macro- infarcts and global or focal insult. In fact, the hypertrophy of ECV 
SMI32(+) neurons in COGFAST seems to indicate the acute and early stage of damage. 
In addition to the data from sporadic cases, the observation by Viswanathan et al. (2006) 
is in agreement with the lack of significant neuronal density changes in the CADASIL 
hippocampal regions. The authors described an increased number of apoptotic neurons 
in the various areas of cerebral cortex including frontal and occipital cortices, and glial 
cells in WM of four CADASIL cases, but minimal neuronal apoptosis in the 
hippocampus. Another CADASIL patient study also pointed out that cholinergic axons 
were relatively spared in the hippocampus, entorhinal cortex and temporal neocortex 
whereas cholinergic denervation is extensive in posterior parietal, dorsal frontal, and 
occipital cortices (Mesulam et al., 2003).  
Our study not only quantitatively corroborated the above previous studies but also 
provided a further insight into the neuronal changes in the hippocampus of CADASIL 
by focusing on a specific subtype of neurons, namely SMI32(+) neurons. SMI32, which 
is non-phosphorylated neurofilament-M and -H, is found in pyramidal projecting 
neurons (type I) and its depletion is a sensitive marker of chronic ischemic stress (Leifer 
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and Kowall, 1993, Voelker et al., 2004). Higher susceptibility of SMI32(+) neurons has 
also been reported in AD and DLB (Thangavel et al., 2008). Although not significant, 
the observed decrease in SMI32(+) but not SMI32(-) density confirmed SMI32 
depletion and the minor loss of pyramidal neurons in hippocampal formation, 
suggesting that the hippocampal formation is not completely spared from 
hypoxic/ischemic damage in CADASIL and COGFAST. The damage, however, is 
probably not the result of decreased microvascular density, at least in the hippocampal 
formation as suggested by this study, as opposed to a Tg mice study showing 
microvascular rarefaction (Joutel et al., 2010). Whether SMI32 immunoreactivity can 
indicate functional integrity of neurons is unknown, but functional or structural 
disruption of the connectivity between hippocampal formation and other regions of the 
brain may underlie the impaired episodic memory retrieval in CADASIL as the 
SMI32(+) neuronal subpopulation consists of long projecting neurons with heavily 
myelinated axons responsible for subcortical and corticocortical connections (Voelker et 
al., 2004, Hof et al., 1995).  
Collectively, our data provided the neuronal basis for the intact memory encoding and 
storage processes in CADASIL. One source of weakness in this study which could have 
affected the results was the number of samples used. Although our sample size was no 
smaller than those in the previous stereological studies on hippocampal neuronal density 
(Harding et al., 2002, Kril et al., 2002a, Kril et al., 2002b, Zarow et al., 2005), it is 
possible that there were insufficient statistical power to detect the milder neuronal loss 
in CADASIL compared to other forms of dementia. Depending on the availability, 
analysis of additional CADASIL cases will strengthen our findings. Further research is 
also needed to provide complete picture of cognitive impairment in CADASIL in terms 
of the locations of damaged area and the pathogenesis. It is of interest to ascertain 
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whether neuronal density changes in frontal cortex (e.g. BA9), representative of 
executive function, or the disconnection of cortical areas and the hippocampal formation 
due to axonal damage is a cause of executive dysfunction.  
 103 
Chapter 6. Severity and Distribution of Axonal Damage 
in CADASIL 
6.1 Introduction 
The hippocampal formation is an essential part of the brain and is responsible for 
memory functions; however, it is not the only structure that is associated with memory, 
or cognitive function (Warburton and Browna, 2010, Chayer and Freedman, 2001). The 
previous chapter discussed the possibility of pathologies other than neuronal loss in the 
hippocampal formation being implicated in cognitive decline in CADASIL, i.e. 
neuronal loss in other areas of the brain and disrupted corticocortical, cortico-
subcortical communication due to WM damage (O'Sullivan et al., 2005). Although WM 
abnormalities alone may not cause cognitive decline, its substantial effects on cognitive 
functions cannot be ignored (Deary et al., 2003).  
The disconnection syndrome, in which brain dysfunction at least in part, resulted from 
disrupted associative connections between various brain regions by WM abnormality, 
has recently regained the interest of researchers (Catani and Ffytche, 2005). 
Disconnection of different circuits resulting in cognitive dysfunction has been suggested 
to occur in AD, frontotemporal dementia, multiple sclerosis and cognitive impairment 
after traumatic brain injury (Collette et al., 2007, Dineen et al., 2009, Stoub et al., 2006, 
Kato et al., 2007). In AD, for example, the functional anterior-posterior disconnection 
(prefrontal cortex - hippocampus  and visual area) together with damage to medial 
temporal structures was associated with delayed memory (Grady et al., 2001). On the 
other hand, studies in multiple sclerosis related worse working memory and processing 
speed to disruption of the splenium of the corpus callosum, superior longitudinal 
fasciculus (SLF), BA40 and BA4 (Dineen et al., 2009, Ranjeva et al., 2005). CADASIL 
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subjects exhibit rather specific spatial distribution of WM lesions as shown by MRI 
(Coulthard et al., 2000), and thus it is plausible that disrupted connectivity of specific 
brain regions underlie the profile of cognitive deficits. Indeed, Tatsch et al. (2003) 
considered disconnections by subcortical lesions as one of the causes of reduced cortical 
metabolism and cognitive dysfunction in CADASIL. The neuropsychological 
manifestations also suggest the disconnection of prefrontal cortex from thalamus and 
basal ganglia: CADASIL patients exhibit mild cognitive impairment, psychomotor 
retardation, executive dysfunctions but not dementia until the later stage of the disease 
(Amberla et al., 2004, Blanco Menéndez et al., 2001). It should be noted that while 
lacunar infarcts have been associated with cognitive dysfunction in CADASIL 
(Viswanathan et al., 2007), WM hyperintensities on MRI did not correlate with 
cognitive function in CADASIL (Liem et al., 2007, Scheid et al., 2006). However, 
abnormalities in normal-appearing WM, which are not detectable with conventional 
MRI but DTI or magnetization transfer imaging, have been shown to contribute to the 
impairment of cognitive function, especially of executive function (Vernooij et al., 2009, 
O'Sullivan et al., 2001, Dineen et al., 2009), suggesting the significance of subtle 
changes in WM.  
In this chapter, we aimed to reveal the distribution and significance of axonal damage in 
CADASIL by quantifying SMI32 immunoreactive axons using a recently developed 3D 
stereological method. We also propose a novel 2D method for the estimation of axonal 
density as a part of this analysis. SMI32 abundantly exists in neuronal cell bodies and 
dendrites but is absent in normal myelinated axons unless they are damaged and 
dysmyelinated (Trapp et al., 1988). As SMI32 staining, which appears as continuous 
lines, small dots or ovoids (retraction bulbs), is detected in axons only after a longer 
dysmyelination periods unlike the amyloid precursor protein, used as a marker for acute 
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injury, it is a useful indicator of chronic axonal damage and possibly axonal 
degeneration (Lindner et al., 2009). Since the WM hyperintensity on T2-weighted MRI 
does not necessarily indicate axonal dysfunction, the evaluation of SMI32 positive 
axonal density in various parts of the brain WM would provide a new insight into WM 
disconnectivity in CADASIL.  
6.2 Materials and Methods  
6.2.1 Brain samples IHC 
For the analysis, we used 4 controls (Cont1, 2, 3 and 4; age = 68, 69, 72 and 78 years 
old) and 3 CADASIL cases (CAD1, CAD 11 and CAD12 in Table 2.1, age = 44, 68 and 
68 years old), which had appropriate fixed blocks of tissue for the areas of interest. The 
blocks included A, B, C, G, K, R, S, Z, AD, AE, AG, AI, AJ and AK as marked on the 
Newcastle Brain Map (Figure 2.1). Formalin fixed, paraffin-embedded blocks were cut 
to produce 10 and 30 µm sections. The sections were stained with anti-non-
phosphorylated neurofilament H (mouse anti-SMI32 1:500, Covance, CA) and CFV to 
visualize damaged axons. Each set of slides was randomly labelled with number and 
corresponding block code by a technician blind to the researcher. 
6.2.2 Length density estimation 
6.2.2.1 Principle of ‗space balls‘ method 
As described in 5.2.2.1, the length density, which is total length per unit volume, is 
estimated from the number of intersections between probes and objects of interest. The 
probes used for the length density estimation include line probes as in chapter 5 and 
cycloids. The disadvantage of these probes is the absolute requirement of isotropic 
object-probe intersections by complete randomisation of the inherent object orientation. 
That is, the ROI in the tissue needs to be extracted and randomly rotated before being 
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sectioned, which is not always possible in a human study due to the often limited 
availability of the tissue. The most recent and now widely accepted spherical probes, 
also referred to as space balls, provides a good solution; the surface of a sphere covers 
all possible orientations and thus does not require complicated randomized sectioning 
methods or counting rules (Mouton et al., 2002). The total length is estimated using the 
following formula 
 
where ∑Q = sum of the intersections between sphere probes and liner objects, ssf = the 
fraction of the total number of sections analysed, asf = the fraction of the sampled area 
and tsf = the fraction of the sampled thickness. The unbiased sampling is achieved only 
if the diameter of the probe is larger than two-fifths of the object diameter (Mouton et 
al., 2002). Therefore, in practice, hemispherical probes are used to increase the diameter 
of the probe relative to the diameter of the objects.  
6.2.2.2 Axonal length density estimation 
The stained 30-μm brain sections, two adjacent sections per sample, were first examined 
using a light microscope to exclude the slides without quantifiable amounts of axonal 
staining in the WM from further analysis. Where a notable amount of staining was 
present, the staining pattern and location were recorded prior to the axonal length 
density measurement. A sampling area of approximately 10 x 12 mm was marked on 
the slides so that corresponding areas of the WM was examined for each case. The 
sections were then viewed under an Olympus BX51 upright microscope coupled with 
mbf Bioscience CX9000 camera and analysed using StereoInvestigator (MBF 
Bioscience, VT, USA). The XYZ motorized stage was controlled by a Modular 
Automation Controller 6000 (Ludl Electronic Products Ltd., USA).  The ROI was 
tsfasfssfa
v
QL
111
2  
v: volume of a sampling box 
a: surface area of a sphere probe 
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outlined at x2 magnification and then switched to x100 magnification for axonal 
counting. The sampling grid size (distance between the centres of hemispherical probes) 
was set to 902 x 751 μm to acquire an average of 150-200 counts per ROI in a sample 
with moderate axonal density. The thickness of the tissue was measured at each 
sampling point using a Heidenhain gauge (Heidenhain GB Ltd, London, UK) in order to 
place the hemispherical probe at the centre of the section thickness (Figure 6.1). The 
radius of the probe was set to 12 μm taking the tissue shrinkage and guard volume into 
consideration. At each sampling point, the sampling depth was scanned through and the 
intersections between the hemispherical probes (appears as a circle on screen) and the 
SMI32 axons in focus were marked for counting. The length density was calculated by 
dividing the total axonal length by the sampled reference volume. 
Figure 6.1. Length density estimation using the space balls method. Hemispherical 
probes were placed at the centre of tissue thickness. The intersections between probes 
(appear as circles with changing size) and focused axons were counted (marked with x). 
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6.2.3 New approach for the quantification of axonal density 
6.2.3.1 Principle of cutting plane angle correction 
The comparison of axonal densities between sections is only possible if the cutting 
plane angle (θ) is the same and thus θ was normalized to 0 degree as follows (Figure 
6.2). θ was estimated from the mean apparent length of the axons (mL), which was 
attained by measuring length (L) of 10 randomly-selected axons, and section thickness 
T. The estimated θ was then used to calculate width of sampling frame (W) using the 
formulae below.  
 
Axons contained fully inside the counting frame, touching both or either of the green 
lines (top and right) but not blue lines (bottom and left) or ones running through the 
counting frame were counted. The number of axons in the sampling fame is equivalent 
to that in the T-µm section when cut completely parallel to the axonal tract. The axonal 
density was calculated by dividing the number of axons per sampling frame by the area 
derived from T and height of sampling frame (H).  
Figure 6.2. Quantification of axonal density by cutting angle correction. Cutting plane 
angle θ and W were calculated from mean apparent length of axons (mL). The number of 
axons in the sampling frame with W was divided by area derived from section thickness (T) 
and sampling frame height (H). 
Axonal density (µm
-2
) = Number of axons 
/ T x H 
θ = tan-1(T / mL) 
W = T / sin(θ) 
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6.2.3.2 Computer software design 
Computer software named AxoCounter was created to simplify the axonal density 
quantification procedure using Microsoft Visual Basic 2008 Express Edition (the main 
source code is presented in Appendix 0). As all the calculations were performed in pixel, 
calibration factor was calculated by dividing the length of user defined calibration line 
in pixel by actual length of the line in µm prior to the experiments.  
mL, θ and W were calculated subsequently after drawing 10 lines along axons of interest. 
When ‗Start Experiment‘ button was pressed, the user was prompted to draw the ROI. H 
was defined as the height of ROI minus guarding length of 10 pixels (5 each from top 
and bottom). The position of sampling frames was determined depending on whether 
the sampling frames overlap or not, which was judged by dividing width of ROI by 
sampling number (Sn) and comparing to W. Sn was set so that the overlap width did not 
exceed one third of W. 
The mean (µ), standard deviation (SD) and coefficient of error (CE) were calculated 
from axonal density per sampling frame at the end of the experiment using the 
following formulae.  
 
 
 
6.2.3.3 Model images 
Model images of WM with known axonal density (0.00025, 0.0005, 0.00075 and 
0.0010 /µm2) and θ (15, 30, 45, 60 and 75 degree) with scales equivalent to x20 and 
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x40 magnifications were analyzed to test the accuracy of the angle correction method. 
10 and 20 model images of 30 µm sections were computer generated by Model Image 
Generator (MiG) for x20 and x40, respectively. The program aligned rows of axons 
with length L (= 30/tan(θ)) with gap between rows (g) = 30/sin(θ) – L, and then 
randomly moved up to Lshift = ± L/2 to transverse direction (Figure 6.3).  
Figure 6.3. Model image generation. The apparent length of axons (L) was calculated from 
section thickness (T) and cutting plane angle (θ).  Axons with L were aligned with gap 
between rows g and then randomly moved up to L/2. 
6.3 Results 
Intense and abundant SMI32 staining was observed in the WM of CADASIL cases 
while controls, especially Cont2 and Cont4, had significantly less staining. Certain brain 
regions had substantially more axonal staining in WM when compared to the other 
tissue blocks from the same case: the most extensive staining by eye was in WM near 
BA4 (primary motor cortex) and BA6 (premotor cortex/ supplementary motor area). 
Close examination of the sections revealed microinfarcts and markedly enlarged PVSs 
in block Z in CAD1 and CAD11. The representative staining pattern in CADASIL is 
illustrated with images in Figure 6.4. SMI32 immunoreactive axons in controls, most 
abundant in block AD and AE, were often thick in diameter, whereas many of those in 
CADASIL cases were thin and twisted, or segmented, showing a sign of degeneration. 
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Figure 6.4. Typical staining pattern of SMI32 positive axons in CADASIL brain. 
Extensive staining was found in block Z, AD and AE. Blue boxes indicate examined areas. Z-
cc: corpus callosum region in the block Z. 
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Figure 6.5. Axonal length density in controls and CADASIL 
cases.  (A) In general, CADASIL had more axonal staining than in 
controls especially in frontal lobes. The density of damaged axons 
correlated with disease duration (CAD1: 8 years, CAD11: 18 years 
and CAD12: 28 years) (B). A few tissue blocks from CAD12 
(marked with †) were not analysed despite the positive staining as 
the staining was mainly in retraction bulbs and few linear stained 
axons were present. Z-cc: corpus callosum region in the block Z.  
6.3.1 Length density of SMI32 positive axons  
The length density of SMI32 positive axons were estimated 
using the space balls method. Consistent with the observation 
by eye, the highest length density was found in the WM at the 
coronal level of primary motor cortex (AE) and premotor cortex 
(Z and AD) in both controls and CADASIL except for CAD11 
(Figure 6.5), implying that these areas are most vulnerable and 
first to show pathological changes in ageing brains. A large 
number of the stained axons in these areas was thicker than 
those in other areas (Figure 6.4), possibly originating from Betz 
cells, which show significant changes during the ageing process 
(Scheibel et al., 1977). The SMI32 axonal length density in 
* 
* * 
† 
n/a 
n/a 
n/a 
† 
 
† 
 
A B 
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temporal lobe (AG) was not as high as in the WM regions at the level of premotor 
cortex (Z, AD and AE). Signs of degenerating axons, which are swollen fragments of 
axons and ‗retraction bulbs,‘ were found in AG, K and AJ. Axonal fragmentation 
reduces the possibility of intersections with probes. It may underlie the lower length 
density of SMI32 axons in those areas. Although extensive axonal staining was 
observed in the WM near motor cortices, it was frontal lobe (blocks S, B and Z) where 
the significant differences between controls and CADASIL were found (p = 0.029, 
0.010 and 0.002, respectively). The severity of the damage differed even between 
CADASIL cases. CAD11 and CAD12, which experienced longer disease duration than 
CA1 (18 and 28 vs. 8 years), had more severe damage in frontal and parietal lobes (B: R 
= 0.811, p = 0.050; Z: R = 0.987, p = 0.001, AI: R = 0.970, p = 0.001 and AK: R = 
0.978, p = 0.022). Generally, the staining intensity in the AD sections from CAD11 was 
weak and few retraction bulbs were observed in WM. The damage to the axons in 
corpus callosum remained negligible in all of the CADASIL cases. It should also be 
noted that the SMI32 staining was rather restricted to the upper part of the brain.  
6.3.2 Model image study 
The accuracy of axonal density quantification by angle correction was assessed by 
analyzing model images with known axonal density and θ. Density measurement by 
AxoCounter was shown to be accurate both at x20 and x40 magnification (Figure 6.6). 
The estimated density was significantly different from actual values only at two points, 
0.00025/µm2 at 45˚ (p = 0.018) and 0.001/µm2 at 30˚ (p = 0.021). To assess whether 
the significant error was caused by faults in AxoCounter or in MiG, different sets of 
images and images generated using modified random shifting were analyzed. The error 
changed in both of the cases, indicating statistical (Type I) and systematic error of MiG 
(data not shown). Although the difference in magnification, in other words, difference 
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in size and number of axons per image, did not affect the accuracy of quantification, it 
was better at x20 magnification as indicated by the mean error percentages (8.66 for x20 
and 11.44 for x40).  
Figure 6.6. Summary of model image analysis. AxoCounter successfully quantified 
density correctly at all the densities and θ with the exception of two (indicated with *).  
6.4 Discussion  
WM integrity has been linked to cognitive function, and the disconnection of brain 
regions has been suggested in various disorders with cognitive impairment (Dineen et 
al., 2009, Hannesdottir et al., 2009, Grady et al., 2001). This small-scale study was 
designed to determine the extent of WM damage in postmortem brains and its relation 
to cognitive dysfunction in CADASIL. When quantifying the SMI32 immunoreactive 
axons, we found that there was widespread decrease in the integrity of the WM in 
CADASIL, possibly affecting corticocortical association pathways. In contrast, control 
cases showed limited axonal damage, and most of the immunoreactivity was restricted 
to the WM near premotor/motor cortices. The comparison of axonal damage distribution 
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in controls and CADASIL cases implies that the affected area spreads from areas above 
the ventricle at the level of premotor and motor cortices, where small infarcts were 
found, to frontal and parietal lobes. The distribution of the axonal damage is consistent 
with those described in the previous MRI studies, which located T2-weighted WM 
hyperintense lesions in frontal, parietal and temporal lobes (Yousry et al., 1999, 
Coulthard et al., 2000, Singhal et al., 2005). We failed to detect damage in the corpus 
callosum in contrast to a previous report, but this could be largely attributed to its low 
frequency in CADASIL (Coulthard et al., 2000, Yousry et al., 1999).  
The most important finding in the current study, however, is the significant axonal 
damage in the frontal/prefrontal WM compared to other areas in brains of CADASIL 
subjects. The extent of WM damage significantly correlated with the disease duration in 
frontal lobes as well as in parietal lobes. It is interesting to compare the findings of 
cognitive profiles in CADASIL. As described in 1.3.1.3, the early cognitive impairment 
in CADASIL is mainly executive dysfunction, and other cognitive dysfunctions, such as 
impaired episodic memory retrieval, slow processing speed and impaired visuospatial 
ability, manifest as the disease progresses with age (Buffon et al., 2006, Amberla et al., 
2004, Peters et al., 2005c). Executive functions are largely attributed to the frontal lobes, 
but the communication with other areas of the brain, such as motor and sensory cortices 
(parietal lobes) as well as limbic and midbrain regions greatly contributes to the ―top-
down control,‖ which interprets sensory input, monitors activity, sends feedback and 
maintains the cognitive control (Miller and Cohen, 2001, Stoet and Snyder, 2009). 
Frontal lobes are also suggested to be involved in the formation of working memory and 
the retrieval of long-term memory (Miller and Cohen, 2001, Chayer and Freedman, 
2001), whereas parietal lobes have been associated with visuomotor transformations, 
spatial perception and episodic retrieval (Wagner et al., 2005, Fogassi and Luppino, 
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2005). The increasing axonal damage in the frontal and parietal WM with disease 
progression suggests that the disconnection of the frontal lobe from other part of the 
brain, for example the parietal lobes, may explain the executive dysfunction in 
CADASIL. Similar results were reported by a DTI study which demonstrated the 
correlation between executive function and various frontal WM regions in CADASIL 
patients (O'Sullivan et al., 2005). The list of the WM structures includes internal capsule, 
cingulum bundle, SLF and inferior longitudinal fasciculus (ILF).  
Although we had the advantage of observing each single degenerating axon and not 
diffuse damaged areas as seen on MRI, the data must be interpreted with caution 
because different axonal tracts can be intermingled with each other in WM. Of all the 
WM tracts listed by O‘Sullivan et al. (2005) to be correlated with executive functions, 
the anatomical distribution of the SMI32 immunoreactive axons seem to suggest the 
involvement of SLF (especially II), which connects frontal, parietal, occipital and 
temporal lobes (Makris et al., 2005). The other listed WM structures, cingulum bundle 
and internal capsule, were absent from axonal damage in our study, but ILF may 
comprise a part of the damaged axons in the occipital lobes (block AK). SLF would 
provide a good explanation for the frequently observed ataxia and hemiparesis in 
CADASIL patients as well as some of the cognitive dysfunction (Yousry et al., 1999, 
Chabriat et al., 1995), as it is responsible for associative motor behaviour, spacial 
attention and somatosensory input and has been linked to spacial working memory, 
verbal task and attention skills (Karlsgodt et al., 2008, Frye et al., 2010, Schmahmann et 
al., 2008, Vestergaard et al., 2010). The result may also corroborate the previous reports 
of cholinergic impairment in motor cortex, parietal and occipital lobes (Manganelli et al., 
2008, Mesulam et al., 2003). ILF, on the other hand, is a bundle of association fibres 
connecting temporal and occipital lobes and is associated with visual memory 
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(Schmahmann et al., 2008, Shinoura et al., 2007). Considering the lack of significant 
difference in SMI32 axonal density in CADASIL occipital lobes as well as a report that 
showed worse visual memory in patients over the age of 60 (Buffon et al., 2006), the 
current findings suggest SLF is the first to be affected and ISF may be damaged only 
after certain disease duration (>8 years). 
Together with the previous neuroimaging studies (Tatsch et al., 2003, Blanco Menéndez 
et al., 2001), our results support the notion that disconnection of corticocortical or 
subcortical-cortical network is involved in cognitive dysfunction in CADASIL. Further 
experimental investigations including the collection of more CADASIL cases are 
needed to estimate the correlation between axonal damage and cognitive dysfunction. 
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Chapter 7.  General Discussion 
7.1 Introduction 
Various studies have investigated the cerebral pathology of CADASIL (Cumurciuc et 
al., 2006, Viswanathan et al., 2006, O'Sullivan et al., 2005, Miao et al., 2004, 
Lewandowska et al., 2010, Chabriat et al., 1999), but a lot of quantitative evaluations of 
those changes, which enable the characterisation of CADASIL in relation to sporadic 
VaD, are still insufficient. The main aim of the programme of the study was to quantify 
and differentiate the morphological pathology of CADASIL vasculature and their effect 
on neuronal population in order to elucidate the pathology underlying the clinical 
manifestations. In chapter 3, vascular and related WM pathology was characterised by 
measuring SI and PVS using newly designed computer programme, which enabled 
faster and more accurate measurement than the previous method by hand. Chapter 4 
identified the distribution and the localisation of mutant N3ECD in small vessels using 
immunogold EM. The following chapter 5 and 6 quantified neuronal density in the 
hippocampal formation and axonal damage in the WM, respectively, in order to 
elucidate the substrate of cognitive impairment in CADASIL. The main findings in this 
study, listed below and discussed in detail in the following sections, were concordant 
with the clinical findings and further provided important implications for future research.  
 Vascular wall thickness was significantly increased in CADASIL even 
compared to sporadic SVD. The severity of wall thickening correlated with the 
extent of PVS dilatation, a profound feature in CADASIL. 
 N3ECD was detected within GOM deposited in the basement membrane of 
arteries/arterioles/capillaries. Some EM immunoreactivity was found associated 
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with membranous cytoplasmic structures in VSMCs, and vesicular inclusions in 
granular pericytes. In addition, there was a marked increase of nucleated 
hematopoietic cells, which is an indication of inflammatory response. 
 Overall neuronal density in hippocampal formation (CA1, CA2, ECV) were 
relatively preserved in CADASIL though minor loss of neurons was indicated 
with preference to projecting pyramidal neurons. 
 WM tracts were severely damaged in the frontal lobes of CADASIL compared 
to controls. The extent of damage significantly correlated with disease duration 
in the frontal and parietal lobes. 
Our findings are subject to at least three limitations. Firstly, the relative small sample 
size, particularly for the damaged axonal density study, could have affected the 
statistical power and resulted in the false negative results. Secondly, the limited 
availability of neuropsychometric scores for CADASIL cases prevented us to relate the 
cerebral pathologies to cognitive features. Lastly, the lack of quantitative MR imaging 
of the cases limited the association of damage as shown by neuroimaging method and 
actual structural changes. In the present project, we obtained total of 12 CADASIL 
brain tissues from several resources in Newcastle, Oxford, London, Bristol, USA and 
Germany, which inevitably resulted in the inconsistency in diagnostic criteria, 
neuroimaging method, neuropsychological tests and postmortem processing protocols. 
Establishing large prospective studies of CADASIL by collaborating centres would 
greatly help reduce the above limitations and thus understanding of CADASIL as a 
model of sporadic SVD causing dementia. For this reason, clinical and 
neuropsychological testing, imaging protocols and postmortem brain processing 
methods should be clearly defined as proposed by Hachinski et al. (2006). 
General Discussion Chapter 7 
 
120 
7.2 Relationship between vascular pathology and WM changes 
The study on the vascular and perivascular pathology revealed significant vascular wall 
thickening and enlarged PVS in CADASIL. PVS is a normal anatomical structure 
surrounding a penetrating vessel and considered pathological when its diameter exceeds 
2-3 mm on MRI (Wang, 2009). Nevertheless, an MRI study in healthy elderly 
population sample without any vascular or neurological disorders linked the number of 
small PVS (< 1-2mm) with severity of WM lesion and cognitive function (MacLullich 
et al., 2004). Enlarged PVS is frequently observed in SVD and was linked to the 
severity of SVD (Rouhl et al., 2008, Doubal et al., 2010). These data indicate that a 
common factor underlies the formation of dilated PVS, WM lesion and silent infarct, 
but the mechanism remains yet to be determined.  
Lack of significant pathology other than in brain strongly suggests the involvement of 
cerebrovasculature-specific function. Three main factors have been suggested so far: 
BBB disruption, hypoxia/ischemia and obstructed perivascular drainage pathway, which 
are closely related to each other, appear to contribute to the dilation of PVS (Roher et al., 
2003, Wardlaw, 2010) (Figure 7.1). BBB is a unique structure existing only in the brain 
and various mechanisms are known to be involved in its disruption, of which 
consequence is a leakage of blood proteins and neurotoxic substances into the brain 
parenchyma. Hypoxia and inflammation, for instance, are known to induce BBB 
breakdown. Hypoxia associated to lacunar infarcts damages endothelial cells and thus 
their structural integrity and function, subsequently destructing the surrounding 
structures starting from glial endfeets, and promoting ischemia-induced inflammation 
and oxidative stress (Eisert and Schlachetzki, 2008, Sandoval and Witt, 2008, Wardlaw, 
2010, Ueno et al., 2002). SVD characteristic vascular pathology, such as atherosclerosis 
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and abnormal autoregulation, further promote oxygen depletion in the lesion and 
exacerbates the tissue destruction (Wardlaw, 2010). BBB breakdown and the following 
PVS dilation in multiple sclerosis have also been speculated to be related to 
inflammatory response (Wuerfel et al., 2008, Inglese et al., 2005). CADASIL 
characteristic vascular pathology includes sclerosis (vessel wall thickening), impaired 
cerebrovascular tone, chronic hypoperfusion and subcortical infarcts (Stenborg et al., 
2007, Scheid et al., 2006, Coulthard et al., 2000). Thus, hypoxia is undoubtedly 
contributing to the disruption of endothelium structure (Brulin et al., 2002), enlarged 
PVS and related WM damage in CADASIL, but immune response-related inflammation 
may also be involved. Similar to the picture in AD, abnormal deposition of proteins, 
such as mutant N3ECD-containing GOM in arteries, arterioles and capillaries in case of 
Figure 7.1. Proposed pathogenesis in CADASIL. Tight junctions (arrowheads) between 
endothelial cells (EC) form blood-brain barrier (BBB) to protect brain from cytotoxic 
substances, whereas solutes in interstitial fluid (ISF) drain out of brain through perivascular 
drainage pathway driven by vascular tone. Reduced vascular tone, vascular thickening and 
BBB breakdown in CADASIL result in the reduced efficiency of drainage pathway. 
Granular osmiophilic material (GOM) deposits surrounding VSMCs may disrupt ISF 
drainage or cause inflammation, which contribute to perivascular space (PVS) enlargement 
and WM damage. BL, basal lamina; Mac, perivascular macrophage. 
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CADASIL, can activate immune system and cause chronic inflammation (Salminen et 
al., 2009). In fact, we observed weak N3ECD immunoreactivity in the vesicular 
inclusions in granular pericytes, which are known for its capacity to uptake solutes and 
small molecules from ISF and have macrophage-like functions including phagocytosis, 
antigen presentation and prostaglandin production (Thomas, 1999).  The increased 
CD45 immunoreactivity in CADASIL brain and a previous study in our laboratory, 
which found phagocytosis of an electron-dense material – presumably GOM – by a 
macrophage-like cell (unpublished data by Low WC), also point to the involvement of 
immune responses.  
The deposition of GOM, which may trigger immune response, can be closely related to 
the functionality of perivascular drainage pathway. As described in 1.4.3, ISF is cleared 
through the lymphatic drainage route within the capillary/arterial wall driven by 
vascular pulsation (Weller et al., 2009). Impaired vascular reactivity is a characteristic 
feature of CADASIL, possibly caused by Notch3 signalling dysfunction with 
contribution of the accumulation of extracellular matrix proteins, which thicken and 
stiffen the arterial wall(Lacombe et al., 2005, Hussain et al., 2004, Dubroca et al., 
2005a). Vascular dysfunction impedes the clearance of proteins via perivascular 
drainage pathway, resulting in their accumulation within vessel wall and subsequent 
damage to the vessel wall  and then surrounding tissues (PEFA) (Weller et al., 2010). In 
support of the notion, our result demonstrated the correlation between vessel wall 
thickening and PVS enlargement. A good example of PEFA is VSMC-derived Aβ 
deposition within blood vessel wall in AD patients (cerebral amyloid angiopathy). 
There are three main clearance mechanisms of Aβ: protease degradation in the 
parenchyma, absorption into blood by low-density lipoprotein receptor-related protein-1, 
and perivascular drainage (Weller et al., 2008). As the vascular pulsation is reduced and 
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vessel stiffen with age, Aβ42 followed by Aβ40 accumulate along the drainage route, 
forming insoluble fibrillar deposits (Weller et al., 2008). The Aβ deposition alters 
composition of basement membrane, destructs VSMCs and causes fibrinoid necrosis, 
eventually increasing susceptibility to haemorrhage and ischemia (Weller et al., 2008, 
Weller et al., 2010). In fact it was previously suggested to correlate with the increase of 
PVS size and number (Roher et al., 2003). Considering the similarity in protein 
activation between NOTCH and amyloid precursor protein (Wolfe, 2002), it is tempting 
to relate the CADASIL pathology to the same pathogenesis, but a few facts should be 
noted and carefully evaluated. In contrast to fibrillary Aβ deposit, mutant N3ECD is 
confined to a relatively large (0.5-2 μm) granular formation (GOM) without forming 
any clearly-distinguishable structure. Some of GOM even appeared to be partly 
dispersed in ISF, implying it is not a rigid structure. Our result indicated that Jagged1 
and ubiquitin are not present in GOM, but it does not exclude the possibility of other 
proteins entrapped in the structure, which may prevent extreme multimerization of 
mutant N3ECD. The difference in the nature of deposition can result in the difference in 
toxicity, as suggested by the EM observation of Tg mice that the amount of GOM does 
not correlate with VSMC degeneration (Ruchoux et al., 2003). Moreover, the authors 
noted that vascular morphological changes – e.g. increased intracellular dense bodies, 
wider intrasmooth muscle and subendothelial space, and cellular deformation – precede 
the appearance of GOM. Hence, GOM may be a consequence of the reduced vascular 
functionality and its pathogenic significance, if there is any, may rather be in its mass, 
which physically obstructs the ISF drainage and further exacerbates perivascular 
damage. The hypothesis is supported by a study which showed that the mechanical 
obstruction of lymphatic drainage system, by macroadenoma, can cause PVS 
enlargement, which can be improved by  removal of the cause (Cerase et al., 2009). 
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Quantification of N3ECD (GOM) accumulation in relation to PVS enlargement would 
be the best way to test the hypothesis.  
Other implications of our study are a possible intracellular accumulation and scavenging 
activity of mutant N3ECD. A few intracellular immunoreactivities were detected in ER-
like structure in VSMCs, or vesicles in granular pericytes as mentioned earlier. 
Although the result was rather suggestive and not sufficient to conclude the presence of 
N3ECD within those structure, future study using human samples with less tissue 
destruction or Tg mice arteries would be beneficial to support or oppose the ER stress 
hypothesis and the involvement of immune responses in CADASIL. 
7.3 Loss of hippocampal neurons and white matter disconnection 
Neuronal density in the hippocampal formation in CADASIL and COGFAST was 
quantified to elucidate the contribution of hippocampal pathology in cognitive 
dysfunction in those disorders. Several studies have demonstrated decreased neuronal 
density in hippocampus in various dementias including AD and mild cognitive 
impairment whereas two previous studies on sporadic VaD reported opposing results 
(Kril et al., 2002a, Kril et al., 2002b,  arow et al., 2005, G mez-Isla et al., 1996, 
Kordower et al., 2001). Our hypothesis was that CADASIL and COGFAST groups, 
which were both demented at the time of death, would show reduced neuronal density 
in the hippocampal areas, at least in CA1 where the vascular density is the lowest and 
experience severer BBB leakage after ischemia (Schmidt-Kastner and Hossmann, 1988, 
Cavaglia et al., 2001).  
Contrary to the expectation, however, the overall neuronal density in the hippocampus 
and entorhinal cortex of CADASIL was relatively preserved showing only mild (not 
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statistically significant) loss of neurons in CA1 and CA2. It is interesting to compare the 
result with the cognitive profile of CADASIL, which is characterized by executive 
dysfunction with preserved hippocampal functions (e.g. episodic memory) until the later 
stage of the disease (Amberla et al., 2004). The minor neuronal change in the 
hippocampus confirms that the hippocampus is the last to be affected and may suggest 
the minimal involvement of hippocampal dysfunction even when the patients were 
clinically demented. Our results provided quantitative evidence to the observation by 
Viswanathen et al. (2006) who reported an increased number of apoptotic neurons in the 
cerebral cortex and glial cells in WM, but minimal neuronal apoptosis in the 
hippocampus. It is also in accordance with another study, which demonstrated that 
cholinergic axons were relatively spared in the hippocampus, entorhinal cortex and 
temporal neocortex whereas cholinergic denervation is extensive in posterior parietal, 
dorsal frontal, and occipital cortices (Mesulam et al., 2003). It should be noted that the 
majority of the neuronal loss in hippocampus appeared to be selectively of SMI32(+) 
neurons. SMI32, a 200kDa nonphosphorylated neurofilament, is expressed in large 
pyramidal projecting neurons as confirmed by the volume difference between SMI32(+) 
and SMI32(-) neurons in chapter 5. Those SMI32 positive pyramidal neurons are most 
abundantly found in the long association pathway connecting frontal, temporal and 
parietal cortices (Hof et al., 1995). The vulnerability of the SMI32(+) neurons have 
been previously reported in AD and ischemia (Leifer and Kowall, 1993, Bussière et al., 
2003, Thangavel et al., 2008). Our result not only confirmed the vulnerability of these 
pyramidal neurons to ischemic stress but also revealed the difference in the distribution 
of neuronal damage in CADASIL and sporadic VaD: CA1 and CA2 were affected in 
CADASIL while it was ECV in COGFAST. The different patterns of neuronal loss 
could stem from the difference in their pathogenesis, but considering the diverse 
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pathology of COGFAST cases, analysis of larger samples is necessary to determine the 
difference between CADASIL and sporadic VaD.  
The above findings led us to hypothesize that WM disconnection underlies the cognitive 
impairment in CADASIL. The disconnection syndrome is a theory that brain 
dysfunction can be, at least in part, attributed to disrupted associative connections 
between various brain regions by WM abnormality (Catani and Ffytche, 2005). The 
involvement of disconnection in cognitive dysfunction has been suggested in various 
forms of dementia including AD (Collette et al., 2007, Dineen et al., 2009, Stoub et al., 
2006, Kato et al., 2007). Since the spatial distribution of WM hyperintensity in 
CADASIL is rather specific involving anterior temporal poles, frontal lobes, external 
capsules and periventricular WM (Singhal et al., 2005), it is plausible that the 
disconnection of specific WM tracts, either by small infarcts, BBB breakdown or other 
factors discussed in the previous section, causes characteristic cognitive impairment in 
CADASIL. The distribution and severity of axonal damage in CADASIL were assessed 
by quantifying SMI32 immunoreactive axons, which indicate chronic axonal damage 
and degeneration (Lindner et al., 2009). The difference between controls and three 
CADASIL cases were rather striking, with greater number of damaged axon covering a 
larger area of WM in CADASIL whereas controls showed less in a restricted area. The 
affected area appeared to be originated from areas above the ventricle at the level of 
premotor and motor cortices, where small infarcts were found, and spread to frontal and 
parietal lobes. The distribution is consistent with those described in the previous MRI 
studies, which located T2-weighted WM hyperintense lesions in  frontal, parietal and 
temporal lobes (Yousry et al., 1999, Coulthard et al., 2000, Singhal et al., 2005). 
However, in the current study, the significant difference in WM damage was only 
detected in the frontal lobes, where the extent of the damage correlated with the disease 
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duration, compare to controls. It is not only concordant with the observation from MRI 
studies, which showed the increased frequency of T1-weighted hypointensity and T2-
weighted hyperintensity with age (Chabriat et al., 1998), but also the clinical 
observations that CADASIL is characterised with executive dysfunction (Buffon et al., 
2006).  
The distribution and the directionality of the damaged axons suggested the involvement 
of a few tracts; since the SMI32 axonal density in corpus callosum remained minimal, 
SLF and a bundle of fibres passing the internal capsule are the likeliest to be disrupted 
in the two CADASIL cases. SLF connects frontal, parietal, occipital and temporal lobes 
and responsible for associative motor behaviour, special attention and somatosensory 
input (Makris et al., 2005, Schmahmann et al., 2008). The projection fibres in the 
internal capsule includes the pyramidal tracts originating from motor and 
somatosensory cortex and projecting to the brain stem and the spinal cord (Heimer, 
1983).  They would provide a good explanation for the frequently observed ataxia and 
hemiparesis in CADASIL patients as well as some of the cognitive dysfunction (Yousry 
et al., 1999, Chabriat et al., 1995), as disruption of SLF has been linked to dysfunction 
of spacial working memory, verbal task and attention skills (Karlsgodt et al., 2008, Frye 
et al., 2010, Vestergaard et al., 2010) while damage in internal capsule were associated 
with motor deficit (Pendlebury et al., 1999). The result is in agreement with the 
previous reports of cholinergic impairment in motor cortex, parietal and occipital lobes 
(Manganelli et al., 2008, Mesulam et al., 2003). In contrast to the motor areas, axonal 
damage in frontal lobes, which play a major role in executive functions, greatly differed 
between CA1 and CA11, possibly reflecting the severity of executive dysfunction in 
these cases.  
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Taken together, our results and the previous neuroimaging studies (Tatsch et al., 2003, 
Blanco Menéndez et al., 2001) support the hypothesis that cognitive dysfunction in 
CADASIL stem from the disconnection of corticocortical or subcortical-cortical 
network. In future investigations, it would be interesting to evaluate the neuronal 
density in other areas of the brain, for example, frontal cortex (layer III and V) where 
the loss of pyramidal neurons have been reported in AD (Hof et al., 1990, Bussière et al., 
2003). 
7.4 Conclusions 
The experiments in this thesis were designed to establish vascular and related neuronal 
pathology in CADASIL in the hope it would provide clues to elucidate its 
pathophysiology. In this regard, the findings from this study made several contributions 
to the current literature as follows.  
 Chapter 3 investigated the vascular and perivascular changes in CADASIL. The 
newly developed computer programme for the experiment greatly helped to 
improve the accuracy of the analysis and to reduce analysis time, and will be a 
useful tool for future studies examining SI and PVS. The quantitative data revealed 
extensive wall thickening and PVS enlargement in CADASIL, which were shown 
to be closely related to each other. The finding suggested either that vascular 
thickening contribute to the perivascular tissue destruction or that same factor 
underlies their pathogenesis.  
 Chapter 4 was dedicated to the examination of another CADASIL characteristic 
vascular pathology, GOM deposition. We demonstrated the presence of N3ECD 
within GOM in the wall of cerebral arteries, arterioles as well as capillaries in 
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postmortem brain tissues, providing strong support for a previous study by Ishiko et 
al., which reported N3ECD in GOM using skin biopsy samples (Ishiko et al., 2006). 
In addition, we found weak intracellular N3ECD immunoreactivities in the ER-like 
structures in VSMCs and vesicular inclusions in pericytes for the first time. 
Together with the increased CD45 immunoreactivity in the WM of CADASIL 
brains, the results of EM provided important implications for future studies: 
involvement of ER stress and inflammation/immune response in CADASIL 
pathogenesis.  
 Chapter 5 evaluated neuronal density in the hippocampal formation, which is often 
decreased in various forms of dementias, in CADASIL and sporadic VaD using a 
3D stereological method. Unexpectedly, overall neuronal density in hippocampal 
formation (CA1, CA2, ECV) were relatively preserved in CADASIL though minor 
loss of neurons were observed with preference to pyramidal projecting neurons. 
The result led to a hypothesis that the cognitive impairment in CADASIL is rather 
due to the disrupted corticocortical connectivity than hippocampal dysfunction, 
which is also in line with its executive dysfunction. 
 The following chapter 6 therefore assessed the distribution and severity of axonal 
damage in CADASIL using the newest stereological method that enables unbiased 
length density estimation without complicated random tissue sectioning. WM tracts 
were severely damaged especially in the frontal lobes of CADASIL. The density of 
damaged axon significantly correlated with disease duration in frontal and parietal 
lobes, suggesting that the disrupted connectivity of frontal lobes from other areas of 
the brain is the cause of executive dysfunction, slow processing speed and memory 
retrieval impairment in CADASIL.  
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Collectively, the present project revealed a close relationship between vascular 
pathology and neuronal/axonal damage, which underlies the cognitive impairment in 
CADASIL. This research has also thrown up many questions in need of further 
investigation as described in detail in the following section.  
7.5 Future directions 
7.5.1 N3ECD-GOM deposition 
The present study demonstrated the presence of N3ECD but not Jagged1 and ubiquitin 
in GOM. Moreover, we found possible involvement of ER stress and inflammation in 
the pathogenesis of CADASIL. An issue that was not addressed in this study was the 
relationship between N3ECD accumulation, inflammatory response and WM damage 
(PVS enlargement). Future research should therefore concentrate on the following 
topics to elucidate the mechanism of how vascular pathology leads to WM pathology.  
 10 μm brain tissue sections double stained with A1-1 antibody and CD45 (or other 
inflammatory cell-related antigen) antibody are used for the study. The amount of 
GOM deposition is measured as the density of N3ECD immunoreactivity per vessel 
and compared with the number of CD45-positive perivascular cells and the size of 
PVS to evaluate the relationships between N3ECD accumulation, 
inflammation/immune response and PVS enlargement.  
 The suggested intracellular N3ECD accumulation should be re-examined using 
more human and mutant NOTCH3 Tg mice samples to confirm the accumulation in 
ER and phagocytosis by pericytes. We have stained Tg mice (R91C, equivalent of 
human R90C) brains with N3ECD antibody, which showed little staining in the 
cerebral vasculature. On the basis of the fact that tail arteries show severer vascular 
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pathology (Ruchoux et al., 2003), it may be better to include tail samples in 
addition to brain tissues.  
 More information on the components of GOM would also help us to elucidate the 
mechanism in its formation. The distribution and amount of Notch3 related proteins 
other than Jagged1 and ubiquitin need to be examined. The list of proteins includes 
Notch ligands (e.g. Jagged 2, Delta 1-4 and YB-1) (Rauen et al., 2009, Kopan and 
Ilagan, 2009), exosome markers (e.g. heat shock protein 8 and CD63) (Mathivanan 
and Simpson, 2009) and molecular chaperons.  
7.5.2 Neuronal density in the frontal and parietal lobes 
The results of this study indicated that the neuronal densities in the hippocampal 
formation are relatively preserved and that frontal-parietal connection is disrupted in 
CADASIL. It is therefore important to quantify the neuronal density, especially of 
pyramidal neurons, using the same experimental set up as in chapter 5. The regions of 
interest include prefrontal (BA9) and parietal cortices (BA39/40), which play important 
roles in executive functions and episodic memory retrieval (Wagner et al., 2005, Chayer 
and Freedman, 2001).  
7.5.3 Notch3 signalling activity in the mutant NOTCH3 transfected cells 
Due to the time constraint, cell-culture study on the Notch3 signalling activity under 
stress was not completed. The working hypothesis was that Notch3 signalling show 
defects when VSMCs are under a stressful environment, such as hypoxia/ischemia. The 
study was design to incubate mutant NOTCH3-transfected VSMCs in hypoxic 
environment achieved by AnaeroPack for cell culture (Mitsubishi Gas Chemical Co., 
Tokyo, Japan) and analyze morphological and protein expression changes using 
fluorescent immunocytochemistry and Western blotting. So far, HA-tagged plasmid 
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DNA (NOTCH3 wildtype, R90C, R133C, and R449C) were constructed and 
transfection methods were tested. Human primary VSMC were transfected with the 
NOTCH3 plasmid using FuGENE® HD Transfection Reagent (Roche Applied Science, 
Cat. No. 04709691001) and Nucleofector
TM
 Kits for Primary Smooth Muscle Cells 
(amaxa), but both methods yielded less than 5% transfection rate even with β-
galactosidase control vector. A possible explanation for the low transfection rate is that 
primary VSMCs are sensitive to insults and resulting in cell death. A collaborating 
laboratory faced same problem with a VSMC cell line (personal communication) and 
thus it is recommended to use either viral vectors or other cell lines. 
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Appendix 
The following sections contain the source code of the computer programmes designed 
and used for analysis in chapter 3 and 6. VasCalc measures Dint, Dext and Dpvs of 
blood vessels and estimates SI, Vwall and PVSc. Axocounter is a programme to 
calculate the density of linear objects from their length and number. 
I. VasCalc main source code 
Public ImageName As String 
Public CalF As Double '1um = xxx pixel 
Public Dint(LineNo - 1) As Double 
Public Dext(LineNo - 1) As Double 
Public Dpvs(LineNo - 1) As Double 
Public mDint As Double 
Public mDext As Double 
Public mDpvs As Double 
Public SI As Double 
Public LArea As Double 
Public VArea As Double 
Public PvsArea As Double 
Public LineNo As Integer 'number of lines used to measure diameter 
Public Counter As Integer 'Mouse click counter 
Private PicWidth As Integer  'width of pictureboc 
Private PicHeight As Integer 'height of pictureboc 
Private DrawLineStart As Boolean 'Line drawing mode control 
Private CalibMode As Boolean 'Calibration mode control 
Private CalibLength As Double 
Private pStart(Counter - 1) As Point 'The position where the mouse button went 'down'. 
Private pStop(Counter - 1) As Point 'The position where the mouse button went 'up'. 
Private pCurr As New Point 'The current mouse location to make the shape appear to follow the mouse cursor. 
Private centerp As Point 
Private Lastline As Boolean 
 
Private Sub btnSI_Click(ByVal sender As System.Object, ByVal e As System.EventArgs) Handles btnSI.Click 
        If btnSI.Text = "SI PVS" Then 
            DrawLineStart = True 
            Me.PicBox.Cursor = Cursors.Cross 
 
            LineNo = nudLine.Value 
            Counter = 0 
 
            cmbSetting.Enabled = False 
            cmbCalib.Enabled = False 
            nudLine.Enabled = False 
 
            'button controls 
            btnSave.Enabled = False 
            btnSaveAs.Enabled = False 
            btnSetDelete.Enabled = False 
            btnNewCalib.Enabled = False 
            btnDelCalib.Enabled = False 
            btnOpen.Enabled = False 
 
            'disable SIPVS button till line-drawing finishes 
            btnSI.Enabled = False 
            btnSI.Text = "Dint OK" 
            btnUndo.Enabled = True 
            btnAbort.Enabled = True 
            txtInstruction.Text = "Analysing '" & ImageName & ".' Measure the internal diameters of a blood  
  vessel (Dint)." 
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            ReDim pStart(0) 
            ReDim pStop(0) 
            ReDim Dint(LineNo - 1) 
            ReDim Dext(LineNo - 1) 
            ReDim Dpvs(LineNo - 1) 
 
        ElseIf btnSI.Text = "Dint OK" Then 'If pressed after measuring Dint 
            
  'Calculate each line length and mean internal diameter 
            For i = 0 To LineNo - 1 'in micron 
                Dint(i) = Math.Sqrt((pStop(i).X - pStart(i).X) ^ 2 + (pStop(i).Y - pStart(i).Y) ^ 2) / CalF 
            Next 
 
            Me.PicBox.Cursor = Cursors.Cross 
 
            'mean calculation 
            Dim sum As Double 
            For Each item As Double In Dint 
                sum += item 
            Next 
            mDint = sum / LineNo 'Mean internal diameter 
 
            'Disable the SIPVS button till line-drawing finishes 
            btnSI.Enabled = False 
            btnSI.Text = "Dext OK" 
            txtInstruction.Text = "Analysing '" & ImageName & ".' Measure the external diameters of the  blood 
   vessel (Dext)." 
 
            Counter = 0 
            ReDim pStart(0) 
            ReDim pStop(0) 
            PicBox.Refresh() 
 
        ElseIf btnSI.Text = "Dext OK" Then 'If pressed after measuring Dext 
            'Calculate each line length and mean external diameter 
            For i = 0 To LineNo - 1 'in micron 
                Dext(i) = Math.Sqrt((pStop(i).X - pStart(i).X) ^ 2 + (pStop(i).Y - pStart(i).Y) ^ 2) / CalF 
            Next 
 
            Me.PicBox.Cursor = Cursors.Cross 
 
            'mean calculation 
            Dim sum As Double 
            For Each item As Double In Dext 
                sum += item 
            Next 
            mDext = sum / LineNo 'Mean external diameter 
 
            'Disable the SIPVS button till line-drawing finishes 
            btnSI.Enabled = False 
            btnSI.Text = "Dpvs OK" 
            txtInstruction.Text = "Analysing '" & ImageName & ".' Measure the diameters of the perivascular  
  spaces (Dpvs)." 
 
            Counter = 0 
            ReDim pStart(0) 
            ReDim pStop(0) 
            PicBox.Refresh() 
 
        Else 
            'Calculate each line length and mean perivascular space diameter 
            For i = 0 To LineNo - 1 'in micron 
                Dpvs(i) = Math.Sqrt((pStop(i).X - pStart(i).X) ^ 2 + (pStop(i).Y - pStart(i).Y) ^ 2) / CalF 
            Next 
 
            'Mean calculation 
            Dim sum As Double 
            For Each item As Double In Dpvs 
                sum += item 
            Next 
 
            mDpvs = sum / LineNo 'Mean internal diameter 
 
            'Disable the SIPVS button till line-drawing finishes 
            btnSI.Text = "SI PVS" 
            txtInstruction.Text = "'" & ImageName & "' loaded: Start Analysis." 
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            Counter = 0 
            ReDim pStart(0) 
            ReDim pStop(0) 
            PicBox.Refresh() 
 
            '**********Calculate SI 
            SI = 1 - (mDint / mDext) 
            LArea = Math.PI * (mDint / 2) ^ 2 
            VArea = Math.PI * (mDext / 2) ^ 2 - LArea 
            PvsArea = Math.PI * ((mDpvs / 2) ^ 2 - (mDext / 2) ^ 2) 
 
            'Open a result window. 
            If Result.ResultLoaded = True Then 
                Result.DataShow() 
                Result.Visible = True 
            Else 
                Result.Show() 
            End If 
 
            DrawLineStart = False 
            Me.PicBox.Cursor = Cursors.Default() 
 
            cmbSetting.Enabled = True 
            cmbCalib.Enabled = True 
            nudLine.Enabled = True 
 
            'Button controls 
            btnSave.Enabled = True 
            btnSaveAs.Enabled = True 
            btnSetDelete.Enabled = True 
            btnNewCalib.Enabled = True 
            btnDelCalib.Enabled = True 
            btnOpen.Enabled = True             
            btnUndo.Enabled = False 
            btnAbort.Enabled = False 
            btnResult.Enabled = True 
            btnSI.Focus() 
        End If 
    End Sub 
  
    '**************** Drawing tool macros *************** 
     
    Private Sub PicBox_MouseDown(ByVal sender As Object, ByVal e AsSystem.Windows.Forms. 
    MouseEventArgs) Handles PicBox.MouseDown 
 
       'If the drawing mode is on 
        If DrawLineStart = True Or CalibMode = True Then 
            If DrawLineStart = True Then 
                If Counter = LineNo Then 'Drawing mode end point 
                    Lastline = True 
                    Exit Sub 
                End If 
 
                Counter = Counter + 1 
                If Counter = 1 Then 
                    btnUndo.Enabled = True 
                    centerp.X = 0 
                    centerp.Y = 0 
                End If 
 
                'Redefine the array 
                ReDim Preserve pStart(Counter - 1) 
                ReDim Preserve pStop(Counter - 1) 
            End If 
 
            If CalibMode = True Then 
                Counter = 1 
                ReDim pStart(Counter - 1) 
                ReDim pStop(Counter - 1) 
            End If 
 
            pStop(Counter - 1).X = 0 
            pStop(Counter - 1).Y = 0 
 
            ' Save the mouse's start postition 
            If e.X < 0 Then 
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                pStart(Counter - 1).X = 0 
            ElseIf e.X > PicWidth Then 
                pStart(Counter - 1).X = PicWidth 
            Else 
                pStart(Counter - 1).X = e.X 
            End If 
 
            If e.Y < 0 Then 
                pStart(Counter - 1).Y = 0 
            ElseIf e.Y > PicHeight Then 
                pStart(Counter - 1).Y = PicHeight 
            Else 
                pStart(Counter - 1).Y = e.Y 
            End If 
 
            'Save the current location for the immediate drawing 
            pCurr = pStart(Counter - 1) 
        End If 
 
        Me.Invalidate() 
    End Sub 
 
    Private Sub PicBox_MouseMove(ByVal sender As Object, ByVal e As System.Windows.Forms. 
    MouseEventArgs) Handles PicBox.MouseMove 
        If Counter > 0 Then 
            If Lastline = True Then 
                Exit Sub 
            End If 
            'If mouse down outside the PicBox and mousemove inside the PicBox 
            If Counter = 0 Then 
                Exit Sub 
            End If 
 
            'If the drawing mode is on, set the current location, and force the redraw. 
            If Me.DrawLineStart = True Or CalibMode = True Then 
                If Not pStart(Counter - 1) = Nothing Then 
                    ' Save the current location for the immediate drawing 
                    If e.X < 0 Then 
                        pCurr.X = 0 
                    ElseIf e.X > PicWidth Then 
                        pCurr.X = PicWidth 
                    Else 
                        pCurr.X = e.X 
                    End If 
 
                    If e.Y < 0 Then 
                        pCurr.Y = 0 
                    ElseIf e.Y > PicHeight Then 
                        pCurr.Y = PicHeight 
                    Else 
                        pCurr.Y = e.Y 
                    End If 
. 
                    Me.Invalidate() 
                End If 
            End If 
        End If 
    End Sub 
 
    Private Sub PicBox_MouseUp(ByVal sender As Object, ByVal e As System.Windows.Forms. 
    MouseEventArgs) Handles PicBox.MouseUp 
 
        If DrawLineStart = True Or CalibMode = True Then 
            If DrawLineStart = True Then 
                If Lastline = True Then 
                    Exit Sub 
                End If 
            End If 
 
            'If mouse down outside the PicBox and up inside the PicBox 
            If Counter = 0 Then 
                Exit Sub 
            End If 
 
            ' Save the mouse's End postition 
            If e.X < 0 Then 
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                pStop(Counter - 1).X = 0 
            ElseIf e.X > PicWidth Then 
                pStop(Counter - 1).X = PicWidth 
            Else 
                pStop(Counter - 1).X = e.X 
            End If 
 
            If e.Y < 0 Then 
                pStop(Counter - 1).Y = 0 
            ElseIf e.Y > PicHeight Then 
                pStop(Counter - 1).Y = PicHeight 
            Else 
                pStop(Counter - 1).Y = e.Y 
            End If 
 
            'Invalidate and for the paint method to be called. 
            Me.Invalidate() 
 
            If DrawLineStart = True Then 
 
                'If first line 
                If Counter = 1 Then 
                    Dim xlength As Integer = Math.Round(Math.Sqrt((pStart(0).X - pStop(0).X) ^ 2) / 2) 
       'Calculate the center point 
                    Dim ylength As Integer = Math.Round(Math.Sqrt((pStart(0).Y - pStop(0).Y) ^ 2) / 2) 
 
                    If pStart(0).X > pStop(0).X Then 
                        centerp.X = pStop(0).X + xlength 
                    Else 
                        centerp.X = pStart(0).X + xlength 
                    End If 
 
                    If pStart(0).Y > pStop(0).Y Then 
                        centerp.Y = pStop(0).Y + ylength 
                    Else 
                        centerp.Y = pStart(0).Y + ylength 
                    End If 
                End If 
 
                'If all the lines were drawn, stop drawing 
                If Counter = LineNo Then 
                    Me.PicBox.Cursor = Cursors.Default                     
                    btnSI.Enabled = True 
                    btnSI.Focus() 
                    Exit Sub 
                End If 
 
                btnUndo.Focus() 
            End If 
 
            If CalibMode = True Then 
                If Counter = 1 Then 
                    btnNewCalib.Enabled = True 
                    btnNewCalib.Focus() 
                End If 
            End If 
 
            PicBox.Refresh() 
        End If 
    End Sub 
 
    Private Sub PicBox_Paint(ByVal sender As Object, ByVal e As System.Windows.Forms. 
    PaintEventArgs) Handles PicBox.Paint 
        Dim g As Graphics = e.Graphics 
        '***************Draw line mode 
        If DrawLineStart = True Or CalibMode = True Then 
            If Counter > 0 Then 
                Dim pts() As Point =  
 
                Using cap_path As New Drawing2D.GraphicsPath 
                    cap_path.AddLines(pts) 
 
                    Using LineCap As New Drawing2D.CustomLineCap(Nothing, cap_path) 
                        Dim Pen As New Pen(Color.GreenYellow) 
                        Pen.Width = 3 
                        Dim PenwCap As New Pen(Brushes.GreenYellow) 
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                        PenwCap.CustomStartCap = LineCap 
                        PenwCap.CustomEndCap = LineCap 
 
                        If DrawLineStart = True Then 
                            PenwCap.Width = 1 
                        ElseIf CalibMode = True Then 
                            PenwCap.Width = 2 
                        End If 
 
                        Using Pen 
                            If pStop(Counter - 1).X = 0 And pStop(Counter - 1).Y = 0 Then 'While still drawing 
                               g.DrawLine(PenwCap, pStart(Counter - 1).X, pStart(Counter - 1).Y, pCurr.X,  
   pCurr.Y) 
 
                                For i = 0 To Counter - 2 
                                    g.DrawLine(Pen, pStart(i).X, pStart(i).Y, pStop(i).X, pStop(i).Y) 
                                Next 
                            Else 'drawing stopped 
                                For i = 0 To Counter - 1 
                                    g.DrawLine(Pen, pStart(i).X, pStart(i).Y, pStop(i).X, pStop(i).Y) 
                                Next 
                            End If 
                        End Using 
 
                        'Display centre point 
                        If Counter > 0 Then 
                            If CalibMode = False Then 
                                Dim Pen2 As New Pen(Color.Cyan) 
                                Pen2.Width = 2 
                                Using Pen 
                                    g.DrawLine(Pen2, centerp.X - 4, centerp.Y, centerp.X + 4, centerp.Y) 
                                    g.DrawLine(Pen2, centerp.X, centerp.Y - 4, centerp.X, centerp.Y + 4) 
                                End Using                              
                            End If 
                        End If 
                    End Using 
                End Using 
            Else 
                Exit Sub 
            End If 
        End If 
    End Sub 
 
I. AxoCounter main source code 
Private Sub btnAngle_Click(ByVal sender As System.Object, ByVal e As System.EventArgs) Handles 
btnAngle.Click 
        If btnAngle.Text = "Measure mL" Then 
            '***************************Define Thickness  
            Thickness = txtT.Text 
            '******************************** 
 
            'Activate line drawing mode, change cursor, disable angle button 
            DrawLineStart = True 
            Lastpoint = False 
            Me.PicBox.Cursor = Cursors.Cross             
            btnAngle.Text = "Calc Angle" 
            btnAngle.Enabled = False             
            btnUndoLine.Enabled = True 
            btnStart.Enabled = False 'Disable start button to avoid error 
            DeleteToolStripMenuItem.Enabled = False 
            lblInstruction.Text = "Draw 10 lines over randomly-selected axons. Press 'Calc Angle' when finished." 
            txtmL.Text = "" 
            txtAngle.Text = "" 
            txtW.Text = "" 
            cmbSetting.Enabled = False 
            txtT.Enabled = False 
            txtMag.Enabled = False 
            nudSn.Enabled = False 
            W = 0 
            ReDim pStart(0) 
            ReDim pStop(0) 
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        Else 'If pressed after drawing 10 mL lines 
            'Calculate mL, angle and W 
            Dim Length(9) As Double 
            For i = 0 To 9 
                Length(i) = Math.Sqrt((pStop(i).X - pStart(i).X) ^ 2 + (pStop(i).Y - pStart(i).Y) ^ 2) 
            Next 
 
            'mL calculation 
            Dim sum As Double 
            For Each item As Double In Length 
                sum += item 
            Next 
 
            mL = sum / 10 
            txtmL.Text = Math.Round(mL / CalF, 3) 
 
            'Radian calculation  
            Dim Radian As Double 
            If mL > PicWidth - 10 Then 'If cutting plane is parallel to the axonal tract 
                MsgBox("Is cutting angle 0 degree?", MsgBoxStyle.YesNo) 
                If MsgBoxResult.Yes Then 
                    Radian = 0 
                    txtAngle.Text = 0 
                Else 
                    GoTo RadianDef 
                End If 
 
            Else 
                '*********************************************** 
RadianDef:      Radian = Math.Atan(Thickness * CalF / mL) 
                '*********************************************** 
                txtAngle.Text = Math.Round(180 * Radian / Math.PI, 2) 
            End If 
 
            If Radian = 0 Then 'If cutting plane is parallel to the axonal tract, use couting line rather than frame 
                W = 1 
                txtW.Text = 1 
            Else 
                'W calculation 
                '******************* Obtain a public variable Sampling width (W) in pixel 
                W = Thickness * CalF / Math.Sin(Radian) 
                '************************************************************** 
                txtW.Text = Math.Round(W / CalF, 3) 
            End If 
 
            'Delete all the mL lines, reset all the variables 
            Array.Clear(pStart, 0, 10) 
            Array.Clear(pStop, 0, 10) 
            Counter = 0 
            Lastpoint = False 
            DrawLineStart = False 
            btnAngle.Text = "Measure mL" 
            btnStart.Enabled = True 
            btnUndoLine.Enabled = False 
            cmbSetting.Enabled = True 
            txtT.Enabled = True 
            txtMag.Enabled = True 
            nudSn.Enabled = True 
            DeleteToolStripMenuItem.Enabled = True 
            lblInstruction.Text = "Click 'Start Experiment' to start counting." 
            btnStart.Focus() 
            PicBox.Refresh() 
        End If 
    End Sub 
 
Private Sub btnStart_Click(ByVal sender As System.Object, ByVal e As System.EventArgs) Handles btnStart.Click 
        If btnStart.Text = "Start Experiment" Then 
            'Disable lad image 
            OpenImageToolStripMenuItem.Enabled = False 
            DeleteToolStripMenuItem.Enabled = False 
            Sn = nudSn.Value 
            btnStart.Text = "ROI OK" 
            btnStart.Enabled = False 
            btnAngle.Enabled = False 
            btnUndoLine.Enabled = False 
            btnAddM.Enabled = False 
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            btnDelM.Enabled = False 
            btnReset.Enabled = True 
            txtT.Enabled = False 
            txtMag.Enabled = False 
            nudSn.Enabled = False 
            'disble seting combo box 
            cmbSetting.Enabled = False 
            lblInstruction.Text = "Define region of interest." 
 
            'Clear previous arrays  
            ReDim ArrM1C(0) 
            ReDim ArrM1D(0) 
 
            'Draw rectangle to define ROI 
            DrawLineStart = True 
            Rectangle = True 'Draw rectangle mode ON 
            Me.PicBox.Cursor = Cursors.Cross 
 
        ElseIf btnStart.Text = "ROI OK" Then 'ROI defined 
            'If valid ROI not drawn 
            If Rheight < 10 Or Rwidth < 0 Then 
                MsgBox("Define valid ROI") 
                Exit Sub 
            End If 
 
            Rectangle = False 'Draw rectangle mode OFF 
            Marker = True 'Draw marker mode ON 
            Me.PicBox.Cursor = Cursors.Default 
            btnStart.Text = "End Experiment" 
            btnStart.Enabled = False 
            lblInstruction.Text = "Press Next to move to the next frame." 
 
            'Marker buttons enable 
            If btnMark1.Text <> "" Then 
                btnMark1.Enabled = True 
                Mc1 = 0 
                M1 = True 'Activate marker 1 
            End If 
 
            Counter = 1 'Sampling frame number 
 
            '********************************************  Calculate Area 
            Area = Thickness * (Rheight - 10) / CalF 'Area in um2 
            '************************************************************* 
 
            'Define sampling frame top left position. Take gurd volum of 5 pixels 
            If (Rwidth - 10) / Sn > W Then 'Sampling frames do not overlap 
                'Draw first sampling frame 
                Sframe.X = Math.Round(ROIStart.X + (Rwidth - 10) / (2 * Sn) - W / 2 + 5, 0) 
                Sframe.Y = ROIStart.Y + 5 
 
            Else 'Sampling frames overlap 
                OL = (Sn * W - Rwidth + 10) / (Sn - 1) 'Overlap width 
                If OL > W / 3 Then 'If counting frames overlat more than 1/3 of frame width 
                    Dim dlg As DialogResult = MsgBox("Too many sampling number." & vbCrLf & "Recommended Sn = " &  
    Int((3 * Rwidth - W) / (2 * W)) & "." & vbCrLf & "Proceed anyway?", MsgBoxStyle.YesNo) 
 
                    If dlg = MsgBoxResult.Yes Then 
                        GoTo OLposition 
 
                    Else 'reset start button. Ask user to change sampling number 
                        Marker = False 
                        DrawLineStart = False                         
                        btnStart.Text = "Start Experiment" 
                        btnStart.Enabled = True                         
                        btnAngle.Enabled = True 
                        nudSn.Enabled = True 
                        'clear ROI position 
                        Erase pStart 
                        Erase pStop 
                        ReDim pStart(1) 
                        pStart(0).X = 0 
                        pStart(0).Y = 0 
                        PicBox.Refresh() 
                        lblInstruction.Text = "Reduce sampling number." 
                        nudSn.Focus() 
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                        Exit Sub 
                    End If 
                End If 
OLposition: 
                Sframe.X = ROIStart.X + 5 
                Sframe.Y = ROIStart.Y + 5 
            End If 
 
            If Sn = 1 Then 'If sampling number is 1 
                btnStart.Enabled = True 
                btnStart.Focus() 
            Else 'If more than one, enable next button 
                btnNext.Enabled = True 
                btnNext.Focus() 
            End If 
            PicBox.Refresh() 
 
        Else 'If the end of the experiment 
            'Store counts, clear current mark counts display and marks, reset mark counter  
            CountStorage() 
 
            'Deactivate marker mode (all the shapes are deleted) 
            Marker = False 
            DrawLineStart = False 
            PicBox.Refresh() 
 
            'Calculate the mean density etc 
            For i = 0 To Sn - 1 
                ReDim Preserve ArrM1D(Sn - 1) 
                ArrM1D(i) = ArrM1C(i) / Area 'Mean density of marker 1 axons (/um2) 
            Next 
 
            'Reset counter 
            Counter = 0 
            M1 = False 
            'Clear counts 
            lblC1.Text = "" 
            lblMC1.Text = "" 
             
            'disable buttons 
            btnUndo.Enabled = False 
            btnClear.Enabled = False 
            btnReset.Enabled = False 
            btnAngle.Enabled = True             
            btnAddM.Enabled = True 
            btnDelM.Enabled = True 
            cmbSetting.Enabled = True 
            txtT.Enabled = True 
            txtMag.Enabled = True 
            nudSn.Enabled = True 
            btnStart.Text = "Start Experiment" 
            lblInstruction.Text = "Load next image and press 'Measure mL'" 
 
            'Enable load image and delete setting 
            OpenImageToolStripMenuItem.Enabled = True 
            DeleteToolStripMenuItem.Enabled = True 
 
            'Open result window. 
            If Result.ResultLoaded = True Then 
                Result.DataShow() 
                Result.Visible = True 
            Else 
                Result.Show() 
            End If 
        End If 
    End Sub 
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